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In December 1990, the U.S. Food and Drug Administration (FDA) approved 
Norplant, the first subdermal implantable contraceptive device ever manufactured. 
Norplant consisted of six thin, silicone rubber rods that were surgically inserted under the 
skin of a woman’s arm, slowly releasing hormones to prevent pregnancies for up to five 
years. Many people in the United States celebrated its approval, including some feminists 
and doctors. They believed new contraceptive research would afford women greater 
reproductive control and additional freedoms. But feminists in Bangladesh, Brazil, and 
Egypt had been claiming that the drug’s testing trials were unethical, and that Norplant 
was unsafe. They warned U.S. activists about these dangers and within months, their 
predictions came to fruition. Judges, lawmakers, and community leaders pressured poor 
and minority women to use Norplant and many claimed they experienced terrible side 
effects from the drug. After U.S. women’s health activists mobilized on patients’ behalf, 
class action lawyers took notice and filed 200 lawsuits against Norplant’s manufacturer 
on behalf of fifty thousand women. Just twelve years after its FDA approval, Norplant 
was removed from the American market. This dissertation investigates the many 
historical constructions that defined Norplant from its development in the 1960s to its 
downfall.  
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CHAPTER I 
 INTRODUCTION 
 
 
In December 1990, the U.S. Food and Drug Administration (FDA) approved 
Norplant, the first subdermal implantable contraceptive device ever manufactured. 
Norplant consisted of six thin, silicone rubber rods that were surgically inserted under the 
skin of a woman’s arm, slowly releasing hormones to prevent pregnancies for up to five 
years. Many people in the United States celebrated its approval, including some feminists 
and doctors. They believed new contraceptive research would afford women greater 
reproductive control and additional freedoms. But feminists in Bangladesh, Brazil, and 
Egypt had been claiming that the drug’s testing trials were unethical, and that Norplant 
was unsafe. They warned U.S. activists about these dangers and within months, their 
predictions came to fruition. Judges, lawmakers, and community leaders pressured poor 
and minority women to use Norplant and many claimed they experienced terrible side 
effects from the drug. After U.S. women’s health activists mobilized on patients’ behalf, 
class action lawyers took notice and filed 200 lawsuits against Norplant’s manufacturer 
on behalf of fifty thousand women. Just twelve years after its FDA approval, Norplant 
was removed from the American market.  
This dissertation investigates the many historical constructions that defined 
Norplant from its development in the 1960s to its demise in 2002. During the course of 
Norplant’s existence, an array of people and institutions used the drug to push their
 
 
 
 
2 
agendas and ideologies. Some policymakers and international non-governmental 
organizations saw it as a way to exert control over minority populations and prevent 
“overpopulation,” particularly in the Global South. Many feminists considered Norplant 
to be a harmful tool that could potentially be used to sterilize poor and minority women. 
Feminists used their critiques to advocate for greater control over their bodies. A group of 
class action lawyers saw Norplant as a way to earn a profit. Through my examinations of 
Norplant’s history, I demonstrate how the contraceptive implant’s meaning changed over 
time and often took on multiple meanings all at once.  
In this dissertation, I consider any instance in which a woman was forced, 
pressured, or incentivized to use Norplant by a government authority or medical 
professional a form of coercion. There are many different forms of coercion and the 
coercive efforts examined in the following chapters range in severity from threats of 
violence to monetary incentives. While noting these different levels of coercion is 
essential, each incident demonstrates how state authorities and non-governmental 
institutions, such as the Population Council, sought in various ways to use Norplant to 
control women’s reproduction, particularly poor women living in the Global South and 
women of color and indigenous women in the U.S.1    
The first plans for Norplant emerged in the 1960s, when Dr. Sheldon J. Segal, an 
embryologist, worked with a team to invent the technology that made the implant 
possible. A long-time advocate of effective and affordable contraception, Segal 
 
1 Mark Haugaard and Howard H. Lentner ed., Hegemony and Power: Consensus and Coercion in 
Contemporary Politics, (Lanham: Lexington Books, 2006); Scott A. Anderson, “The Enforcement 
Approach to Coercion,” Journal of Ethics and Social Philosophy (2010). 
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considered Norplant the greatest advancement in contraception since the birth control 
pill, which was FDA approved in 1960. The Population Council, a New York-based non-
governmental organization (NGO) with associates around the globe, financed the 
development and testing of Norplant. This organization promoted “population control” as 
the answer to reducing global poverty and focused on developing contraception for poor, 
uneducated women, especially in impoverished nations.2  
Population control was a postwar expression of eugenics, a pseudo-science that 
encouraged the sterilization of individuals who society deemed “unfit” in order to 
improve humanity. In the late nineteenth and early twentieth centuries, scientists and 
politicians viewed eugenics as a legitimate science dedicated to improving the human 
race. Eugenicists argued that undesirable traits, like alcoholism and feeblemindedness, 
could be passed down from parent to child, and they considered the sterilization of 
individuals marked “unfit” to be humane acts. Doctors deemed the medical procedure to 
be safe, simple, and nearly painless. The state and the medical community celebrated the 
doctors performing the surgical sterilizations for preventing the birth of individuals who 
would be “burdens” upon society.3 Assuming that eugenics was an accredited science, 
 
2 Dorothy Roberts, Killing the Black Body: Race, Reproduction, and the Meaning of Liberty. (New 
York:  Pantheon Books: A Division of Random House, Inc., 1997), 139; Elizabeth Siegel Watkins, “From 
Breakthrough to Bust: The Brief Life of Norplant, the Contraceptive Implant,” Journal of Women's History 
22:3 (2010); Linda Everett, “The Population Council: from eugenics to Norplant,” Executive Intelligence 
Review 20: 19 (May 14, 1993): 23, accessed on July 3, 2019, 
https://larouchepub.com/eiw/public/1993/eirv20n19-19930514/eirv20n19-19930514_023-
the_population_council_from_euge.pdf; Laura J. Frost and Michael B. Reich. Access: How do Good 
Health Technologies Get to Poor People in Poor Countries, (Cambridge: The Harvard Center for 
Population and Development Studies, 2008). 
3 Harry Bruinius, Better for all the World: The Secret History of Forced Sterilization and America’s Quest 
for Radical Purity, (New York: Alfred A. Knopf, 2006), 4. 
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state-run eugenics boards justified thousands of sterilizations, the majority of which were 
aimed at minority women, including African American, Native, and Latinas. But the 
eugenicists’ reputation was denigrated when Nazis used eugenics to warrant the atrocities 
they performed during the Holocaust. Following the war, society determined that 
eugenics was not a reputable science.4 
Following World War II, scientists and political leaders no longer used the term 
“eugenics,” but the practice of forcibly sterilizing populations considered undesirable 
continued. Under the guise of population control and family planning, the U.S. 
government and international NGOs continued to sterilize susceptible communities. For 
instance, as late as the 1970s, some healthcare practitioners coercively and permanently 
sterilized poor women of color and indigenous women, often shortly after they gave 
birth. In some cases, doctors and nurses convinced patients to consent to the practice (and 
sign forms) in the midst of labor. Many non-English speaking patients were given 
informative pamphlets and counseling about sterilization only in English.5  
 
4 Randall Hansen, and Desmond King, Sterilized by the State: Eugenics, Race, and the Population Scare in 
Twentieth-Century North America, (New York: Cambridge University Press, 2013); Wendy Kline, 
Building a Better Race: Gender, Sexuality, and Eugenics from the Turn of the Century to the Baby Boom, 
(Berkeley: University of California Press, 2001); Rebecca M. Kluchin, Fit to be Tied: Sterilization and 
Reproductive Rights in America, 1950-1980, (New Brunswick: Rutgers University Press, 2009); Nancy 
Ordover, American Eugenics: Race, Queer Anatomy, and the Science of Nationalism, (Minneapolis: 
University of Minnesota Press, 2003); Bruinius, Better for all the World, 2006); Joanna Schoen, Choice 
and Coercion: Birth Control, Sterilization, and Abortion in Public Health and Welfare, (Chapel Hill: UNC 
Press, 2005); Angela Franks, Margaret Sanger’s Eugenic Legacy: The Control of Female Fertility, 
(Jefferson, NC: McFarland & Company, Inc., Publishers, 2005); Paul A. Lombardo, ed. A Century of 
Eugenics in America: From the Indiana Experiment to the Human Genome Era, (Bloomington: Indiana 
University Press, 1992); Later scholars pointed out the pseudo science’s hypocrisy and undeniable link to 
racism and white supremacy.  
 
5 Hansen, et. al., Sterilized by the State, 2013; Kline, Building a Better Race, 2001; Kluchin, Fit to be Tied, 
2011; Ordover, American Eugenics, 2003; Bruinius, Better for all the World, 2006; Schoen, Choice and 
Coercion, 2005; Jennifer Nelson, Women of Color and the Reproductive Rights Movement, (New York: 
NYU Press, 2003); Jennifer Nelson, More Than Medicine: A History of the Feminist Women’s Health 
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 In tracing the battles over Norplant, this dissertation builds upon historical studies 
of eugenics and population control movements. Historians have documented the legacy 
of eugenics in the postwar period and its connection to population control ideologies and 
practices. For instance, historian Rebecca Kluchin uses the term neo-eugenics to describe 
the continued “ideas, practices, and policies” of eugenics after World War II. According 
to Kluchin, the government’s use of Norplant to control poor and minority women’s 
reproduction highlighted two themes central to neo-eugenic thought.6 First, that white 
middle-class women are more competent mothers than their African American 
counterparts, and second, that the government has the right to control the reproduction of 
women dependent upon the state for welfare benefits.7 Kluchin, along with scholars like 
Nancy Ordover and Harriet A. Washington, employs Norplant’s history to show how 
population control practices based on eugenic theories were fundamental to 1990s 
political narratives and social policies that blamed poor and minority women for 
economic downturns.8  
My research suggests that Norplant’s connection to population control politics 
dates back to the 1960s. I argue that Norplant was a product of the population control 
 
Movement, (New York: New York University Press, 2015); Andrea Smith, Conquest: Sexual Violence and 
American Indian Genocide. (Brooklyn: South End Press, 2005); Elena R. Gutiérrez, Fertile Matters: The 
Politics of Mexican-Origin Women’s Reproduction, (Austin: University of Texas Press, 2008); Andrea 
Tone, Devices and Desires: A History of Contraceptives in America, (New York: Hill and Wang: A 
Division of Farrar, Straus and Giroux, 2001). 
6 Kluchin, Fit to be Tied, 3. 
7 Kluchin, Fit to be Tied, 3. 
8 Harriet A.Washington, Medical Apartheid: The Dark History of Medical Experimentation on Black 
Americans from Colonial Times to the Present, (New York: Anchor Books: A Division of Random House, 
Inc., 2006), 7, 206-211; Nancy Ordover, American Eugenics: Race, Queer Anatomy, and the Science of 
Nationalism, (Minneapolis: University of Minnesota Press, 2003); Kluchin, Fit to be Tied, 2009. 
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movement, which grew in popularity in the 1950s and 1960s, and the drug’s unethical 
testing trials in places like Bangladesh, Brazil, Egypt, and Indonesia demonstrate that the 
Population Council sponsored the contraceptive’s development with the intent of using it 
to limit population growth in the Global South.  
In the 1980s, feminist activists from the Global South were the first to substantiate 
Norplant’s link to population control politics. Their investigations of the drug’s testing 
trials revealed alarming ethical violations, including the dissemination of inaccurate and 
incomplete information, the use of threats to attract participants, and evidence 
demonstrating that many healthcare practitioners conducting the trials refused to remove 
the Norplant device upon patients’ requests. After discovering the poor treatment of 
testing trial participants, feminists in places like Bangladesh, Indonesia and Brazil 
mobilized. Third World feminists’ early campaigns against Norplant focused on 
dismantling the testing trials, providing local women with accurate information about 
Norplant, and warning international feminists and women’s health activists of Norplant’s 
ties to temporary sterilization practices.9   
After Norplant was FDA approved in 1990, some policymakers, judges, and local 
leaders in the U.S. attempted to use Norplant to control poor and minority populations. 
These temporary sterilization practices were part of a larger effort to criminalize 
 
9 Stevienna de Saille, Knowledge as Resistance: The Feminist International Network of Resistance to 
Reproductive and Genetic Engineering, (Sheffield: Palgrave Macmillan, 2017), 142; Jacqui Alexander, 
“Mobilizing against the State and International ‘Aid’ Agencies: ‘Third World’ Women Define 
Reproductive Freedom,” in From Abortion to Reproductive Freedom: Transforming a Movement, ed. 
Marlene Gerber Fried, (Boston: South End Press, 1990), 52-53; Farida Akhter, Resisting Norplant: 
Women’s Struggle Against Coercion and Violence, ed. Farida Akhter (Dhaka: Narigrantha Prabartana, 
1995); Barbara Mintzes, Anita Hardon, and Jannemieke, ed., Norplant: Under Her Skin, (Delft: Eburon, 
1993). 
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populations of color and reform the welfare system during the second half of the 
twentieth century. Beginning in the 1970s, right-wing political figures and institutions 
constructed narratives that blamed the nation's economic recession and rises in criminal 
activity on poor and minority populations. Playing into these politicized narratives, in the 
1980s, President Ronald Reagan’s administration passed policies that placed harsh 
minimum sentencing laws on crack cocaine related crimes, an inexpensive drug often 
associated with poor and minority communities. Conversely, the legal consequences 
linked to powder cocaine, a more costly drug frequently used by white and middle and 
upper-class populations, remained nominal. As a result of these policies, the nation’s 
incarceration rates skyrocketed.10  
Similarly, in the 1970s political discussions around welfare recipients became 
increasingly disparaging. Drawing on rare examples of welfare fraud, the Republican 
party political machine produced the myth of the welfare queen, a cartoonish image of a 
welfare recipient who was both lazy and cunning. By the 1990s, this false representation 
of welfare recipients was promoted by both political parties, and welfare recipients were 
forced to deal with political reforms that cut their monetary benefits and placed strict time 
limits on their welfare eligibility. Historical and sociological studies examining the 1990s 
argue that social policies, and particularly welfare reform, passed during the Clinton 
administration negatively impacted people living in poverty, and particularly 
 
10 Charisse Jones, “Crack and Punishment: Is Race the Issue?” New York Times, October 28, 1995, 
accessed on November 2, 2019, https://www.nytimes.com/1995/10/28/us/crack-and-punishment-is-race-
the-issue.html; Elizabeth Hinton, “Why We Should Consider the War on Crime,” Time Magazine, August 
17, 2014, accessed on October 14, 2019, https://time.com/3746059/war-on-crime-history/; Elizabeth 
Hinton, From the War on Poverty to the War on Crime: The Making of Mass Incarceration in America 
(Cambridge: Harvard University Press, 2016). 
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communities of color. The Clinton administration’s welfare and criminal justice reforms 
reinforced racial stereotypes that painted Black men as criminals and Black women as 
lazy and unfit for motherhood.11 Politicians used this rhetoric to argue that incentivizing 
Norplant use for the working-class would eradicate poverty-related issues. 
This dissertation demonstrates that the use of Norplant in the U.S. as a tool to 
sterilize vulnerable populations was more pervasive than many scholars have suspected. 
Lawmakers at the state level, county judges, city officials, and community leaders tried to 
use Norplant to limit birth rates amongst poor and minority populations. For example, 
many state lawmakers proposed plans that would incentivize the use of Norplant among 
welfare recipients by offering them money to have the device inserted. Additionally, 
clinics in Baltimore public schools offered students the option to have Norplant 
implanted with the hope of decreasing the city’s high teenage pregnancy rates. These 
practices were not confined to a single region. They impacted poor and minority women 
across the U.S. To justify these tactics, political and community leaders argued that an 
increased Norplant use amongst poor and minority women would help solve the problem 
 
11 Edward D. Berkowitz, America's Welfare State From Roosevelt to Reagan, (Baltimore: The John 
Hopkins University Press, 1991); Marisa Chappell, The War on Welfare: Family, Poverty, and Politics in 
Modern America, (Philadelphia: University of Pennsylvania Press, 2010); Lisa Marie Cacho, Social Death: 
Radicalization Rightlessness and the Criminalization of the Unprotected, (New York: New York 
University Press, 2012); Linda Gordon, Pitied but not Entitled: Single Mothers and the History of Welfare, 
(New York: Free Press. 1994); Alice Kessler-Harris, In Pursuit of Equity: Women, Men, and the Quest for 
Economic Citizenship in 20th-Century America, (New York: Oxford University Press, 2001); Julilly 
Kohler-Hausmann, “Welfare Crises, Penal Solutions, and the Origins of the ‘Welfare Queen,’” Journal of 
Urban History 4 (2015); Pamela Loprest,  Stefanie Schmidt, Ann Dryden Witte, “Welfare Reform under 
PRWORA: Aid to Children with Working Families,” Tax Policy and the Economy 14 (2000); Yascha 
Mounk, The Age of Responsibility: Luck, Choice, and the Welfare State, (Cambridge: Harvard University 
Press, 2017); Brenda Stevenson, The Contested Murder of Latasha Harlins: Justice, Gender, and the 
Origins of the LA Riot, (Oxford: Oxford University Press, 2013); Elizabeth Hinton, From the War on 
Poverty to the War on Crime: The Making of Mass Incarceration in America, (Cambridge: Harvard 
University Press, 2016). 
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of poverty. This rationalization closely resembles arguments previously employed by 
eugenicists and population control advocates.12  
My analysis of 1990s social policy builds on the work of legal scholar Dorothy 
Roberts, who in her 1997 book, Killing the Black Body: Race Reproduction and the 
Meaning of Liberty, argues that white men’s efforts to control black women’s 
reproduction has been a longstanding form of racial oppression. For example, prior to the 
Civil War, enslaved women’s value and treatment reflected their abilities to produce 
healthy offspring that would enrich their masters. Later in the 1930s, eugenics and birth 
control advocate Margaret Sanger strongly encouraged African Americans to use birth 
control believing that fewer children would benefit the Black community and help curb 
their poverty. While Roberts suggests that American lawmakers, community leaders, and 
judges used Norplant to control Black women’s fertility and maintain a social hierarchy 
that favored white males, this dissertation delves into the topic more deeply and has 
uncovered an even more complicated history.13  
The efforts targeted a wider range of minority women both in the U.S. and in the 
Global South than historians have acknowledged. Policies that forcefully encouraged 
Norplant use targeted Black and Latina women as well as Native communities living on 
reservations and poor white women who relied on Medicaid. Beginning in the early 
1990s, healthcare professionals working for the Indian Health Service (IHS), a 
government agency focused on providing Native communities with healthcare, 
 
12 Kluchin, Fit to be Tied, 2009.; Washington, Medical Apartheid, 2006; Ordover, American Eugenics, 
2003; Roberts, Killing the Black Body, 1997. 
13 Roberts, Killing the Black Body, 6, 25, 75. 
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aggressively prescribed Norplant to Native women without fully considering the drug’s 
risks, contraindications, and their patients’ medical histories. These insufficient medical 
procedures caused thousands of women to suffer from an array of side effects, including 
headaches, pain and scarring at the place of insertion, significant weight gain, and 
irregular and serious bleeding.14  
 Historians who study the U.S. women’s health movement have shown how, in the 
1990s, women of color and indigenous women developed the concept of “reproductive 
justice” to draw attention to the unlawful and immoral controls placed on minority 
women’s bodies and to spotlight the ways minority women often experienced 
reproductive health discrimination differently than white women. Reproductive justice 
activists fought not only for safe, legal, and affordable abortions but also for access to all 
forms of reproductive health care, affordable childcare and prenatal care, and freedom 
from state-sanctioned sterilizations.15 Historians and activists have begun to document 
reproductive justice organizations’ grassroots campaigns against Norplant, and they have 
interpreted the contraceptive device’s removal from the American market as an early 
reproductive justice victory.16  
 
14 Natasha Lewry, “The Impact of Norplant in the Native American Community,” (Native American 
Women’s Health Education Resource Center: A Project of the Native American Community Board, June 
1992); Lin Krust, “A Study of the Use of Depo-Provera and Norplant by the Indian Health Services 
(Revised),” (Native American Women’s Health Education Resources Center: A Project of the Native 
American Community Board, July 1993); Charon Asetoyer, interview by Joyce Follet, transcript of video 
recording, September 2, 2005, Voices of Feminism Oral History Project, Sophia Smith Collection, Smith 
College, Northampton, MA 01063, 49; Farida Akhter, Resisting Norplant: Women’s Struggle Against 
Coercion and Violence, (Dhaka: Narigrantha Prabartana, 1995). 
15 Jael Silliman et al., Undivided Rights, 4. 
16 In 2004, a team of African American, Latin American, and white American women activists wrote the 
first history of the 1990s reproductive justice movement, Undivided Rights: Women of Color Organize for 
Reproductive Justice. This source outlines many different feminist and women’s health organizations’ 
agendas and tactics at the end of the twentieth century. Jael Silliman et al., Undivided Rights, 2004; Kline, 
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By demonstrating that U.S. feminist activism opposing Norplant drew on and was 
in conversation with a transnational campaign rooted in the Global South, this 
dissertation connects the U.S. reproductive justice and women’s health movements in the 
1980s and 1990s to the larger international feminists’ movement. Even before Norplant 
was FDA approved, the feminists in the Global South, who uncovered testing trials’ 
ethical violations, warned feminists in the U.S. of Norplant’s link to reproductive abuses. 
These alerts prompted American reproductive justice and women health organizations to 
mobilize against the drug and the policies surrounding it. U.S. feminists learned about the 
drug and its link to reproductive abuses after feminists in the Global South had 
mobilized. In this way, U.S. feminists were the beneficiaries of these early campaigns.17  
In the mid-1990s, class action lawyers began filing cases against Wyeth-Ayerst on 
behalf of Norplant patients. Previous scholarship examining feminists’ interactions with 
class action lawsuits has explored cases in which women’s health activists used class 
action litigation to shed light on medical devices and pharmaceutical drugs they 
 
Bodies of Knowledge, 2010; Kelly Suzanne O’Donnell, “The Political is Personal: Barbara Seaman and the 
History of Women's Health Movement" Ph.D. diss., (Yale University, 2015); Sandra Morgen, Into Our 
Own Hands: The Women’s Health Movement in the United States, 1969-1990, (New Brunswick: Rutgers 
University Press); Nelson, More than Medicine: 2015; Smith Conquest, 2005; Jane Lawrence, “The Indian 
Health Service and the Sterilization of Native American Women,” The American Indian Quarterly 24:3 
(Summer 2000); Lorretta J. Ross and Rickie Solinger, Reproductive Justice: An Introduction, (Oakland: 
The University of California Press, 2017); Lorretta J. Ross, Lynn Roberts, Erika Derkas, Whitney Peoples, 
Pamela Bridgewater, eds. Radical Reproductive Justice: Foundation, Theory, Practice, Critique, (New 
York: First Feminist Press, 2017).  
17 Meredeth Turshen, Women’s Health Movements: A Global Force for Change, (Houndmill: Palgrave 
Macmillan, 2007); Betsy Hartmann, Reproductive Rights and Wrongs: The Global Politics of Population 
Control, Third Edition, (Chicago: Haymarket Books, 2016); Rosalind Pollack Petchesky, Global 
Prescriptions: Gendering Health and Human Rights, (London: Zed Books, 2003); Stevienna de Saille, 
Knowledge as Resistance: The Feminist International Network of Resistance to Reproductive and Genetic 
Engineering (Sheffield: Palgrave Macmillan, 2017); James G. III. Connell, Norplant and the New 
Paradigm of International Population Policy, 2 Wm. & Mary J. Woman & L. 73 (1995).  
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considered unsafe. Beginning in the 1970s, as more lawyers recognized the possibility for 
significant profits, product liability class action litigation, which pitted thousands of 
plaintiffs against a single often wealthy corporation, rose in numbers. This shift led to 
massive class action lawsuits ending in substantial settlements that profited both the 
lawyers and the plaintiffs.18 Although only a few women’s health activists participated in 
the class action litigation, my research demonstrates that class action litigators employed 
feminist arguments against Norplant to construct their cases.  
The litigation against Norplant grew rapidly, and by the late 1990s, about 50,000 
plaintiffs had signed onto two hundred class action lawsuits across the country.19 
Although most of the participating attorneys had no connection to the feminist 
movement, when constructing their cases against Norplant, they used women’s health 
activists’ arguments concerning Norplant’s risks and side effects. At the same time, the 
lawyers ignored reproductive justice and women’s health advocates’ call to end coercive 
population control policies because they believed those arguments could curtail their 
chances of winning a large settlement. I contend that the attorneys assumed the 
stereotypes characterizing poor and minority women as greedy and lazy would hinder 
such a case. While the class action lawsuits did not win a large settlement for the 
 
18 Marcia Angell, Science on Trial: The Clash of Medical Evidence and the Law in the Breast Implant 
Case, (London: W.W. Norton & Company, 1996); Hensler, Nicholas M. Page, Bonita Dombey-Moore, 
Beth Giddens, Jennifer Gross, and Erik K. Moller, Class Action Dilemmas: Pursuing Public Goals for 
Private Gain, (Santa Monica: RAND Institute for Civil Justice, 2000), 10; “Supreme Court to Decide 
Whether to Certify Largest Class Action in History,” The Bottom Line HR: News You Can Use 6:1 
(February 2011). 
19 Elaine Tyler May, American and the Pill: A History of Promise, Peril, and Liberation, (New York: Basic 
Books, 2010), 139. 
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plaintiffs, the publicity surrounding them gravely impacted Norplant sales leading 
Wyeth-Ayerst to remove the contraceptive device from the American market in 2002.20  
The class action litigation against Norplant reveals the ways feminists’ labor is 
both co-opted and overlooked. Class action lawyers studied reproductive justice and 
Third World feminists’ Norplant investigations to research the drug and its history, attract 
plaintiffs, and construct their legal arguments. Despite the clear connection between the 
feminist movement and the class action litigation, lawyers refused to address their 
plaintiffs' racial or socio-economic identities or the link between Norplant and population 
control politics in the 1990s. Because lawyers ignored feminist arguments addressing 
issues of forcible sterilizations, much of the public remained unaware of Norplant’s link 
to population control efforts.21 
The following chapters explore different phases in Norplant’s lifespan. Chapter 
two contextualizes the circumstances of Norplant development beginning in the 1960s. In 
it, I argue that Norplant was linked to the population control movement, and the 
Population Council intended to use the contraceptive implant to limit pregnancies 
amongst poor women living in the Global South. Because many women in the Global 
South needed effective contraceptives, the Population Council and governmental 
authorities were able to push Norplant use in nations like Bangladesh and Indonesia. 
 
20 Arthur Gonzaléz interview by Justina Licata, Skype, November 7, 2018.  
21 “Native American Women’s Group Issued Critical Reports on Norplant,” Mealey’s Litigation Reports: 
Norplant 1:5 (January 23, 1995, 11); “A 1988 Report from Bangladeshi Interest Group Questions Norplant 
Trials,” Mealey’s Litigation Reports: Norplant 1:1 (November 3, 1994), 37-38; “Judicial Panel on 
Multidistrict Litigation” Federal Judicial Center, accessed on March 4, 2019, 
https://www.fjc.gov/history/timeline/judicial-panel-multidistrict-litigation. 
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Further, my research reveals that Third World feminists were the first to advocate against 
Norplant during the drug’s testing trials. This chapter takes a detailed look at feminist 
driven campaigns in Bangladesh and Egypt. In doing so, I demonstrate the lengths 
feminists in the Global South had to take to gain knowledge and assist women in their 
local communities. Despite these struggles, Third World feminists did not stop their 
efforts at their border, instead late in the 1980s, they used their knowledge to warn 
women’s health activists in the U.S. and around the globe. 
The third chapter shifts to the U.S., examining the many ways judges, lawmakers, 
and community leaders used Norplant to attempt to control minority and poor women’s 
reproduction. In the early to mid-1990s, several county judges compelled women 
convicted of child abuse or neglect to use Norplant, state lawmakers’ from across the 
U.S. proposed programs that encouraged welfare recipients to use the contraceptive 
implant, and one foster mother established a nonprofit organization that paid women 
struggling with substance abuse to either be surgically sterilized or use long-term forms 
of birth control, including Norplant. Additionally, the city of Baltimore’s health 
commissioner created a program that allowed public school health clinics to prescribe 
Norplant to their teenage patients. Each incident caused tense debates both locally and 
nationally, dividing previously aligned communities and creating unexpected bedfellows. 
For example, Baltimore’s Norplant program caused a massive rift within the African 
American community, revealing ideological disputes and divisiveness among classes. 
Through my examination of these incidents, I argue that Norplant’s history must be 
examined alongside other policies that have come to define the bipartisan, right-leaning 
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political shift in the 1980s and 1990s, including welfare reform, the War on Drugs, and 
the rise in incarcerations. 
Chapter four focuses on the feminist activism against Norplant in the U.S., with 
particular emphasis on Native American Women’s Health and Education Resource 
Center’s campaign against the IHS’s use of Norplant on Indian reservations. In the late 
1980s, after Third World feminists warned them of Norplant’s connection to coercive 
sterilizations, women’s health and reproductive justice activists spoke out against 
Norplant’s pending FDA approval. Later when Norplant became available in the U.S., 
women’s health and reproductive justice activists generated multiple campaigns to get rid 
of the device and halt the coercive policies surrounding the implantation and removal of 
Norplant. They worked to overturn abusive policies, assert personal and private 
reproductive control, and rectify inaccurate stereotypes attached to poor and minority 
women. The women of color and indigenous women driving these campaigns were part 
of the rise of the reproductive justice movement, which expanded the reproductive rights 
agenda to better represent the experience of all women.  
Chapter five investigates the more than two hundred class action lawsuits filed on 
behalf of Norplant patients. When constructing their cases, profit-seeking class action 
lawyers co-opted feminists’ arguments against Norplant, but they avoided addressing the 
drugs ties to coercive population control politics because they believed it would hinder 
their cases. I argue that the political attacks painting poor and minority women as lazy 
and entitled stopped lawyers from constructing arguments that confronted the temporary 
sterilization practices. Although the lawsuits did little to help the women who were 
 
 
 
 
16 
pressured into using Norplant, they did convince the public that the contraceptive device 
was dangerous. After Norplant’s sales plummeted in the late 1990s, Wyeth-Ayerst 
removed it from the American market in 2002.  
  My Epilogue brings the story closer to the present. Although Norplant is no 
longer available for use, Nexplanon, another subdermal implantable contraceptive device, 
has replaced it. Many women are grateful to have the option to use a subdermal 
implantable contraceptive device as their birth control method. Conversely, evidence 
shows that governments and NGOs continue to use Nexplanon, along with other long 
acting reversible contraceptives (LARCs), including intrauterine devices (IUDs) and 
Depo-Provera, to temporary sterilize women in the U.S. and around the globe. 
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CHAPTER II  
 
THE GLOBAL ORIGINS OF THE FEMINISTS CAMPAIGN AGAINST NORPLANT  
 
 
Feminists in the Global South initiated a powerful international campaign against 
Norplant. In the 1980s and 1990s, feminists from Latin America, Asia, Africa, and the 
Middle East mobilized against Norplant. These early grassroots campaigns eventually 
became a larger international women’s movement. As early as the 1980s, feminists in 
Bangladesh, Indonesia, Brazil, and Egypt, questioned Norplant’s safety and spoke out 
against its testing trials’ ethical violations. Many of these activists were part of feminist 
organizations, such as Unnayan Bikalper Nitinirdharoni Gobeshona (UBINIG) in 
Bangladesh or the Human Reproductive Rights Studies Commission (CEDRH) in Brazil, 
that were fighting against oppressive governments that used women’s reproduction to 
control working class and minority populations; often through state-sanctioned 
sterilizations. While they understood the importance of access to birth control, they 
viewed the use of provider controlled contraceptive, like Norplant, to limit the 
reproduction of poor and indigenous groups as part of a long history of colonial and racist 
oppression linked to eugenic practices.  
The mobilizations against Norplant in Bangladesh, Brazil, Egypt, and Indonesia 
directly influenced U.S. feminists’ and women’s health advocates’ perception of Norplant 
before the drug was Food and Drug Administration (FDA) approved and helped put 
activists from different countries into conversation. Further, the activists in Bangladesh
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developed pioneering research methods that U.S. women's health organizations would 
emulate in the 1990s.1  
Norplant’s creation and development in countries like Brazil and Chile, was part 
of a long history of global population control politics and family planning policies. Early 
in the twentieth century, scientists’, doctors’, and lawmakers’ use of popular eugenic 
theories led to an important shift in U.S. birth control politics. Eugenicists in the U.S. 
argued that the sterilization of “feebleminded” individuals, particularly women, would 
prevent unwanted children, preserve a stronger race, and save the nation money.2 
Americans’ desire to prevent the widespread growth of poor communities led to an 
important shift in birth control rhetoric. Where birth control had been seen as a 
technology that helped women control their reproduction, eugenicists and population 
control advocates viewed birth control as a way to prevent poor and minority populations 
from increasing. Therefore, the need for more effective birth control technology became 
essential to the growth of eugenics. Though some women, particularly white and wealthy 
women, often celebrated new forms of birth control as potentially empowering, others, 
especially poor women and women of color understood that the scientific, medical, and 
 
1 Stevienna de Saille, Knowledge as Resistance: The Feminist International Network of Resistance to 
Reproductive and Genetic Engineering, (Sheffield: Palgrave Macmillan, 2017), 142; Jacqui Alexander, 
“Mobilizing against the State and International ‘Aid’ Agencies: ‘Third World’ Women Define 
Reproductive Freedom,” in From Abortion to Reproductive Freedom: Transforming a Movement, ed. 
Marlene Gerber Fried, (Boston: South End Press, 1990), 52-53. In 1990, feminist and scholar Jacqui 
Alexander observed, “The histories of ‘third world’ women have been marked by colonialism and 
imperialism, both by the superimposition of European political and economic interests as well as by the 
ideology which colonizers produced to justify and legitimate their rule.” She continued by commenting on 
women’s agency, “there continues to be colonization of a different kind which...women in ‘third world’ 
2 Randell Hasen and Desmond King, Sterilized by the State: Eugenics, Race, and the Population Scare in 
Twentieth Century North America, (New York: Cambridge University Press, 2013), 104. 
 
 
 
19 
legal communities often used contraceptives as a way to control the reproduction of 
certain populations.3  
Scholars have shown that the U.S. government and private organizations used the 
concept of population control as a means to perpetuate colonialism in the second half of 
the twentieth century.4 Following World War II, the U.S. became a major world power, 
and the nation’s need for raw materials from the Global South increased. A group of 
American scientists, philanthropists, and reformers expressed concern over the imminent 
possibility of a global population upsurge. Fears of overpopulation were reinforced by 
crowded cities, air and water pollution, high numbers of unplanned births, and the 
conservative political narrative that blamed increases in taxes on welfare benefits when 
they were a small fraction of the federal budget, especially compared to the nation’s 
defense spending in the mid-twentieth century.5  
Significant political figures became deeply involved in the population control 
movement, including one of the U.S.’s most prominent philanthropists, John D. 
Rockefeller III, who believed, “the relationship of population to material and cultural 
resources of the world represents one of the most crucial and urgent problems of the 
day.”6 In 1952, Rockefeller invited Planned Parenthood leaders, thirty conservationists, 
 
3 Iris Lopez, Matters of Choice: Puerto Rican Women’s Struggle for Reproductive Freedom, (New 
Brunswick; Rutgers University Press, 2008), 5. 
4 Betsy Hartmann, Reproductive Rights and Wrongs: The Global Politics of Population Control, Third 
Edition, (Chicago: Haymarket Books), 97; Monica Bahati Kuumba, “Neo-Colonialism through Population 
Control: South Africa and the United States, Africa Today 40:3 (3rd Quarter, 1993), 79; Matthew Connelly, 
Fatal Misconception: The Struggle to Control World Population, (Cambridge: The Belknap Press of 
Harvard University Press), 2-3.  
5 Rebecca M. Kluchin, Fit to be Tied: Sterilization and Reproductive Rights in America, 1950-1980, (New 
Brunswick: Rutgers University Press, 2009). 33-34. 
6 Hartmann, Reproductive Rights and Wrongs, 97. 
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and development and demographic experts to a population conference in Williamsburg, 
Virginia. The conference produced the Population Council, a New York based agency 
with partners around the world. This international non-governmental organization (NGO) 
advocated for “population control” as a means of curtailing global poverty and focused 
on creating new forms of contraception for poor, uneducated women, especially in the 
Global South. From its start, the organization had close ties to the eugenics movement. In 
fact, one of its co-founders, Fredrick Osborne, was once the president of the American 
Eugenics Society.7 Scholars argue that the Population Council’s sophisticated approach 
to population control rid it of “its racist and eugenic content.”8 The NGO would become 
not only the world’s leading institution for population related research, but it would also 
be central to this political debate with long standing connections to the Rockefeller 
Foundation, the UN, and the Ford Foundation.9 The Population Council would go on to 
fund the development and testing of Norplant.10  
Shortly after it was founded, The Population Council began advising nations’ 
governments on ways to establish family planning programs that provided indigenous 
women with contraception options, including sterilization.11 Early family planning 
 
7 Linda Everett, “The Population Council: from eugenics to Norplant,” Executive Intelligence Review 20:19 
(May 14, 1993, 23): accessed on July 3, 2019, https://larouchepub.com/eiw/public/1993/eirv20n19-
19930514/eirv20n19-19930514_023-the_population_council_from_euge.pdf; Wolfgang Saxon, 
“Fredrickson Osborn, A General, 91, Dies,” New York Times, January 7, 1981, accessed on July 3, 2019, 
https://www.nytimes.com/1981/01/07/obituaries/frederick-osborn-a-general-91-dies.html. 
8 Thomas M. Shapiro, Population Control Politics: Women, Sterilization and Reproductive Choice, 
(Philadelphia: Temple University Press, 1985), 63. 
9 Connelly, Fatal Misconception, 159.  
10 Dorothy Roberts, Killing the Black Body: Race, Reproduction, and the Meaning of Liberty, (New York: 
Pantheon Books: A Division of Random House, Inc., 1997), 139; Shapiro, Population Control Politics, 64-
65. 
11 Hartmann, Reproductive Rights and Wrongs, 97. 
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programs focused on demographics measuring their objective to reduce high fertility 
rates and minimize population growth. The Population Council argued that family 
planning programs, which were meant to provide women with reproductive care and 
supply them with safe and effective birth control, would increase “living standards and 
human welfare, economic productivity, natural resources, and the environment in the 
developing world.”12 While the council did hope to improve the lives of indigenous 
people, neither the organization nor governments in the Global South prioritized 
women’s reproductive health and rights. Instead, they approached issues related to 
women’s health paternalistically, rather than empowering women to make decisions 
about their bodies.13 
The history of Norplant’s testing trials in the Global South is reminiscent of the 
birth control pill’s trials in Puerto Rico during the 1950s. Birth control and eugenics 
advocates in the early twentieth century believed that effective contraceptives and 
sterilization practices would improve a nation's overall quality of life, especially amongst 
working class populations.14 Since the U.S. acquired Puerto Rico in 1899, policymakers 
and journalists characterized the island as a victim of severe overpopulation.15 The U.S. 
 
12 Judith R. Seltzer, The Origins and Evolution of Family Planning Programs in Developing Countries, 
(Santa Monica: Population Matters: A RAND Programs of Policy-Relevant to Research Communication, 
2002), xiii. 
13 Seltzer, The Origins and Evolution of Family Planning Programs in Developing Countries, xiii. 
14 Laura Briggs, Reproducing Empire: Race, Sex, Science and U.S. Imperialism in Puerto Rico, (Berkeley: 
University of California Press, 2002), 99-100, 108.  
15 Lopez, Matters of Choice, 5-6; Betty Wand, Georges Chakiris, The Sharks, Their Girls, “America,” West 
Side Story, Columbia Masterworks Records, 1961, MP3. This rhetoric was so pervasive, it became a part of 
Americans' understanding of Puerto Rico. For example, in the popular 1960s musical West Side Story, a 
Puerto Rican character reflecting on the issues affecting her home country and the hardships her and her 
fellow Puerto Ricans faced after immigrating to the U.S., sings the lyrics, “Always the population growing” 
while performing the upbeat number “America.” 
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concealed their use of Puerto Rico’s resources and their continued political involvement 
by emphasizing their concerns over the territory’s rapidly increasing population.16 And 
the U.S. government justified their eugenic practices, in particular their coercive use of 
birth control, by blaming Puerto Rican women for the territory’s severe overpopulation.17 
This led to an influx of birth control clinics in the 1930s. Charlotte Bermudez, a North 
American woman who started a clinic in Puerto Rico, once told Margaret Sanger, “So 
many of the natives are unmoral [sic]. We want to put the status of the home and legally 
married woman and the legitimate children on a higher plane than they are at present.”18 
These prejudicial beliefs about Puerto Rican women’s purity and ethics are a part of a 
larger history of white upper class women exerting their power over the working class 
and minority women and deciding who is worthy of assistance and who is not.19  
Early researchers of the contraceptive pill were unaware of the drug’s possible 
side effects; therefore, they hesitated to use the technology. By 1955, three 
pharmaceutical companies had patents and completed animal studies, which would allow 
them to begin clinical trials. While two of the companies felt it was still too dangerous to 
 
16 Briggs, Reproducing Empire, 108. 
17 Lopez, Matters of Choice, 5-6; Briggs, Reproducing Empire, 74-108; Rebecca M. Kluchin. Fit to be 
Tied: Sterilization and Reproductive Rights in America, 1950-1980; (New Brunswick: Rutgers University 
Press, 2009), 3; Neo-eugenics is the continued legacy of eugenics in the post-baby boomer era. Although 
neo-eugenics was not a formal movement, many groups including scientists, physicians, and politicians 
adhered to its goals. The main difference between eugenicists and neo-eugenicists is the individuals 
targeted for sterilization. Prior to the Second World War, eugenicists focused their attention on eastern and 
southern European immigrants. In the 1950s and beyond, neo-eugenicists placed their attention on African 
Americans, Native Americans, and people of Hispanic descent. Neo-eugenics, like eugenics, used 
reproductive fitness, or the belief that the sterilization of “unfit” individuals would strengthen the human 
gene pool and improve society for all, as justification for their actions.  
18 Briggs, Reproducing Empire, 95. 
19 Linda Gordon, The Moral Property of Women: A History of Birth Control Politics in America, (Urbana: 
University of Illinois Press, 1974), 72-85. 
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conduct trials, the third, Searle, started testing the oral contraceptive in Puerto Rico.20 
During the 1940s and 1950s, Searle worked with Clarence Gamble, who used his 
family’s fortune to test an array of contraceptive technologies in Puerto Rico, including 
the oral birth control pill.21 The largest trial in 1956 attracted hundreds of Puerto Rican 
women who had previously been denied their request for a surgical sterilization because 
they did not fulfill the country’s strict restriction of having three children by the age of 
twenty. The lack of effective birth control options motivated women to participate despite 
the possible dangers.22  
As scientists had predicted, the trials proved that the oral contraceptive was still a 
mystery to the researchers and the medical professionals conducting the trial. Patients 
were not given enough information about the drug, causing many to take the 
contraceptive incorrectly.23 Participants experienced an array of side effects, including 
acute headaches, nausea, irregular bleeding, and vomiting. Some patients’ side effects 
were so severe they were hospitalized.24 Additionally, several women became pregnant. 
These negative experiences led about half of the participants to abandon the trial.25 
Despite the clear ethical violations, Searle pressed on with the Pill trials, even beginning 
 
20 Briggs, Reproducing Empire, 99-100, 131. 
21 Lopez, Matters of Choice, 16-17; Elizabeth Siegel Watkins, On the Pill: A Social History of Oral 
Contraceptives, 1950-1970, (Baltimore: The John Hopkins University Press, 1998), 15; Johanna Schoen, 
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Hill: UNC Press, 2005), 208-215; Two prominent female activists, Margaret Sanger and Katherine 
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22 Schoen, Choice and Coercion, 209. 
23 Schoen, Choice and Coercion, 213. 
24 Briggs, Reproducing Empire, 137; Lopez, Matters of Choice, 17. 
25 Briggs, Reproducing Empire, 137; Schoen, Choice and Coercion, 213; Andrea Tone, Devices and 
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a new trial in Haiti in 1957. Puerto Rico was also the test site for Depo Provera and 
various other intrauterine devices (IUDs).26 The Puerto Rican trials confirmed the U.S.’s 
ability to overlook ethical violations, especially when their objective was to control 
populations that Americans saw as outsiders. Just a few years later in 1960, the oral birth 
control pill was FDA approved, but initially, doctors were only permitted to prescribe it 
for two consecutive years because researchers were still unaware of the drug’s long-term 
side effects.27  
The U.S. government began supporting population control legislation more 
aggressively in the 1960s. In 1966, the Food for Freedom bill addressed concerns 
regarding the global population boom in relation to the world’s food supply. The bill 
allowed food aid revenues to financially support family planning services throughout the 
Global South. In addition, the following year, Congress agreed to allocate thirty five 
million dollars to the Agency for International Development (USAID) for population 
programs.28 A USAID representative stated that the government’s financial support gave 
the agency a greater ability to offer women, “a full spectrum of assistance.” In 1969, the 
U.S. government, under Nixon’s administration, urged the United Nations (UN) to 
become a leader in population control policies.29 
Just a few years later, the UN named 1974 the World Population Year and held a 
conference on population in Bucharest, Romania. The conference revealed that the UN 
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saw the global population growth as a danger that hindered economic and social 
development. While many world powers saw population growth as an obstacle, a number 
of nations in the Global South felt the issue was being used to evade examining more 
profound sources of underdevelopment, including inequality in international 
relationships.30 A representative from India stated that “development is the best 
contraceptive,” while also expressing his nation’s concerns over the West’s high level of 
consumption of resources.31 At the conference, feminists joined other critics of 
population control policies in advocating for family planning programs that focused on 
women’s rights and overall better healthcare for communities in need. But the U.S. 
government remained committed to promoting population control around the world.32 
As fears of overpopulation mounted, the Population Council injected more funds 
into contraceptive research of implantable devices, vaginal rings, injectable birth control, 
a weekly pill, and post-coital pills.33 Because the organization focused heavily on 
improving population control in the Global South, it is evident that Norplant’s original 
purpose was to aid nations in their efforts to stabilize their population growth rates. The 
development of the first implantable contraceptive device was galvanized by the 
introduction of two new birth control technologies, the IUD and the oral contraceptive 
pill, in the mid-twentieth century, which gave family planning programs additional tools 
for preventing pregnancies and stabilizing a nation’s population growth. The 
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technologies’ successes led organizations and foundations, both public and private, to 
dedicate more funding to the research and development of new contraceptive 
technologies.34 
In the 1960s, the Population Council’s Center for Biomedical Research began the 
development program that would lead to the creation of Norplant. To conduct this 
research the Population Council received funding from the National Institute of Health 
and the United States Agency for International Development (USAID).35 As a 
postgraduate fellow, Dr. Horacio B. Croxatto, a Chilean physician-scientist, presented the 
use of Silastic, or medical grade plastic, subdermal implants for long-term, reversible 
hormonal birth control.36 This early concept would eventually lead to the creation of 
Norplant. Dr. Sheldon Segal, the director of biomedical research at the Population 
Council and a well-known, leading innovator in contraception research, headed the 
project. In 1963, Segal was appointed the Director of the Division of Bio-Medical 
Science of the Population Council, after being a member of the division for seven years. 
He was also a visiting professor of Reproductive Physiology at the All India Institute of 
Medical Sciences in New Deli and published many articles relating to embryology, 
endocrinology, and fertility regulation. As an advocate for effective and affordable 
contraception, Segal considered Norplant an important advancement in birth control 
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technology because it would allow “‘a woman to substitute one clinic visit for a thousand 
days of pill taking.’”37  
The invention of a medical grade silicone polymer, Silastic, along with the 
discovery that a very low daily dose of oral progestin effectively prevented fertility, 
created the possibility of an implantable contraceptive. Thanks to these two scientific 
breakthroughs, in 1966, the Population Council began investigating the use of a Silastic 
capsule filled with progestin inserted under a woman’s skin as a new form of 
contraceptive technology. At this time, Silastic was being used in experimental surgeries, 
which led doctors to discover that oil-soluble dyes slowly diffused out of the medical 
grade plastic. Segal used this information to test if oil-soluble hormones would also seep 
through a Silastic capsule.38 Early experiments showed that one capsule would prevent 
pregnancies for only one or two years; therefore, they considered more capsules. By 
1974, the Population Council had begun testing a six-capsule Silastic delivery system.39  
This implantable birth control employed two methods to prevent a woman from 
conceiving. First, it suppressed ovulation in just over fifty percent of a woman’s 
menstrual cycles, and second, it thickened the cervical mucus making it more difficult for 
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the sperm to reach a woman’s egg.40 These two processes made the device highly 
effective; in fact, over the five year period, only 3.9 percent of users became pregnant 
while on Norplant.41 Also, the Population Council attested that studies showed that a 
woman’s fertility would return shortly after the Norplant device was removed from her 
arm, making the contraceptive reversible.42 Segal and his colleagues chose to use 
levonorgestrel as the progestin in Norplant because it was FDA approved and used in 
other forms of birth control, including some pills, and at the time it was the “longest-
working reliable progestin” available.43 In 1966, Wyeth-Ayerst, the pharmaceutical 
company that developed levonorgestrel, permitted the Population Council to use 
levonorgestrel in their research of an implantable birth control device.44 
Clinical trials, which occurred between 1970 and 1975, established the most 
effective and safe combination of rods and hormone creating the Norplant system.45 
Segal and the Population Council choose to conduct the trials through a large clinical 
research group called the International Committee for Contraceptive Research (ICCR), 
which they created. Outside research groups, and not a team created by the drug’s 
developer, typically conducted a drug’s pharmaceutical testing, therefore the ICCR was 
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considered to be unorthodox.46 During preliminary studies in Chile, Brazil, and India 
many women experienced ovarian hypertrophy, an increased number in ectopic 
pregnancies, which occur when a fertilized egg implants outside of a woman’s uterus and 
can be extremely dangerous for both the mother and the child, and contraceptive failure. 
These results led the Population Council to raise the hormone dosage in the implant 
making it more effective at preventing pregnancies while also decreasing the risk of 
ectopic pregnancy.47 Following these modifications in 1975, the ICCR began conducting 
Norplant’s first multinational clinical trials in Brazil, Chile, Denmark, the Dominican 
Republic, Finland, and Jamaica.48  
Following the clinical research, in the 1980s, Norplant’s accessibility trials were 
conducted. These trials examined how the drug’s users reacted to the drug and whether or 
not they chose to continue using it, while also investigating its acceptability to possible 
patients, their husbands, and the family planning clinic personnel.49 Through these trials, 
the Population Council made Norplant accessible to women living in Bangladesh, 
Colombia, Dominican Republic, Ecuador, Egypt, Haiti, Indonesia, Kenya, Mexico, 
Nepal, Peru, Sri Lanka, Thailand, and the U.S.50 The Population Council used 
accessibility studies to create local experience with the drug and determine its feasibility 
in a number of countries before it was put on the market.51 By the time Norplant was 
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FDA approved in 1990, it had undergone more accessibility studies than any other 
contraceptive.52 The size of the trials varied from 205 participants in a study in San 
Francisco to over 2,500 in a study that spanned four different countries.53  
In the 1980s, feminists in Bangladesh, Brazil, Egypt, and Indonesia organized 
against the Norplant trials. This was a moment in which they were already mobilizing for 
access to healthcare, freedom from sexual violence and state sanctioned sterilizations, 
and seeking greater socio-economic justice.54 In Bangladesh, feminists argued that the 
government prioritized reducing the nation’s growing population over indigenous 
women’s rights and reproductive health. Bangladesh liberated itself from Pakistan in 
1971, but prior to its independence, outside institutions, including the Population 
Council, funded family planning programs that pushed the use of IUDs and 
vasectomies.55 Following the nation’s independence, the new government established the 
National Population Council and committed to decreasing fertility without any attention 
paid to the improvement of women’s health.56 Betsy Hartmann, a U.S. women’s health 
and reproductive rights activist and the director of the Population and Development 
Program, witnessed the effect of family planning programs in a small village in 
Bangladesh when she visited the nation in 1975. These workers encouraged the use of 
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birth control pills, IUDs, and sterilization, but they did not inform women about the risks 
and side effects associated with each nor did they encourage them to ask questions.57 
Western foreign institutions, including the UN’s Population Fund and the World Bank, 
that provided the Bangladeshi government with significant financial aid, pressured the 
nation to substantially reduce their population growth. In 1984, the government started a 
“‘cash program’” to incentivize sterilization. Policies penalized family planning 
personnel who did not meet sterilization quotas.58  
The Bangladeshi women’s movement dates back to the nation’s anti-colonial 
struggles. Although initially, in the 1970s and 1980s, the movement was made up of 
mostly professional, urban women, beginning in the 1990s, a greater variety of women 
organizations began to participate. These organizations ranged from local grassroots 
groups focused on their members’ immediate communities to national organizations that 
mobilized on an international level. Bangladeshi feminist worked on an array of issues 
relating to poverty and gender disparities, including economic opportunities for women, 
violence against women, equal political representation, and family law reforms.59 
In the 1980s, Bangladeshi women activists began to respond to their 
government’s population control policies. They created organizations like Unnayan 
Bikalper Nitinirdharoni Gobeshona (UBINIG), which in English translates to Policy 
Research for Development Alternative. UBINIG, which is still in existence today, is an 
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organization based in Dhaka, Bangladesh’s capital. Since 1984, UBINIG has fought 
against population control policy and for greater reproductive rights for women. The 
organization was created to search for development alternatives that would aid people 
living in poverty and Bangladesh’s marginalized populations. Using both scientific data 
and women’s lived experiences, UBINIG researched issues related to harmful population 
policies, women’s rights, healthcare, workers’ rights, environmental concerns, human 
rights violations, and international trade. As the organization grew, its interactions with 
feminists on the international level increased dramatically. Some of UBINIG’s most 
significant campaigns include working with garment workers to improve working 
conditions and establishing fair wages, researching the effects of trafficking on rural 
women living in poverty, and helping an array of diverse Bangladeshi communities to 
maintain their cultural traditions, such as food, music, crafts, and theatrical 
performance.60  
In February 1981 at the 16th Meeting of the National Council for Population 
Control and Family Planning in Bangladesh, the national government discussed initial 
plans for a Norplant trial.61 USAID and the Bangladesh government funded the 
Bangladesh Fertility Research Program (BFRP), a Bangladeshi organization dedicated to 
national family planning and biomedical research, to conduct a Norplant study.62 To 
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obtain participants, BFRP placed an advertisement in the newspapers that called 
Norplant, “a wonderful innovation of modern science.”63  
Farida Akhter, who would go on to become one of UBINIG’s leading members, 
responded immediately to the BFRP’s call for Norplant test trial volunteers. In a 
newspaper article, she pointed out that while Norplant had not yet completed its animal 
trials, it was already available to women living in Chiang Mai, Thailand. Akhter believed 
that the Population Council’s and the Bangladeshi government’s desire to control the 
population led them to disregard Norplant’s health risks.64 “The Population Council 
perhaps cannot just wait till the animal test is completed,” she observed, “when they 
know that the ‘over populated’ Third World countries have millions of women to test the 
drugs.”65 Akhter also questioned why a number of powerful nations, including the U.S., 
Australia, Canada, Norway, Sweden, and the UK, were funding Bangladesh’s and many 
other nations’ family planning programs. She was convinced that international donors 
pressured nations in the Global South to use banned drugs and host new drug trials.66 
Lastly, Akhter’s article highlighted BFRP’s failure to mention that Norplant was still 
undergoing testing. She feared that women would be given inaccurate and incomplete 
information about the drug’s safety. “How long will the women of Bangladesh and other 
poor countries act as guinea-pigs for testing drugs produced in developed countries?” she 
asked. “Why do countries like Bangladesh have to solve their population problem risking 
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the lives of their women?”67 She called on people to protest. One hundred fifty doctors, 
healthcare workers, and pharmacists responded by sending a petition to the nation’s 
Minister of Health and Population Control. Their actions forced the Bangladeshi 
government to postpone the trial.68  
 In 1985, the BFRP began another Norplant trial in Bangladesh, but due to the 
upheaval in 1981, this trial was initiated silently.69 A UBINIG development worker 
discovered the trial while researching women’s living conditions in the slums of Dhaka 
City. The development worker met Jahanara, a pregnant mother of four who was 
struggling to find a doctor to perform an abortion. The UBINIG researcher took the 
pregnant mother to a clinic that would only perform an abortion if Jahanara agreed to be 
permanently sterilized following the procedure.70 Because she could not afford to miss 
the three days of work that was required following a tubal ligation, she refused. After 
traveling to a hospital in Dhaka, healthcare providers again advised Jahanara to undergo a 
surgical sterilization. This time, when she refused, they also offered her injectable 
contraceptive options, including Depo-Provera and Norplant. Jahanara was encouraged to 
try Norplant because the healthcare counselor claimed that it did not have any side 
effects. After the counselor had Jahanara sign a consent form with her fingerprint, most 
likely because she was illiterate, the UBINIG researcher, who had escorted Jahanara to 
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the hospital and was aware of Norplant’s risks, realized that the provider was not 
accurately portraying the contraceptive device because they desperately needed trial 
participants. The researcher convinced Jahanara to leave the clinic before she had 
Norplant implanted. Reflecting on the events in a subsequent report, the researcher 
expressed her relief that “Jahanara was saved from Norplant.”71  
 This event catalyzed UBINIG’s second campaign against Norplant. First, 
UBINIG gathered information about the secretive Norplant trial. The medical center that 
controlled the trial refused to cooperate with UBINIG, and many of the trial participants 
did not want to be interviewed, therefore the only way they were able to learn about the 
testing was by visiting the clinics that were participating in the trial. From their visits, 
UBINIG learned that the trial participants were mostly women living in slum areas. Many 
had previously been on the injectable contraceptive, Depo-Provera, and had switched to 
Norplant because the clinicians conducting the trial inaccurately described the implant as 
another injection.72 They learned that over six hundred women between the ages of 
eighteen and forty had had Norplant inserted since 1985. Representatives from the clinics 
said they screened patients for jaundice, hypertension, and diabetes before the insertion 
and removed the device and brought patients to the hospital if any complications arose. 
All insertions took place one to seven days following the start of a woman’s menstrual 
period. While they were encouraging all mothers to use Norplant, any woman who 
breastfed was not able to join the trial because they feared that the progestin could get 
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into the breast milk and harm the child. The clinic workers also stated that they gave all 
participants checkups one, three, and six months following the insertion.73 All of these 
procedures were standard for an accessibility trial, but UBINIG’s researchers would soon 
learn that these procedures were not properly followed throughout the trial.  
Additionally, the clinics, which treated mostly women living in poverty, claimed 
that they recruited participants by providing women who inquired about contraception 
with a leaflet discussing Norplant’s strengths, risks, and side effects. When UBINIG 
acquired this leaflet, they found that it included many inaccuracies. For instance, it stated 
that Norplant was one hundred percent effective, but typically 0.2 to 1.3 percent of 
women on Norplant became pregnant. While these numbers were low, UBINIG believed 
that any misrepresentation of Norplant was potentially harmful. The leaflet also asserted 
that Norplant was easier to use than other forms of birth control. Yet UBINIG pointed out 
that a trained medical professional was required to have Norplant removed, making it 
inconvenient for any user who changed their mind.74  
Most critically, the leaflet did not include any information about Norplant’s risks 
and side effects. During their initial visit, UBINIG discovered that healthcare providers 
were pushing women seeking family planning options to use Norplant, even offering 
women a monetary benefit. Additionally, many of the doctors believed that long-acting 
contraceptives were a better option for their poor patients because they assumed the 
women could not remember to take a daily birth control pill.75 UBINIG’s interviews with 
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doctors revealed that they hoped to limit the Global South’s population and saw patients 
as expendable. One doctor boldly stated, “In order to have a good thing there is always a 
price to pay. If two or three women die--- what’s the problem? The population will be 
reduced.”76 
In 1986, UBINIG conducted interviews with ten Norplant trial participants in 
Basila, a village in an outlying district of Dhaka. Akhter later remembered that gaining 
the trial participants’ trust took time because they were afraid of possible repercussions.77 
Despite this, the interviews revealed a number of ethical violations. For instance, the 
clinics were not following the trial’s standard procedures, especially when vetting and 
informing the participants. Like most of the women participating in the trial, these ten 
women were either poor or lower middle-class with little formal education. In fact, only 
two were literate. While their ages ranged from sixteen to forty-five, all of the 
interviewees were mothers, and most had more than one child.78 The interviews also 
revealed that four of the women had recently given birth and therefore were breastfeeding 
while on Norplant. This directly contradicted the medical professionals’ claim that 
women nursing were not allowed to participate in the trial.79 When recalling their 
experiences at the clinics, the interviewees stated that Norplant appealed to them over 
other contraceptive options partially because healthcare professionals often understated 
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the drug’s side effects or did not conduct any counseling before the insertion.80 
Furthermore, none of the women interviewed read the leaflet discussing Norplant’s 
positive aspects and possible risks and side effects before the insertion.81 Many had 
previously used Depo-Provera, the injectable contraceptive, but it was often difficult to 
get to the health clinics every three months for the shots. Therefore, clinic personnel 
encouraged them to switch to Norplant because it lasted five years and required fewer 
clinic visits.82 One of the most shocking revelations was that the interviewees were not 
aware that they were participating in a testing trial. They were “guinea pigs of medical 
research,” UBINIG concluded.83 Only one woman knew the name “Norplant,” the others 
only knew of the drug as the “5-Year Needle.”84  
During the interviews, women spoke about how Norplant affected their health. 
Following the insertion, all ten women experienced Norplant related side effects. The 
most common was amenorrhea, or the loss of menstruation, followed by irregular 
bleeding. A few women experienced less common side effects such as vertigo, a burning 
sensation in hands and feet, body aches, tiredness, and leukorrhoea, or a white or 
yellowish vaginal discharge.85  
UBINIG observed that the professionals conducting the trial were not properly 
addressing the patients’ side effects. While all of the women dealt with uncomfortable 
side effects, only three had the device removed early, and only after they persisted by 
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visiting the medical center two or three times. One woman commented on this experience 
in her interview, “When I had problems and could not bear it any longer, I went to the 
center, but they refused to take it out. They said, ‘Why did you take it, then?’... I had to 
lie and said that my two children had drowned in the river and my husband wanted 
another child. This time they took it out.”86 
In 1986, UBINIG began to publicize its findings. At a press conference held to 
protest the Norplant test trials in Bangladesh, the organization called on the Bangladeshi 
government to end the “unethical research.”87 Although the media supported UBINIG’s 
claims that Bangladeshi women were being treated as “‘animals of biomedical 
experimentation,’” neither the BFRP nor the government responded to the allegations.88 
Deeming this silence “a gross violation of human rights,” UBINIG reached out to other 
women’s health activists in Bangladesh and the rest of the world.89 
One of the first organizations UBINIG partnered with was the Feminist 
International Network of Resistance to Reproductive and Genetic Engineering 
(FINRRAGE); an organized alliance formed at the 1984 at the International Women’s 
Conference in Sweden.90 The organization was mostly made up of Anglo-European 
feminists who opposed population control activists in the “global South.”91 In 1989, 
UBINIG and FINRRAGE organized a conference in Comilla, Bangladesh focused on 
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women’s health, genetic engineering, and reproductive technologies.92 One hundred 
forty-five women from thirty-four countries attended the conference, and Norplant was a 
leading topic discussed.93 The conversations around Norplant demonstrated that the 
ethical violations committed against women during those trials were remarkably similar 
to the transgressions in Brazil, India, and Indonesia.94 Leading activists at the conference 
issued a statement against Norplant, IUDs, and injectable contraceptives.95 In March of 
the same year, UBINIG joined up with other women’s non-governmental groups in Sri 
Lanka, Pakistan, India, and Nepal to form The Resistance Network Against Abuse of 
Contraceptives on Women’s Bodies. This coalition held protests and appealed to 
Bangladesh’s Health Minister to end the use of Norplant and other controversial 
contraceptives.96  
As UBINIG began collaborating with other Bangladeshi feminists and women’s 
health organizations to combat the coercive use of Norplant, other women’s activists 
across the globe also took up the fight. For instance, Soheir Morsy investigated and 
exposed ethical violations during Egypt’s large Norplant trial. An Egyptian born feminist 
who moved to the U.S. with her family as a teenager, Morsy possessed a complex 
understanding of gender norms across cultures. “My sensitivity to gender differentiation 
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did not develop until my arrival in the United States,” she recalled. "Stereotypical 
characterizations of Arab women put me on the defensive and forced me to research the 
subject in order to present coherent arguments in defense.”97 These experiences led her to 
study women’s health in Egypt, with particular interest in the peasant woman’s 
experience.98 
During her fieldwork, as an Arabic-speaking Egyptian woman, Morsy had 
"privileged access to female spheres of activities,” and many of the women she 
interviewed were pleased to see her interest in their lives, culture, and well-being.99 She 
also utilized her position as a mother to gain other mothers’ trust and access to local 
women’s birth and postpartum rituals. On the other hand, Morsy employed her upper-
class position and her high level of education, a Ph.D. in medical anthropology from 
Michigan State University, to work in research spaces customarily designated for men in 
Egypt. Her education and upper-class origins led working-class men to interact with her 
more openly. They saw her as “a doctor-in-the-making who could discuss a variety of 
topics without shame.”100 These multiple identities aided Morsy in her investigation of 
Egypt’s Norplant trials.  
In the 1980s, Morsy investigated the International Islamic Center for Population 
Studies and Research at Al Azhar University’s and Alexandria University’s decision to 
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conduct a collaborative Norplant acceptability trial.101 Egyptian researchers proposed a 
three-year study that included about a thousand women living in rural villages and Cairo. 
Each university’s faculty would conduct a portion of the study; servicing about 250 
Norplant implants each.102 In her investigation of the large Egyptian trials, Morsy 
examined the nation’s history of population control policy and tracked which nations and 
international institutions funded Egypt’s family planning programs. She found that during 
the second half of the twentieth century, the international community, and particularly the 
U.S., pressured Egypt to adopt population control measures. In 1965, the Egyptian 
government introduced the nation’s first family planning programs, but their effects on 
the nation’s population growth were limited.103 Population control advocates believed 
that Egypt’s population continued to grow because healthcare professionals were not 
administering the oral contraceptive pill efficiently and that many women chose to stop 
using it.104 The international community quickly became interested in Egypt’s inability to 
control its growing numbers. The U.S. government provided Egypt with generous 
funding for birth control both directly through USAID and indirectly, through 
organizations like the International Planned Parenthood Federation. In fact, between 1975 
and 1983, over half of the U.S.’s allocations to Egypt’s health and development were 
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appropriated to population control programs. Responding to this pressure, the state-
regulated press used cartoons to single out women, and their ability to procreate, as a 
hindrance to the development of the nation.105 In the early 1980s, Egypt’s Supreme 
Council for Family Planning urged universities to organize a field study of Norplant 
because the government hoped that access to the contraceptive implant would be a safe 
way of preventing pregnancies throughout the country.106  
Morsy tracked the Egyptian press’s coverage of Norplant and the impending drug 
trials. She pointed out that the press heavily advocated for Norplant, considering it a 
major technological advancement and often referring to it as “the magic capsule.”107 
Additionally, the media either downplayed or completely ignored questions about 
Norplant’s safety, side effects, and the possibility of coercion. To support their claims, 
the press cited only Norplant advocates, including Dr. Mamdouth M. Shaaban, a 
professor at Assiut University within the Department of Obstetrics and Gynecology, who 
strongly endorsed the contraceptive device and the Egyptian Ministry of Health, which 
classified Norplant as a safe contraceptive option.108 Without taking into account the 
contrast in healthcare access between women in western nations and women in poor 
communities in Egypt, the press extolled progressive nations like Finland, which had 
already approved Norplant for use, and encouraged Egyptian women to emulate 
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“‘international’ contraception trends.”109 Furthermore, Morsy found that the Egyptian 
press ignored the disproportionate power dynamic between the family planning 
physicians and trial participants and how it could potentially lead to reproductive abuses. 
Anthropological studies showed that Egyptian public health clinics had historically 
mistreated rural women, therefore, even before the trial began, Morsy believed that 
healthcare practitioners would likely prescribe Norplant inappropriately.110 
A number of Egyptian medical professionals and scientists criticized the use of 
Norplant as a way to curb their nation’s population growth. In fact, researchers from the 
Alexandria University Faculty of Medicine said they were not convinced of the method’s 
safety.111 They felt that it could be a particularly poor contraceptive choice for women 
living in rural Egypt because a shift in menstruation could be especially problematic for 
their day-to-day lives.112 Moreover, many Egyptian physicians pointed out that even 
though the U.S. had researched and developed Norplant, the clinical trials were 
predominantly in Global South. The physicians believed the Population Council had 
outsourced the trials because of their concerns over Norplant’s safety and their 
unwillingness to risk the health of U.S. citizens. They did not want Egyptian women to be 
treated like experimental specimens.113 
As a professional anthropologist, Morsy used her fieldwork training when she 
interviewed sixty trial participants and several members of the clinical staff at Assiut 
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University. She examined both the pre-insertion procedures and the ways Norplant 
impacted women’s health.114 Her conversations with Assiut personnel demonstrated that 
they were well versed in the drug’s risks and contraindications. The medical staff 
believed that because their patients were “‘uneducated’ or as one physician put it… ‘very 
limited’” they would not be able to understand how the contraceptive technology 
worked.115 Moreover, a Norplant researcher told Morsy that the contraceptive device 
“‘may suit very much our rural women who are careless in taking the daily pill.’”116 
Although physicians were required to prescribe Norplant according to scientific-based 
reasoning, Morsy concluded that they were applying class-based stereotypes to their 
patients in determining their suitability for the drug.  
In Morsy’s interviews with Norplant patients, she asked questions about their 
experiences at family planning clinics, how they heard about Norplant, why they decided 
to use the contraceptive device, and the role their husbands played in the process. Her 
interviews also covered Norplant’s health effects, with particular focus on altered 
menstruation cycles, the impacts on their children’s health, especially if they were 
nursing, the effects of Norplant on their sexual relationships, and their decisions to either 
continue using the device or to remove it before the five year period. As an 
anthropologist trained to conduct professional research, Morsy was perceptive of her 
subject’s body language and non-verbal communication. In addition, she used her 
personal connection to Egyptian women to gain her interviewees’ confidence, especially 
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when discussing intimate personal details related to their bodies and reproduction. During 
the interview process, Morsy observed and considered verbal, nonverbal, and 
surreptitious responses. She described this technique in her article, “Others replied 
secretly at opportune moments, for example when they hugged me or shook my hand at 
the end of the meeting.”117  
 Just as she predicted, Morsy’s interviews with trial participants demonstrated that 
the Norplant testing trials were not following proper procedure, and in the process, 
women were abused. Morsy noticed that the Egyptian press’s strong promotion of 
Norplant greatly influenced participants’ early perceptions of the contraceptive device. 
Others became interested in Norplant after another woman, who claimed to have used 
Norplant for a number of years, encouraged them to try it. Morsy later learned that clinics 
had “allegedly paid” these recruiters to promote Norplant to patients.118 Similar to 
patients in the Bangladesh trials, Morsy found Egyptian women suffering from a range of 
side effects, including irregular menstruation, excessive bleeding and amenorrhoea, 
depression, weight loss, fatigue, headaches, and dizziness.119  
Morsy documented the stress women experienced when doctors refused to 
remove the drug early. One woman, who Morsy called Amira, never experienced a 
normal menstrual cycle during the four years she was on Norplant. She initially lost her 
period and later suffered from hemorrhaging for several weeks at a time. In addition, she 
was often afflicted with dizziness, headaches, and fatigue. Amira asked her physician to 
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remove her Norplant on several occasions, but “the doctor simply refused.”120 Eventually, 
Amira sought help from another doctor outside of the family planning clinic who agreed 
to remove the implant, but he charged her a fee and said he did it only as a favor to 
Amira’s husband.121  
 Morsy published her research on Norplant and the Egyptian testing trials as a 
chapter in the book, Norplant: Under Her Skin. In 1989, the Women and Pharmaceuticals 
Project, a collaboration between the Dutch NGO, WEMOS and Health and Action 
International, sponsored a meeting at the European Women and Health Conference in 
Madrid. The meeting, which was attended by women's activists from Bangladesh, Brazil, 
India, Indonesia, Thailand, Denmark, Finland, and the Netherlands, focused mainly on 
new contraceptive technologies.122 Due to the dramatic increases in Norplant use in the 
late 1980s, much of the conversation revolved around the new contraceptive device. 
Activists who participated in movements against Norplant that had exposed the ethical 
violations during the drug’s test trial informed others of Norplant’s dangerous side effects 
and the threat of coercion. The conversations led to more questions about Norplant’s risks 
as well as discussions of issues such as the prescribing process, how menstruation 
disturbances affected women’s lives, and how Norplant affected women’s reproductive 
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rights.123 In order to answer the many questions that arose, the Women and 
Pharmaceuticals Project agreed to fund three field studies in Indonesia, Finland, and 
Brazil between 1989 and 1991. In 1993, each study, including Morsy’s investigation of 
Egypt, became chapters in Norplant: Under Her Skin. The Women and Pharmaceuticals 
Project, which was created to research, inform, lobby, and work with other international 
women’s health organizations to improve reproductive drugs and healthcare, published 
the book. The goal was to circulate information about Norplant, the ethical violations 
committed during its testing trials, and the feminists working to end the coercive use of 
the implantable contraceptive globally.124  
Similar to Morsy’s investigation of Egypt’s Norplant trials, Norplant: Under her 
Skin’s other chapters reveal reproductive atrocities in places like Indonesia, Thailand, and 
Brazil. These additional studies confirmed that ethical violations and coercive prescribing 
practices were common and that the testing trials were mostly targeting poor women 
living in the Global South. Poor prescribing practices were especially problematic in 
Indonesia where Norplant was first offered in 1987.125 At the time, population control 
personnel recruited trial participants using a method sometimes referred to as “‘Norplant 
safaris.’”126 During these safaris, family planning staff used military troops and 
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community leaders to persuade women to use the birth control device. One woman 
interviewed recalled a community leader threatening her with police force if she chose 
not to use Norplant. Trial recruiters provided women with limited verbal information and 
no written resources about the drug, its side effects, and risks. In addition, they told 
patients that Norplant was the safest form of contraception available to them (when in 
fact the oral contraceptive pill and intrauterine devices (IUDs) were established as safer 
options).127 These coercive practices resulted in more Norplant insertions in Indonesia 
than any other nation. By 1994, 1.8 million women, 9.5 percent of the country’s 
contraceptive users, were implanted with Norplant.128  
Norplant: Under Her Skin’s chapter examining Indonesia focused heavily on 
Norplant’s impact on Indonesian women’s ability to practice their religious beliefs after 
the contraceptive device was inserted. Irregular bleeding was particularly taxing on 
women who observed traditional Islamic practices related to womanhood and fertility 
because they were unable to pray, fast, or enter a mosque when they were menstruating. 
In addition, many women were also restricted from having sex or washing their hair 
while they were bleeding.129 Feminists pointed out that these traditions made Norplant a 
poor choice of birth control for any practicing Muslims.130  
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Additionally, the book’s chapter on Brazil demonstrated how feminist campaigns 
against Norplant were shifting women’s, doctors’, and governments’ perceptions of 
Norplant. The Brazilian trial’s ethical violations were proportional to other studies. They 
included inadequate counseling prior to insertion, poor medical follow-up, and medical 
professionals often refused to remove patient’s Norplant implants even after they 
expressed distress.131 But unlike other nations, the strong feminist response in Brazil was 
taken seriously, leading the nation’s Human Reproductive Rights Studies Commission of 
the Ministry of Health to ask women activists for assistance and guidance regarding the 
Norplant trials.132 Based on the feminist’s exposure of forced sterilizations, in 1986, the 
Brazilian government chose to order a police investigation and a suspension of the 
Norplant trials.133 
The feminist activists contributing to Norplant: Under Her Skin were well-
educated activists participating in the global women’s health movement and mobilizing 
against coercive population policies. They hoped their findings would create dialogue 
amongst other women’s health activists, governmental institutions, the global 
community, and the Population Council. Anita Hardon, one of the book’s editors and a 
medical anthropologist, later stated in an article that their intent was not to advocate for 
the ban of Norplant, but to help the World Health Organization (WHO) and the 
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Population Council to “formulate guidelines" for Norplant’s use.134 Hardon and her 
fellow feminist contributors believed that if trained medical professionals properly 
administered Norplant, it had the potential to be a good birth control option.135 
The studies presented in Norplant: Under Her Skin led some scientists and 
doctors to re-evaluate Norplant’s safety. A number of medical and scientific publications 
reviewed the work. While many reviewers strongly agreed with the book’s findings and 
praised the contributors’ efforts to expose Norplant link to reproductive abuse targeted at 
poor and minority populations, some also warned the reader that Norplant: Under Her 
Skin had an “overtly feminist” tone. Overall, the reviewers urged their readers, many of 
which were medical professionals, to consult the text before prescribing Norplant.136 In 
addition, Hardon attested that the book compelled many scientists devoted to the 
development of contraceptive technologies to engage with the women’s health 
movement.137  
Conversely, the Population Council strongly objected to the book's central claims. 
The woman responsible for Norplant’s introduction program, Karen Beattie, called the 
book’s analysis “skewed” and challenged the book’s co-authors’ knowledge of clinical 
research and practice. Also, in 1993, the Population Council published its own pamphlet 
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titled Introducing Norplant in Developing Countries. The publication detailed how the 
drug was being implemented throughout the world. After reviewing the booklet, women 
who had contributed to Norplant: Under Her Skin argued that the Population Council had 
made false accusations about the drug’s safety and left out crucial information about its 
side effects. For instance, the booklet claimed that the birth control device would not 
harm a nursing mother’s child, and it failed to include irregular bleeding on its list of 
most common side effects. Feminists argued that there was not enough definitive 
scientific evidence to determine the drug’s impact on nursing mother’s children. 
Additionally, when questioned about their decision to omit irregular bleeding from the 
list of common side effects, the Population Council stated that they did not believe that 
“intermenstrual bleeding,” or spotting, impacted a woman’s daily routine like a 
menstruation could, therefore they did not consider it to be a side effect. This justification 
infuriated feminists because they believed irregular bleedings could harmfully impact a 
woman’s quality of life.138 
The feminist contributors who studied Norplant’s testing trials hoped Norplant: 
Under Her Skin would help women to combat oppressive policies and campaign against 
future misuses of Norplant. Because feminists believed that traditional medical trials 
distorted their evidence to benefit Norplant’s developer, activists produced Norplant: 
Under Her Skin to uncover women’s true experiences with the drug. The researchers 
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sought to accurately represent the Norplant “user’s perspective.”139 This woman centered 
approach to medical research was innovative, especially when compared to the 
Population Council funded trials. Feminists and women’s health activists throughout the 
world embraced the book, and in the early 1990s, it became an important source for U.S. 
based feminists as they built campaigns against Norplant. Grassroots organizations, like 
the Native American Women’s Health and Education Resource Center (NAWHERC) 
used Norplant: Under Her Skin to better understand the risks associated with the 
contraceptive device, while also learning about the other incidence of coercive practices 
targeted at vulnerable populations.140 Despite these early feminist efforts to stop 
governments’ and international organizations’ from using Norplant to infringe upon 
women’s reproductive rights, these oppressive practices continued to impact poor and 
minority women living in the U.S. 
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CHAPTER III 
NORPLANT AND SOCIAL POLICY IN THE 1990s 
 
 
 On December 10, 1990, the U.S. Food and Drug Administration (FDA) approved 
Norplant for public use. Initially, many U.S. doctors and longstanding feminist groups 
like the National Organization for Women (NOW) and Planned Parenthood hailed it as 
the greatest advancement in contraceptive technology since the 1960s when the birth 
control pill first became available to the public. Dr. Daniel Callahan, director of the 
Hastings Center, a research institute, called Norplant “the dream method that people who 
work on birth control have looked for for decades.” Because of Norplant’s long-term 
effectiveness, many women saw it as a significant step forward in their reproductive 
freedom. 
	 Two days after the FDA’s approval, the Philadelphia Inquirer’s deputy editorial-
page editor, Donald Kimelman, published a controversial editorial titled, “Poverty and 
Norplant: Can Contraception Reduce the Underclass?” Kimelman, who began writing for 
the Philadelphia Inquirer in 1979, frequently presented commentary on social policies 
affecting people living in urban centers. In “Poverty and Norplant,” he suggested that 
Norplant could help address the growing rates of Black poverty. He claimed that about 
half of the nation’s African American children were living in poverty and that researchers 
suspected this number would increase. While stating that women should not be forced to
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 use Norplant, he proposed using it to curb Black poverty and teenage pregnancy by 
offering women on welfare monetary incentives to voluntarily use the device.1  
 Because of its racist and eugenic connotations, Kimelman’s article received 
national media attention. It infuriated many feminists, particularly African American, 
Native, Latina, and Asian and Pacific Islander women, who spoke out against the 
editorial and drew attention to the longstanding reproductive oppression of poor and 
minority women.2 In addition, the editorial upset Norplant’s scientific developer, Sheldon 
Segal, who wrote about his disapproval in an opinion piece printed in the New York 
Times on January 6, 1991. In the article, Segal stated that he was “totally and unalterably 
oppose to the use of Norplant for any coercive or involuntary purpose.”3 Instead, Segal 
argued fervently that he and his team created Norplant to empower women and provide 
them with greater reproductive freedom. Ultimately, the backlash forced the Inquirer to 
print an apology that described the piece as “misguided and wrongheaded.”4  
The controversy over the Inquirer piece was not an isolated incident. Norplant 
was part of a wave of controversial social policies in the 1990s that promoted the use of 
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neo-eugenic practices to attempt to curb the reproduction of poor and minority women 
across the U.S.5 Federal, state, and local governments along with an organization called 
Children Requiring a Caring Kommunity (CRACK) tried to force poor and minority 
women to use Norplant. These efforts were part in parcel of the War on Drugs, rising 
rates of mass incarceration, and attacks on welfare recipients. Further, as politicians 
sought to limit poor and minority women’s childbearing, they also vehemently opposed 
abortions. While historians have traced the effects of late-twentieth century welfare, drug, 
and policing policies on people of color, Norplant’s history demonstrates that the 
backlash was even more pervasive than most have recognized and that it included 
policies specifically intended to curb poor women’s childbearing.6 Women and men 
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experienced the restrictive and punitive social policies passed in the 1990s in different 
ways.  
 When Norplant was introduced to the American market in 1990, social policies 
were already making life much more difficult for poor people and people of color. For 
decades, political leaders blamed them for economic downturns and criminal activity, 
particularly in the nation’s large cities. In the 1980s, Ronald Reagan’s administration 
passed a series of policies that criminalized urban spaces and targeted people of color. 
These efforts also included aggressive law enforcement strategies targeted at petty drug 
offenses and harsh minimum sentencing laws on crack cocaine. In the mid-1990s, the 
sentencing disparity between crack cocaine, which was used primarily by poor people, 
and powder cocaine, which middle and upper-class white people tended to use, was 
staggering. The mandatory minimum for possession of five grams of crack cocaine was 
five years, but to receive the same amount of prison time, a person had to be caught with 
five hundred grams of powder cocaine.7 As a result of Reagan’s aggressive War on 
Drugs, the term used to define his administration's politically charged anti-drug 
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campaign, incarceration rates increased at a record pace.8 In 1970, police made about 
320,000 adult drug-related arrests; by 2000, that number rose to well over one million.9  
 Several violent incidents including the Rodney King beating, Latasha Harlins’s 
murder, and the L.A. Riots illustrated the racial tensions felt in the U.S. in the early 
1990s. In March 1991, four white Los Angeles Police Department (LAPD) officers 
brutally beat Rodney King, a twenty-five year old Black man, after a short car chase.10 
During the beating, the officers struck King over fifty times with their batons.11 His 
wounds were so severe the Los Angeles hospital was forced to send King to their trauma 
center for treatment. Without the LAPD’s knowledge, an amateur cameraman captured 
the incident. After the cameraman sold the footage to the media, both local and national 
news televised the video of the beating. The media attention led to a nationwide 
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discussion around race and police brutality. Despite significant outcry, especially from 
the African American community, a jury acquitted all of the officers the following year.12  
Just two months after the King beating, a forty-nine year old Korean convenience 
store owner, Soon Ja Du shot and murdered Latasha Harlins, a fifteen year old African 
American girl in Compton, California. When Du thought that Harlins was attempting to 
steal orange juice from her store, she and Harlins violently clashed. From behind the 
counter, Du grabbed at Harlins’ sweater. Harlins swung back at Du, hitting her three 
times. When Harlins was able to break free, she placed the bottle of orange juice on the 
counter and turned away most likely to leave the store. Du then pulled a gun out from 
under the counter and shot Harlins in the back of the head, killing her. Later during her 
murder trial, Du’s lawyers argued that her son modified the gun without her knowledge, 
giving it a hair trigger. Like the Rodney King beating, a security camera captured Latasha 
Harlins’s murder and the media televised the shocking footage. Although Soon Ja Du was 
found guilty of voluntary manslaughter, Judge Joyce Karlin chose to immediately release 
her on probation, only requiring Du to complete three hundred hours of community 
service and pay the expenses for Harlins’s funeral.13 In Judge Karlin’s sentencing 
remarks she stated that Du was not a threat to society and that Du reacted so dramatically 
because her family were the victims “of repeated robberies and terrorism” in their store.14 
Judge Karlin’s weak sentencing horrified African Americans and the racial tension 
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following the Rodney King beating and Latasha Harlins’s murder ignited the massive 
five-day long riot in Los Angeles in 1992. The L.A. Riot caused the incineration of over 
1,100 buildings, over 2,300 people were injured, and fifty-four individuals were killed.15  
Meanwhile, members of both the Democratic and Republican parties were 
stigmatizing welfare recipients. Welfare was never popular but the distrust of recipients 
of public assistance grew significantly after World War II, when welfare became 
synonymous with Black women migrating from the South to the North. In the 1970s, 
mostly Republican politicians from across the U.S. promoted anti-fraud campaigns 
targeted at ending the misuse of welfare benefits. While evidence showed that fraud was 
occurring on a very limited scale, these campaigns significantly increased suspicions of 
all women on welfare.16 During his 1976 presidential campaign, Ronald Reagan 
frequently disparaged welfare recipients describing them as lazy and deceitful and 
referring to them as “welfare queens.” The concept of the welfare queen illegitimately 
receiving large amounts of money from the state came to influence the political debate 
over welfare throughout the 1980s and 1990s.17  
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At the same time, many Democratic politicians began supporting policies 
previously associated with right-wing ideologies, like tax cuts and limiting welfare 
benefits. They argued that minimizing the government’s interaction with the marketplace 
would help the U.S. be more competitive in the global economy. In the early 1990s, 
Democratic President Bill Clinton epitomized this stance as he ran for president on a 
platform that advocated for sweeping welfare reforms and aggressive crime control 
policies.18 Ultimately, this political shift led to the passing of the Personal Responsibility 
and Work Opportunity Act (PRWORA) in 1996. The PRWORA eliminated the 
entitlement to welfare, approved stringent work requirements and time limits for all 
welfare recipients, and denied benefits to legal immigrants.19 While scholars have 
examined the negative effects of the PRWORA on welfare recipients, the role of 
Norplant in these struggles has been left out of the narrative.20  
Political rhetoric around teenage pregnancy was similarly linked to political 
attacks on poor and minority women, with particular emphasis on African American and 
Latina teenage girls. Although statistics show that the early 1990s saw a decline in 
teenage pregnancy rates, during President Clinton’s 1995 State of the Union Address, he 
argued that teenage pregnancy and children born out-of-wedlock was the U.S.’s “most 
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serious social problem.”21 At the time, both Democrats and Republicans argued that 
teenage pregnancy was a primary cause of many of society’s ills and the money spent on 
teenage parents and their children was depleting the nation’s resources. This political 
discourse created false perceptions and fears that allowed governments to place greater 
controls on teenage mothers’ lives and reproduction, including encouraging adolescent 
girls living in areas with high teenage pregnancy rates to use Norplant.22 
 To understand how Norplant came to play a role in late-twentieth century politics 
requires an exploration of the history of state-sanctioned sterilizations in the U.S. This 
practice dates back to the nineteenth century and the birth of the eugenics movement, 
which advocated for the sterilization of women deemed “unfit” for motherhood.23 
Eugenicists argued for the sterilization of women they believed would pass “defective” 
hereditary traits like “feeblemindedness” and alcoholism onto their children. In the early 
twentieth century, as eugenic theories became more widely accepted, political leaders 
began to consider reproduction a public health issue rather than a private decision. Some 
politicians and public advocates believed they should decide who was fit for motherhood. 
For instance, racist ideologies led eugenicists like Margaret Sanger to promote the use of 
permanent sterilization and birth control amongst women of color, especially African 
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American women, as a way to improve humanity.24 U.S. politicians employed eugenic 
theories to justify forced sterilizations of women labeled “feebleminded” until World 
War II when German Nazis used the same theories to justify the mass genocide of Jews. 
The Holocaust abruptly altered society’s acceptance of eugenics, but practices targeted at 
minority and poor populations continued long after the Second World War ended. 25  
 As discussed in the previous chapter, overflowing cities, air and water pollution, 
and increases in taxes to pay for welfare benefits in the post-war era led to an increased 
interest in population control policies in the U.S. and around the world.26 Advocates of 
“population control” argued for curbing poor women’s reproduction to combat rising 
population rates.27 Because the compelled use of oral contraceptives was difficult to 
enforce, they welcomed the introduction of early provider controlled contraceptives like 
IUDs. While initially not as effective as the birth control pill, IUDs were provider 
controlled, and therefore a woman could not choose to stop using the contraceptive 
device on her own. In the 1960s, the Population Council, a powerful nongovernmental 
organization (NGO) that advocated for global population control, developed the first 
IUD. With the hope of curbing population growth, the Council first made IUDs available 
to women living in the Global South. Shortly after, Planned Parenthood and clinics 
serving low-income communities in the U.S. began prescribing and inserting IUDs. 
During the 1970s, IUDs became more widely available to the American public. Almost 
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immediately, hundreds of major medical issues and eighteen women’s deaths were 
attributed to an IUD called the Dalkon Shield. The legal battle that followed resulted in 
over 11,000 lawsuits and A. H. Robins, one of the most successful manufacturing 
companies in the nation and Dalkon Shield’s producer, declaring bankruptcy. The 
controversy surrounding the Dalkon Shield made it difficult for population control 
activists to promote IUDs.28 Because Norplant was also a provider-controlled device that 
effectively prevented pregnancies for up to five years, it presented a new opportunity for 
people who wished to control women’s bodies through temporary sterilizations. It did not 
take long for the coercion to begin.  
 Just one month after Norplant’s FDA approval, a judge employed the drug as part 
of a woman’s parole agreement. On January 2, 1991, Darlene Johnson was convicted of 
child abuse for beating two of her four children with an electric cord and belt buckle.29 At 
the time, Johnson was a twenty-eight year old African American pregnant mother of four, 
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living in Visalia, California. After becoming a mother at sixteen, she used the welfare 
system to support her family. When a 60 Minutes reporter asked her about the case 
against her, Johnson admitted that she had beaten her children but stated that she still 
believed she was a good mother.30 Although Johnson was eligible for a six-year prison 
term, California county judge Howard Broadman ordered her to attend parenting classes, 
undergo mental health counseling, and serve three years of probation. He also required 
Johnson to have Norplant inserted into her arm for three years.31 To complicate the 
situation further, the media revealed that Johnson was diabetic and thus vulnerable to 
additional health risks associated with Norplant.32  
 Despite initial criticisms from feminists and human rights advocates, Judge 
Broadman remained steadfast in his belief that his order to sterilize Johnson for three 
years was justified. Broadman was already well known for creative punishments. Before 
Johnson’s case, he sentenced a man to wear a t-shirt that described his theft crime for a 
year as a part of his parole.33 In Johnson’s case, Broadman claimed the safety of her 
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children as his justification. He explained his decision: “The compelling state interest in 
the protection of the children of the state supersedes this particular individual’s right to 
procreate.”34  
Although Johnson initially agreed to the terms of the parole agreement, she 
disclosed that she was led to believe that her only alternative was serving four years in 
prison.35 After the ACLU came to her aid, Johnson decided that forced sterilization 
restricted her constitutional rights, and with the help of the ACLU, her court appointed 
attorney appealed the decision. Together they aimed to prove that the government had no 
right to mandate a woman’s use of birth control.36  
 This case angered many special interest groups, including anti-abortion advocates 
who spoke out against Norplant. Many used arguments about fetal rights and the rights of 
unborn children to oppose the use of Norplant.37 The fetal rights rhetoric reflected anti-
abortion advocates’ responses to the significant advancements in fetal medicine in the last 
decades of the twentieth century. Doctors’ abilities to study a fetus, track its 
development, and treat very premature infants inspired a fundamental shift in the 
perception of the maternal-fetal relationship, in which the medical community along with 
politicians and activists increasingly viewed the fetus as an individual separate from its 
mother. Increasingly, the fetus’s health was prioritized over the mother’s well-being.38  
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The American Life Lobby and the Family Research Council led the initial anti-
abortion campaigns against Norplant. These organizations, like women health activists, 
argued that Norplant was hurried onto the American market, and they believed the 
contraceptive device to be “‘an early abortion causing drug’” because it used hormones to 
block pregnancies.39 Hormonal-based contraceptives like Norplant do not always prevent 
ovulation (the release of an egg), but they do thin the lining of a woman’s endometrium, 
or the uterine wall. They prevent pregnancies because fertilized eggs are unable to 
implant in the uterine wall. Because many anti-abortion activists believe that “life begins 
at conception,” they reason that hormonal contraceptives cause early abortions.40  
 On March 6, 1991, an anti-abortion activist, who disagreed with Judge 
Broadman’s decision to use Norplant as a part of Johnson’s punishment, protested 
violently. Harry Raymond Bodine entered the Tulare County courthouse in Visalia, 
where Broadman worked, and fired one shot at him, narrowly missing his head.41 After 
shooting, Bodine set down his gun and firmly stated, “‘I’m guilty. I did it…Those drugs 
[referring to Norplant] kill babies.’”42 Bodine was charged with attempted murder, and 
Broadman subsequently removed himself from Johnson’s case.43  
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 While Johnson’s attorney and the ACLU continued the legal fight, the court threw 
out Johnson’s appeal after she was found to have used cocaine and ordered to return to 
prison for breaking her parole.44 Because the appeals court decided to not proceed with 
the case, no precedent was set, and judges across the country continued to employ 
Norplant as part of parole agreements.45 By 1994, U.S. judges had ordered seven women 
to have Norplant forcibly inserted.46 
 Welfare recipients were also at risk of being coerced into using Norplant. Before 
significant welfare reforms were passed in the mid-1990s, state representatives across the 
U.S. proposed programs that would either require women on welfare to be implanted 
with Norplant or provide additional monetary benefits to welfare recipients who chose to 
use the contraceptive implant. The first of these programs was proposed in Kansas. 
Republican state representative Kerry Patrick proposed the bill that would provide 
women on welfare with a $500 one-time grant if they agreed to an implant and an 
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additional $50 for each year the woman remained on Norplant.47 The controversial 
proposal incited much debate both within the state and nationwide.48 Patrick claimed that 
it was, “time we stopped worrying about the rights of the mother and started worrying 
about the rights of the children she’s bringing into the world.”49 With this incentive 
program, Patrick intended to prevent pregnancies amongst women on welfare, and 
publicly he used the rights of children and anti-abortion rhetoric to justify the Norplant 
incentive program. These justifications were reminiscent of anti-abortion advocates’ 
arguments against abortions. Therefore, both a woman’s right to have a safe and lawful 
abortion and a woman’s right to have a child was being attached to political ideologies 
aligned with the right.50  
 Leading the fight against Patrick’s incentive proposal in Kansas was the 
Democrat representative Kathleen Sebelius. Sebelius, who would later become the 
Secretary of Health and Human Services under Democratic President Barack Obama, saw 
Norplant as a significant breakthrough in birth control technology that could aid women. 
Seeing powerful men use the contraceptive device to “control women’s reproductive 
choices” horrified her. 51  
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Meanwhile in Louisiana, David Duke, a former Grand Wizard of the Ku Klux 
Klan was running for governor. As a part of his platform, Duke proposed an initiative 
program that would give mothers on welfare cash payments if they used Norplant. 
Although Duke considered his proposal to be “tough love” for welfare recipients, others 
considered these proposals to be forced sterilization.52 An article in The Harvard 
Crimson, the daily student newspaper, commented: “When women are desperate for 
money to help raise their children, the carrot of increased benefits for using Norplant 
becomes a stick, and choice becomes coercion, even extortion.”53 Duke lost the race but 
in 1991, as a member of Louisiana’s State Senate, he proposed legislation offering $100 a 
year to any woman on welfare who used Norplant.54  
Almost immediately, other state legislatures across the U.S. proposed programs 
that encouraged poor women to use Norplant. In 1993 alone, seventeen legislative 
measures related to Norplant were proposed in ten states: Arizona, Arkansas, Colorado, 
Florida, Illinois, Maryland, North Carolina, Ohio, South Carolina, Tennessee, and 
Washington. An examination of the 1992 presidential results demonstrates that these 
states were not dominated by a single political party -- both Democrats and Republicans 
advocated these policies.55 Most of the proposed measures offered monetary incentives to 
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women who chose to go on Norplant, and a few of the bills required AFDC recipients to 
use Norplant to maintain their cash assistance.56 The state delegates who sponsored the 
bills maintained that they were not pressuring women to use Norplant because the 
monetary incentive offered was too small to create significant change in a woman’s life. 
In other words, they believed that although the extra money would be enough to gain the 
attention of women living on welfare, it was not enough to be considered coercion.57 
Feminist and human rights organizations opposed the policies arguing that they were 
coercive sterilizations.58 A lawyer working at the ACLU observed that the organization 
would have loved to see these programs be a part of a larger effort to make reproductive 
health care better rather than “a bribe that pushes women into one choice instead of 
creating more choices.”59 Ultimately, due to the backlash and media attention, none of the 
incentive programs passed the proposal stage. 
While the incentive programs were never put into practice, temporary 
sterilizations ramped up after Norplant’s introduction to the American market. Every 
state’s (and D.C.’s) Medicaid program agreed to pay for a recipient’s Norplant device 
and insertion. While this gave many poor women access to the contraceptive device, 
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some feminists, especially feminists of color and indigenous feminists, argued that it was 
coercion because Medicaid did not cover all forms of contraceptives. Also, many states’ 
Medicaid programs did not cover Norplant’s removal, which could cost as much as two 
hundred dollars, especially if the removal happened before the standard five-year 
period.60 In South Dakota, Oklahoma, and South Carolina, the state would not pay to 
have the device removed early unless a woman experienced a medical complication 
authorities deemed worthy.61  
Many Medicaid recipients struggled to convince healthcare providers to remove 
their Norplant device upon request. For instance, Su Jaan Fields, a twenty-one year old 
woman living in Detroit in the early 1990s, chose to use Norplant following her 
daughter’s birth because Medicaid covered the costs. When she had Norplant inserted, 
her nurse practitioner did not counsel her on the side effects and risks associated with the 
drug. Fields was surprised when she experienced severe cramping, constant bleeding, 
migraines, dizziness, and fatigue. Her symptoms prompted her to return to the clinic to 
have the device removed. Field’s nurse practitioner tried to treat her symptoms with 
estrogen, birth control pills, Motrin, and vitamin C.62 After two and a half years of 
suffering, Fields switched clinics. Her new doctor agreed to remove the Norplant device, 
but when she underwent the surgery the doctor found that the capsules had been inserted 
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too deeply. After an hour-long painful procedure, which tore ligaments in her arm, the 
doctor was still unable to locate the sixth capsule and decided to leave it in.63 Two years 
following the ordeal, Fields discussed her experiences with Norplant in an article in Ms. 
Magazine. She stated that she was still suffering from frequent migraines caused by 
Norplant.64  
 Native American women living on reservations were frequently the victims of 
unethical prescribing practices. As a form of reparations, beginning in the 1920s, Native 
Americans living on reservations were provided free healthcare services. Later in the 
1950s, the Indian Health Service (IHS), a division of the U.S. Public Health Service, 
became the primary healthcare provider for Native peoples and the agency’s paternalistic 
approach to healthcare often led to oppressive practices.65 As early as 1991, the IHS 
began aggressively prescribing Norplant.66 Native American feminists researched this 
practice and concluded that the federal agency lacked a standard prescribing procedure to 
secure informed consent. They also lacked systems to monitor women’s health following 
insertion procedures. The result was that healthcare providers were prescribing Norplant 
without making patients were good candidates for the drug. Native American women had 
high rates of health problems such as diabetes and high blood pressure that made 
Norplant a poor birth control choice for them. Yet patient surveys revealed that IHS 
practitioners pushed Norplant upon them without informing them of the possible risks 
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involved. Further, the IHS did not have a tracking system to remind their patients to 
remove their device after the five-year period. This decision put Norplant patients’ lives 
at risk because if a woman became pregnant while the device was still in her arm, she 
was at risk of an ectopic pregnancy.67 
 Another incentivized use of Norplant came from an organization that paid cash to 
individuals struggling with substance abuse to be permanently or semi-permanently 
sterilized.68 This organization came on the heels of the punishment for possessing crack 
cocaine under Reagan’s War on Drugs and amid growing efforts to criminalize women 
who used the drug during their pregnancy. Policymakers used fetal rights arguments to 
argue for the protection of the unborn child and justify a widespread racialized attack 
against women alleged to use crack during their pregnancies.69 The image of the “crack 
baby,” a term that described a developmentally delayed newborn who was exposed to 
crack prior to birth, vilified Black mothers and justified prosecuting and sterilizing 
women who tested positive for drugs after giving birth.70 In this political climate, Barbara 
Harris, a mother of six living in Orange County, California, founded an organization 
called Children Requiring a Caring Kommunity (CRACK) in 1994. Initially, the 
organization’s sole mission was to pay women who used crack cocaine to be sterilized 
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either surgically or through the use of long-acting reversible contraceptives like 
Norplant.71  
Harris experiences as a foster parent inspired her to found CRACK. In 1989, she 
had become a foster parent to an eight-month-old baby girl, Destiny. The child’s 
biological mother had used Phencyclidine (also known as PCP), crack cocaine, and 
heroin during her pregnancy. At birth, Destiny had medical issues doctors believed were 
related to withdrawal and they said she was in danger of lifelong learning disabilities. 
Just a few months after Harris brought Destiny into her family’s home, she received 
another call from the foster system notifying them that Destiny’s birth mother had 
delivered another child suffering from similar symptoms. They decided to become foster 
parents to the infant. This situation occurred another two times leaving them with four 
foster children from the same birth mother.72  
 In the early 1990s, after failing to get the attention of the district attorney and 
police, Harris lobbied Republican Assemblyman Phil Hawkins, who represented the 
mostly blue-collar region in Los Angeles County’s South Bay, to sponsor the Prenatal 
Neglect Act. If passed, the act would have punished any woman who knowingly used a 
controlled substance while pregnant with either a misdemeanor or a felony depending on 
the seriousness of the child’s condition at birth. While Hawkins argued that the act was 
born out of Harris’s personal experience as a foster mother, scholars have shown that it 
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was also part of a larger political movement to reform welfare legislation in the early and 
mid-1990s. Political figures associated with both the Democratic and Republican parties 
supported these reforms.73 To gain support for the bill, Harris discussed the issue on talk 
shows. On an episode of The Oprah Winfrey Show, Harris talked about drug users like 
the biological mother of her adopted children: “If these women use Norplant… they 
couldn’t get pregnant. I believe that that is the solution.”74 Organizations that opposed the 
bill, like the ACLU and Planned Parenthood, considered it to be disadvantageous.75 They 
worried that women drug users fearing prosecution and arrests would be less likely to 
seek out prenatal care. Additionally, the proposed act targeted women living in poverty 
because they were ineligible and unable to afford treatment services. Instead of 
criminalizing women suffering from drug addiction, the opposition wanted to provide 
more treatment options.76 Some pointed out that women who chose to be permanently 
sterilized may later regret their decision. A Planned Parenthood representative 
commented: “Some women are able to kick their habits and get off of this addiction and 
then what happens if they have made a decision with a method of birth control that is 
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considered to be permanent.”77 The strong opposition to the bill ultimately led 
California’s Senate to defeat it in 1996.78  
Rebuffed by the failed legislation, Harris turned to the private sector and her 
organization to fix the issue. Through CRACK, Harris offered both fathers and mothers 
struggling with abuse $200 (later the price increased to $300) in cash if they could prove 
that they were permanently sterilized. The organization also offered individuals who had 
never given birth cash for long-term birth control use, including Norplant patients.79 To 
spread the word about CRACK, Harris placed advertisements on public transportation in 
neighborhoods in which police and prosecutors considered to have high levels of illegal 
drug activity. As a way to gain additional attention, many of the advertisements were 
abrasive, including statements like “Don’t Let a Pregnancy Ruin Your Drug Habit” or 
“‘If You Use Drugs, Get Birth Control, Get $200 Cash.’”80 
 In the mid-1990s, Harris again appeared on a number of news programs and 
daytime talk shows to publicize her message and organization. During many of these 
appearances, she became heated and confrontational with other guests or the hosts. For 
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instance, on The Gabrielle Show, a daytime talk show hosted by actress and trade union 
leader Gabrielle Carteris, Harris told a group of recovering and drug addicted mothers 
that they should be temporarily sterilized at least until each were clean for five years.81 
While on The View, ABC’s popular daytime talk show hosted by the longtime journalist 
Barbara Walters, Harris was asked about Judge Judy Sheindlin’s, the family court judge 
who starred in the show, Judge Judy, comment that CRACK was rewarding individuals 
for bad behavior. The judge felt that drug users should be placed in jail, not sterilized. 
Harris firmly disagreed, arguing that Sheindlin was “uninformed.”82 She believed that 
because women sent to jail or treatment centers had the potential to relapse, the only 
answer to the problem was long term birth control or permanent sterilization.  
Feminist and civil rights organizations such as the National Advocates for 
Pregnant Women, the New York City Health and Hospitals Corporation, and the National 
Association for the Advancement of Colored People (NAACP) argued that Harris took 
advantage of women at their most vulnerable moment. When The View’s host Walters 
pointed out that the money Harris’s organization gave to people suffering from substance 
abuse could easily be used to feed a drug addiction, Harris responded, “that is their 
choice, but the babies don’t have a choice.”83 Many people agreed with her arguments 
and supported her organization. During the 1990s and early 2000s, she secured private 
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donations from many donors, including the principal heir to the Mellon fortune, Richard 
Mellon Scaife, and funded sterilizations in all fifty states and Washington D.C. Although 
it is no longer called CRACK, Harris still runs an organization that gives cash to drug 
users who choose to be sterilized.84  
 A state-sanctioned attempt to use Norplant to temporarily sterilize poor women 
took shape in late-twentieth century Baltimore. In the late 1980s and early 1990s, a time 
when many African American residents of the city were confined to run-down 
neighborhoods and struggled to find decent jobs, the city’s public health officials 
attempted to use Norplant to curb teenage pregnancy. Baltimore experienced some of the 
highest crime and teenage pregnancy rates in the U.S. The city ranked second in both 
murder and violent crimes, with much of the violence being drug related. Law 
enforcement’s efforts to eradicate the violence focused on severely prosecuting petty 
crimes and led to significant distrust between the city’s leaders and its African American 
residents.85 
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These racial tensions and violence coincided with some of the highest teenage 
pregnancy rates in the nation. In 1991, while Maryland’s birthrate was 66.8 births for 
every 1,000 women between the ages of fifteen and forty-four, in Baltimore it was 100 
for every 1,000.86 Critics noted that the majority of these teenage mothers relied upon 
government assistance programs, such as Aid to Families with Dependent Children 
(AFDC), the special supplemental food program for Women, Infants, and Children 
(WIC), food stamps, and Medicaid, costing the state and federal government about 222 
million dollars each year.87 Furthermore, adolescent mothers were more likely to 
experience difficult pregnancies and give birth to babies with low birth weights. To care 
for a premature baby in the Neonatal Intensive Care Unit (NICU) cost Medicaid about 
$1,500 each day and typically $14,000 total. Critics claimed that these infants’ early 
medical traumas often led to deficient development and supplementary education 
expenses for special needs.88  
Shortly after Norplant’s FDA approval, Baltimore city officials created an 
initiative giving teenage students access to Norplant in their school-based health clinics. 
The measure focused on getting Norplant into majority minority public schools. Before 
the program was enacted, in their efforts to reduce teenage pregnancies, city officials had 
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employed many tactics. City officials had placed health clinics in inner-city malls and 
offered teenagers an array of services, including family planning counseling for more 
than 5,000 adolescents each year. They also launched a citywide media campaign 
advocating abstinence. In the public schools, they organized male outreach activities and 
mandated sex education classes. Lastly, two of Baltimore’s middle schools and six of its 
high schools offered family planning services in their healthcare centers. Some city 
officials claimed these citywide programs led to a stabilization of birth rates amongst 
teenagers. Yet in 1992, Baltimore still had some of the highest teenage pregnancy rates in 
the nation.89 
 Clinicians staffing Baltimore’s high school health centers were permitted to 
provide students with family planning counseling, exams, and vouchers that could be 
exchanged for birth control at an off-site pharmacy. This policy had been put into 
practice in 1985. Yet since many students failed to redeem their vouchers for 
contraceptives, in 1990, the health department began offering oral contraceptives, foams, 
and condoms in high school health centers. Surveys revealed that seventy-five percent of 
parents favored this policy.90 In 1992, as a pilot trial, they added Norplant to the list of 
available contraceptives in one public school. While Baltimore’s Health Commissioner, 
Peter Beilenson, claimed that a number of parents and students requested it, the decision 
can also be attributed to a privately funded grant.91 In 1992, the Abell Foundation, a 
Baltimore-based organization dedicated to financing health, education, and economic 
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development ventures in the city, awarded Maryland’s health department a $200,000 
grant to help the city of Baltimore introduce Norplant to low-income women who 
qualified for state-based medical assistance and lacked private insurance. Soon after, as a 
pilot test, they added Norplant to the list of available contraceptives in one public 
school.92  
The school chosen for this pilot trial was Laurence G. Paquin, a combined middle 
and high school that exclusively taught pregnant teens and girls who were already 
mothers.93 Of Paquin’s 350 female students, all but five were Black.94 Despite these 
numbers, Dr. Beilenson avowed that the policies had no racial bias.95 Baltimore’s health 
officials said that they chose Paquin for two reasons. First, statistically, teenage mothers 
are at higher risk of becoming pregnant than their peers. Second, Paquin’s African 
American principle, Dr. Rosetta Stith, was exceptionally supportive of the program. Stith, 
a Baltimore native, had a reputation as a strong supporter of both her teenage students as 
well as their young children.96 She believed that many of her students, and teenage 
mothers in general, did not consider the consequences of having children because the 
environment they were raised in promoted dependence on welfare.97 Stith affirmed that 
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her students enthusiastically supported the Norplant program, telling the New York Times 
that the students considered the implant an “advanced method that would let them go on 
with their lives without worrying about getting pregnant, or remembering to get their 
birth control prescription filled.”98  
 As the public became increasingly aware of Baltimore’s Norplant program, a 
tense national debate broke out. This dispute uncovered a deep-seated divided within the 
African American community over the issue of sex. In the 1960s, Black psychologists 
Kenneth B. Clark argued that middle-class African American’s attitudes towards sex 
differed greatly from working-class African Americans, and this was particularly true for 
women. He contended that middle-class Blacks girls linked sex to their social status and 
ambitions for upward mobility. Conversely, working-class African American adolescents 
associated sex with pursuits of acceptances, affection, and love. Therefore, the dishonor 
often associated with children born out of wedlock was much more prevalent amongst 
middle-class African Americans populations. In the 1990s, sociologists William Julius 
Wilson attested that increases in joblessness in the nation’s inner-cities made Clark’s 
analysis of the connection between sex and social status even more pertinent.99  
The controversy surrounding Baltimore city officials’ decision to make Norplant 
available in public schools illuminated these sharp divides within the African American 
community. Some activists and organizations considered Baltimore’s program to be a 
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form of race-based population control linked to a long history of discrimination against 
Black mothers. Others, mostly middle and upper-class African Americans, insisted the 
program would aid young mothers as they worked toward completing their high school 
education.   
The Nation of Islam (NOI) and its minister, Louis Farrakhan, opposed 
Baltimore’s program and Norplant altogether. Historically, the NOI advocated for a 
racially segregated society, and its male leaders promoted strict gender norms and 
celebrated nuclear family units headed by Black men. The NOI promised to protect its 
female members and value their femininity with the expectation that they would comply 
with strict gender roles that were centered on child-rearing. While the vow of protection 
and security was alluring for many African American women, this agreement, as 
historian Ula Yvette Taylor demonstrates in her book The Promise of Patriarchy, led to 
gender relations built on a stringent hierarchy and subordination.100 Because the NOI had 
long prioritized men’s protection of Black women and racial purity, it strongly objected 
to any use of birth control and charging its female members with the task of 
reproduction.101 In the early 1990s, NOI representatives argued that Norplant was 
developed to “destroy” Black women and children and that Baltimore's policy was a 
premeditated attack on African Americans. Linking Baltimore’s Norplant program to the 
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U.S.’s history of discrimination against African Americans, Farrakhan called it 
genocide.102  
Alongside the NOI, the Clergy United for the Renewal of East Baltimore 
(CURE), an organization of African American ministers representing over 200 of 
Baltimore’s Black churches, questioned the city’s Norplant program.103 They argued that 
white Americans should not be allowed to dictate African Americans’ procreation.104 
CURE leader Rev. Melvin Tuggle pointed out white city officials’ hypocrisy: “You know 
as well as I know that they wouldn’t let their twelve-year-old girl get Norplant. And I 
know their daughters are just as sexually active as anybody else.”105  
Conversely, Dr. Joycelyn Elders, Clinton’s African American Surgeon General, 
supported Baltimore’s attempts at decreasing the city’s teenage pregnancy rates. 
Throughout her career, she fearlessly took on contentious issues, especially regarding sex 
and the spread of sexually transmitted diseases (STDs). Amid the AIDS epidemic, she 
ardently promoted condom use. Elders famously displayed a bouquet made of condom 
wrappers on her desk in Washington D.C. She also vehemently disagreed with 
abstinence-only sex education, even going so far as to encourage educators to teach 
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young people about masturbation. While Elders political beliefs were often seen as 
controversial, her supporters commended her commitment to serving vulnerable 
populations.106  
During her tenure as Surgeon General, Elders made reducing teenage pregnancy a 
primary goal. Because she believed that much of the nation’s poverty stemmed from 
teenage pregnancies, she unwavering advocated for efforts to lower unwanted pregnancy 
rates. Elder’s dedication to the issue was reflected in her unapologetic and polarizing 
comments about Baltimore’s Norplant program. “Black people don’t want their children 
born to children,” she said. Directly addressing African Americans who disagreed with 
the program, she asserted “whoever goes around talking about genocide is someone who 
likes to see people in slavery.”107  
Reproductive rights organizations quickly joined the debate. Many feared that the 
program could gravely affect teenage patients’ health. For instance, Maryland’s Planned 
Parenthood argued that Norplant’s many side effects, particularly the risk of excessive 
bleeding, made it a poor choice of birth control for teenage girls. Instead of making 
Norplant easily accessible to students who might make rash decisions, Planned 
Parenthood recommended educating high school students about Norplant, its benefits and 
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drawbacks, and where, when, and how to get it.108 The National Women’s Health 
Network, the National Black Women’s Health Project’s (NBWHP), and national Planned 
Parenthood worried that supplying teens with Norplant would lead to an increase in 
STDs, and particularly AIDS, the fatal disease that was becoming increasingly common 
in the city, especially amongst African Americans.109 In an appearance on the Donahue 
Show, Stith, Paquin’s principle, directly responded to these critics, claiming that her 
students knew that they needed to use condoms along with hormonal contraceptives to 
prevent STDs. Countering the public perceptions of young Black poor women as 
promiscuous, she also emphasized that they did not see contraception as a “license for 
casual sex.”110  
 Many Paquin students spoke out in support of the program, saying that Norplant 
would help them earn their diplomas. For instance, Consuela Law and Kimberly Lucas 
each had two children by the time they were nineteen. Both women chose to have 
Norplant inserted believing it would help them get to college and acquire good jobs.111 
“Without it I'd probably have more children," Law said. "I want to complete my 
education."112 Another student featured in a CBS Evening News report addressed the 
critics who called Baltimore’s program ethnic genocide. She told a reporter, “It is not a 
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race thing, it is a pregnant thing.”113 Eleven of the estimated one hundred nonpregnant 
Paquin students had Norplant inserted during the first semester of the program.114 
In 1993, the growing opposition to Baltimore’s decision to make Norplant 
available to students in their high school’s health clinic forced the city council to hold an 
open hearing. Approximately 300 people attended the emotionally-charged event that 
lasted more than six hours.115 The audience and speakers consisted of city council 
members, city officials, Paquin students, religious leaders, residents, and more than one 
hundred members of the NOI. Jamil Muhammad, a member of the NOI and Louis 
Farrakhan’s official representative, proclaimed, “I will not sit by and let my sisters and 
my children be destroyed by Norplant.”116 Carl Stokes, an African American city 
councilman, described the program as “a social and medical experiment on children.” 
Stokes accused the chairman of the hearing of cutting off individuals who testified 
against the program. Other opponents voiced concerns over the lack of protection 
Norplant provided against STDs and the drug’s insufficient testing.117  
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 Several Paquin students spoke out in favor of the program attesting that it had 
helped them regain stability and hope for their future.118 Beilenson also spoke up to 
defend the program, stressing that no student had or would be coerced into using 
Norplant.119 He along with the hearing’s chairman accused their adversaries of using the 
program as a political platform to further their own agenda. The hearing was so 
contentious that it led Washington D.C.’s health commissioner to halt plans for a 
program that would have provided Norplant devices to as many as fifty young women 
living in low-income neighborhoods. Not wanting to cause a similar controversy, 
Washington D.C. officials ultimately chose not to implement the program.120 
 Following the hearing, Baltimore’s health officials closely monitored the 
program’s impact on Paquin’s student body. They contended that while some of the 
students experienced minor side effects, none chose to have their Norplant device 
removed. In addition, the post-insertion checkups revealed that most of the Norplant 
patients claimed to have increased their condom use, resulting in only one case of STD 
transmission. Officials attributed the increase in condom use to the counseling given both 
before and after each student received their implants.121 
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 These initial successes motivated city officials to expand the program to five 
additional schools.122 Before implementing the programs, they spoke with Baltimore’s 
prominent religious groups, a citywide community health advisory group, and local 
parents. They also made an effort to educate the schools’ faculty and administrative staff. 
City officials gave a series of presentations to the students covering an array of related 
topics, including abstinence, Norplant, and other birth control options. Prioritizing 
student accessibility, City officials argued that school-based clinics were the ideal 
location for offering teenage girls birth control. By 1995, the city had expanded the 
program into three additional high schools with plans to enter more.123 Evidence suggests 
that while some student users became staunch Norplant advocates, the number of teenage 
girls who chose to use it was low. It was not a popular choice in school clinics.124  
 In 1995, Maryland’s state senate entered the tense conversation surrounding 
Norplant. That year, four African American, Democratic state senators, Clarence Mitchell 
IV, Talmadge Branch, Anthony C. Muse, and Emmett C. Burns, Jr., introduced House 
Bill 511 (HB 511). The bill aimed to prohibit public school health clinics from 
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distributing any form of long-term contraceptives.125 Before the state senate voted on the 
bill, community members, political and religious leaders, and specialists testified. Much 
of the discussion mirrored the debate that occurred around Baltimore’s Norplant program, 
and many of the same organizations and political figures participated. For instance, the 
NOI strongly supported the bill, with one of their representatives arguing that Baltimore’s 
Norplant program had exploited young African American women. “We, in the Black 
community, do not feel that we should be the perpetual guinea pigs…in some grand 
social experiment,” he said.126 Several community and medical leaders expressed 
opposition to the bill, fearing that HB 511 could lead to restrictions that would prohibit 
school-based clinics from prescribing or distributing any form of contraception. Dr. 
Vanessa Cullins, the Director of Reproductive Health for the city of Baltimore and the 
Director of Family Planning Services at John Hopkins’ Bayview Center, stated that 
because the bill banned “long-term contraception,” not specifically “Norplant,” it had the 
potential to prohibit other contraceptive options prescribed in the schools.127  
A number of testimonies focused on how Baltimore’s Norplant program saved 
taxpayers’ dollars, issuing statements that presumed that public school students would 
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become welfare recipients.128 For instance, Cullins’s testimony stressed the state’s 
financial costs associated with teenage pregnancy. She estimated that for each live birth 
the state paid $5,832 in AFDC and food stamp costs and that teenage mothers would 
depend upon social programs for ten years. Cullins cited her study of teenage girls’ birth 
control choices following a birth or abortion, which showed that girls who chose 
Norplant continued to use the device longer than others who chose alternative methods 
and were much less likely to become pregnant unintentionally.129 Such arguments 
convinced many senators--HB 511 did not pass. This outcome allowed school- based 
clinics throughout the state to prescribe Norplant and other forms of long-term 
contraceptives to teenage girls. Further, Maryland’s Congress introduced two more bills 
to prevent Norplant from being distributed in school-based health clinics but failed to 
pass either one.130  
 In the 1990s, American judges, lawmakers, and community leaders tried to use 
Norplant to reduce the welfare state, curb teenage pregnancy, and temporarily sterilize 
women who used illegal drugs. These efforts were part of a wider assault on poor African 
American communities. Black men were the primary targets of the phenomenal growth 
of imprisonment that accompanied the War on Drugs on city streets. Some women of 
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color and indigenous women also got caught up in this dragnet, but they were more likely 
to be targeted through policies directed at their childrearing and procreation such as the 
elimination of welfare and the outcry about “crack babies.” Norplant was part of this 
gender-based assault on poor and minority people’s lives.  
Feminists, and particularly feminists of color and indigenous feminists, fought 
back. 
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CHAPTER IV  
 
THE U.S. WOMEN’S HEALTH MOVEMENT AGAINST NORPLANT 
 
 
U.S. feminists began mobilizing against Norplant even before the drug came onto 
the market. They learned from and built upon the already existing activism in nations in 
the Global South like Bangladesh and Egypt and generated their own campaigns aimed at 
informing U.S. women about Norplant’s risks and side effects and ending the coercive 
population control initiatives and policies surrounding implantation and removal. 
Feminists of color propelled the activism against Norplant in the U.S., and their 
campaigns were part of the rise in the reproductive justice movement that called for a 
more inclusive women’s health agenda that included issues related to coercive 
sterilizations.  
In 1990, when Norplant was approved for use in the U.S. by the Food and Drug 
Administration (FDA), Unnayan Bikalper Nitinirdharoni Gobeshona (UBINIG) and its 
allies in the Resistance Network responded quickly. They wrote letters to the U.S. 
Agency for International Development (USAID) and the FDA expressing their outrage 
that the agency would approve a provider controlled device that “by nature” was 
coercive. They challenged the drug’s safety, arguing that the Norplant trials violated 
participants’ human rights and their findings were based on insufficient research 
practices. Moreover, the Bangladeshi activists argued that Norplant’s FDA approval held
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 weight globally, therefore, was problematic for both U.S. women and women around the 
world.1  
In addition to writing to government institutions, UBINIG shared their concerns 
with a number of U.S. women’s health organizations. In the 1980s, they had built global 
communication networks largely through their participation in United Nations 
conferences and other international meetings. The networks and alliances formed at these 
conferences took cues from grassroots mobilizations in the Global South. Feminists 
working in these regions and transnationally expanded the idea of reproductive rights to 
portray a woman’s reproductive needs throughout her life.2  
As shown in the first chapter, these trends played out in the fight against Norplant, 
with women in the Global South leading the charge. During the 1980s, recognizing that 
international alliances would strengthen their efforts, organizations in the Global South, 
like UBINIG, reached out to other national and international women’s organizations. 
Activists in Bangladesh first called upon groups with which they already had established 
relationships. For instance, in 1985, UBINIG asked the U.S. based National Women's 
Health Network (NWHN) for assistance because they had a connection with its current 
president, Sybil Shainwald. Shainwald, a lawyer, women’s health activist, and member of 
the NWHN, had represented a group of Bangladeshi women in a case against the 
 
1 Jael Silliman, Marlene Gerber Fried, Loretta Ross, Elena R. Gutierrez eds., Undivided Rights: Women of 
Color Organize for Reproductive Justice, (Cambridge: South End Press, 2004); Farida Akhter, 
“Correspondence on Norplant Approval: Letter to US Agency for International Development,” in Resisting 
Norplant: Women’s Struggle Against Coercion and Violence, ed. Farida Akhter (Dhaka: Narigrantha 
Prabartana, 1995), 86; Akhter, “Correspondence on Norplant Approval: Letter to US Agency for 
International Development,” 86-87. 
2 Rosalind Pollack Petchesky, Global Prescriptions: Gendering Health and Human Rights, (London: Zed 
Books, 2003), 1-5. 
 
 
 
96 
company that developed the Dalkon Shield (an intrauterine device (IUD) in the 1970s. 
Soon after it was discovered that the Dalkon Shield had caused eighteen deaths and 
hundreds of unintended sterilizations, women’s health advocates like Shainwald used the 
U.S. court system to help victims in the U.S. and Bangladesh and warn women of the 
dangers associated with the contraceptive device. During these legal proceedings, 
Shainwald made valuable connections with women’s health activists in Bangladesh, and 
these relationships continued after the lawsuits ended.3  
Because of this long standing relationship, the NWHN was one of the first 
American women’s health organizations to learn from UBINIG about the Norplant 
testing trials. UBINIG warned the NWHN of the many issues surrounding Norplant and 
asked them to join the international campaign to end the coercive policies.4 The NWHN 
was receptive; it was one of the first and most diverse women’s health organizations, 
founded in 1975 in Washington D.C by a group of educated white middle-class women.5 
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Unlike other white-led organizations, the NWHN supported women of color and 
indigenous women activists from its inception. The organization prioritized a diverse 
board, which consisted of both individual members and other women’s health 
organizations, and lent support to campaigns fighting against forced sterilizations 
targeted at minority women and medical racism’s impact on improper and unethical 
prescribing practices.6 In 1985, its president, Sybil Shainwald, was keen on preventing 
the drug’s FDA approval.  
Since its founding, the NWHN had lobbied the FDA to properly investigate drugs 
and urged the medical industry to consider women’s needs. The organization also often 
formed alliances with consumer groups and liberal politicians. Historian Kelly O’Donnell 
compared the NWHN’s to a “consumer movement” because the organization made it a 
priority to alert the government and the public of drugs they considered unsafe and urged 
people to boycott.7 
After UBINIG alerted them of the many problems with Norplant, the NWHN 
began their own investigation.8 They reached out to other women’s organizations in the 
Global South and requested information from the FDA. In 1987, the NWHN issued their 
own report assessing Norplant’s risks and side effects, and the concerns outlined in the 
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report revealed UBINIG’s influence.9 Much of the Network’s concerns were related to 
Norplant link to population control policies and sterilization practices. The NWHN feared 
American healthcare providers, like the healthcare professionals that had conducted the 
trials, would abuse their power. They argued that it was likely that the provider-
controlled drug would be used to curb pregnancies amongst minority and poor 
populations in the U.S. They were especially worried about women who did not have 
consistent and easy access to healthcare.10  
Additionally, the NWHN’s report extensively discussed Norplant’s testing trials, 
shedding light on the significant and irregular side effects and risks associated with the 
contraceptive device and revealing the trials’ many ethical violations. The organization 
discovered that a number of healthcare professionals had inappropriately implanted the 
device into adolescent girls along with pregnant and lactating women. They argued that 
in these cases, the healthcare professionals knowingly put women’s lives in danger 
because they needed additional trial participants. The NWHN’s report also pointed out 
that the trials’ results failed to address a number of concerns, including Norplant’s 
connections to ovarian cysts and ectopic pregnancies, how the drug affects pregnant 
women, and its long-term impact on women’s fertility Finally, To ensure Norplant’s 
safety, they called for an investigation of all the deaths that occurred during the trials.11 
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Two years later in 1989, the NWHN used this information to testify against 
Norplant’s FDA approval. Loretta Ross, a reproductive justice activist and member of the 
National Black Women’s Health Project (NBWHP), the NWHN, as well as the Director 
for Women of Color Programs for National Organization for Women (NOW), testified in 
front of the FDA’s Fertility and Maternal Health Drug Advisory Committee.12 In the late 
1980s, the NBWHP, the first women’s health organization dedicated to a single minority 
group and a former division of NWHN, was participating in a number of campaigns 
related to minority women’s reproductive health, including early activism against 
Norplant. As a prominent member of both the NWHN and the NBWHP, Ross was chosen 
to present their arguments to the FDA. Her testimony highlighted concerns over 
Norplant’s testing trials, safety, and especially its long-term effects on women’s bodies. 
Furthermore, Ross pointed out that women of color and poor women would be at 
particular risk because they were more likely to have unreliable access to healthcare.13  
 
12 Loretta J. Ross interview by Joyce Follet, Voices of Feminism Oral History Project, SSC; Judy 
Norsigian, “Testimony on the Approval of Norplant as a Method of Birth Control Before the Fertility and 
Maternal Health Drugs Advisory Committee: The Food And Drug Administration,” April 27, 1989, box 33 
folder 4: “Contraceptive: Norplant,” 1989, LJRP, SSC. Lorretta Ross, a prominent African American 
women’s rights activist, was motivated to fight for greater reproductive rights after an intrauterine device 
(IUD), called Dalkon Shield, sterilized her in the 1970s. Despite improper medical testing and a warning 
from the pharmaceutical company’s top executives, A.H. Robins Corporation bought the Dalkon Shield 
with the intention of putting it on the American market. Although issues regarding patient’s health arose, A. 
H. Robins continued to produce and distribute the IUD. The Dalkon Shield IUD caused over 200 septic 
abortions, which is a dangerous infection caused by an abortion or miscarriage, and eleven deaths in the 
1970s. Investigations proved that A. H. Robins Corporation, the producer and distributor of the IUD, was 
aware that the Dalkon Corporation had inadequately tested the birth control device. In 1976, as a twenty-
three year old woman, Ross was involuntarily sterilized by complications caused by the Dalkon Shield This 
experience led Ross to become one of the first African American woman to sue A. H. Robins inspiring 
other Dalkon Shield victims to also take legal action. It also led her to a life of activism fighting for 
reproductive rights, particularly for women of color and indigenous women. 
13 Norsigian, “Testimony on the Approval of Norplant as a Method of Birth Control Before the Fertility and 
Maternal Health Drugs Advisory Committee: The Food And Drug Administration,” 1989; “Testimony on 
the Approval of Norplant as a Method of Birth Control Before the Fertility and Maternal Health Drugs 
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 Like the NWHN, the BWHBC, the women’s health organization whose 
groundbreaking book, Our Bodies, Ourselves, changed the way women learned about 
their bodies, looked to the research and activism in foreign nations surrounding 
Norplant’s testing trials to both form an opinion on the contraceptive device and build 
alliances with other women’s health organizations.14 At the Sixth International Meeting 
on Women and Health in Manila in November 1990, the BWHBC along with other 
organizations from Bangladesh, Brazil, Canada, Cameroon, England, India, Mexico, the 
Netherlands, Nigeria, the Philippines, Thailand, and the U.S. encouraged population 
politics reforms in an official statement to USAID, a U.S. agency that assists in foreign 
nations’ developments.15 In the statement, feminist activists shared their collective 
concerns over the coercive use of Norplant during the drug’s trials and urged USAID to 
 
Advisory Committee: The Food And Drug Administration,” April 27, 1989, box 197 folder 15: Cover 
Letters…, 1993-2005 Norplant, NWHNR, SSC.  
14 Kline, Bodies of Knowledge, 16-17. In 1969, twelve women attending a workshop titled “Women and 
Their Bodies” at a women’s liberation conference at Emmanuel College in Boston discussed their shared 
aggravations and disappointments associated with visits to doctors’ offices. Following the conference, the 
workshop participants continued meeting to discuss the issues. When they discovered they were unable to 
construct a list of OB/GYNS they felt listened to their patients’ concerns, respected her position, and took 
the time to explain all procedures and medications, they decided that each member would research a topic 
about women’s bodies that they had a personal interest in and then share their findings with the other group 
members and to other women living in Boston through a series of workshops. This initial group of 
participants, which would eventually become the BWHBC, continued to research and share more issues 
related to women’s health, they decided to compile their work and publish 5,000 copies under the title, 
Women and Our Bodies in 1970. The following year, they changed the name to the now famed title, Our 
Bodies, Ourselves, and sold an additional 15,000 copies; Boston Women’s Health Book Collective, The 
New Our Bodies, Ourselves: Updated and Expanded for the ’90s, (New York: Simon & Schuster Inc., 
1992), 288-292; The BWHBC’s Our Bodies, Ourselves quickly became an essential tool for women to 
learn about their bodies and the male controlled medical industry in the 1970s. As the demand continued 
the BWHBC to publish an updated version of Our Bodies, Ourselves with a larger publisher, and the 
organization continues to this day to publish updated editions. The 1992 edition of Our Bodies, Ourselves 
demonstrated the BWHBC’s complicated opinion of Norplant. Within the book’s chapter on contraception, 
is an entire section dedicated to Norplant. This section details Norplant’s risks, side effects, and high price, 
while also informing the reader of the ways the drug had been used to sterilize poor and minority women.  
15 Betsy Hartmann (Population and Development Program Director) to Beverly Baker (NWHN Executive 
Director), March 14, 1991, box 175 folder 1: Contraceptive Norplant 1985-93, NWHNR, SSC.  
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take responsibility for establishing that all family planning programs focus on women’s 
health rather than population demographics.16 Finally, the statement called on USAID to 
expand the funding of female barrier birth control methods, their distribution, and 
informative programs on their effectiveness rates.  
Further, women of color and indigenous women reproductive justice activists also 
constructed multiple grassroots operations to combat the coercive use of Norplant. In the 
early 1990s, minority women’s organizations developed the concept of reproductive 
justice to shed light on the illicit and unethical limits placed on minority women’s bodies 
and to emphasize that the white women led reproductive rights movement neglected to 
address many discriminations affecting women of color and indigenous women. They 
believed in a comprehensive reproductive rights agenda that included access to 
reproductive healthcare, the right to affordable childcare and prenatal care, freedom from 
coercive sterilizations, and the right to have and raise healthy children, not just the right 
to safe and legal abortions.17 In the 1990s, reproductive justice activists centralized 
Norplant in their political agenda. While a number of reproductive justice organizations, 
including the NBWHP, the NLHO, and coalition groups like SisterSong, participated in 
the movement against Norplant, none were as extensive as NAWHERC’s and its founder 
Charon Asetoyer’s campaign.  
 
16 “Women Attending the 6th Int’l Meeting on Women and Health (November 1990) and other Concerned 
Women,” to Duff Gillespie, USAID, July 8, 1991, MC 503, box 23, folder 10: [Norplant: U.S. Aid and 
International Corr. and related], 1991-1997, BWHBCAR, SL. 
17 Silliman et al., Undivided Rights, 4; Loretta J. Ross and Rickie Solinger, Reproductive Justice: An 
Introduction, (Oakland: University of California Press, 2017). 
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NAWHERC’s campaign against the Indian Health Service’s (IHS) use of 
Norplant was built upon decades of grassroots reproductive rights activism. Although the 
U.S. government created the IHS, the federal agency responsible for providing Native 
people living on reservations with free healthcare, to aid Native communities ravaged by 
centuries of violent oppressions, it often applied controls on Native peoples’ personal 
sovereignties.18 For hundreds of years, NAWHERC argued, white supremacists and 
colonialists had used sexual violence against Native women to control Native populations 
and cement racial hierarchies.19 With European colonizers viewing Native people’s 
bodies as dirty and overly sexualized, these beliefs were used to justify a long history of 
sexual violence, body and genitalia mutilation, and thousands of forced and coerced 
sterilizations.20  
In the 1960s and 1970s, the IHS sterilized Native women living on reservations at 
alarmingly high rates.21 The population control movement, which advocated for the use 
of sterilization to minimize additional population growth, inspired the IHS to fund a 
sterilization campaign that encouraged IHS healthcare providers to permanently sterilize 
their patients. Although centuries of genocide had already depleted Native populations, 
the IHS claimed their actions were warranted because Native women were having about 
 
18 Jane Lawrence, “The Indian Health Service and the Sterilization of Native American Women,” The 
American Indian Quarterly, Vol. 24, No. 3, Summer 2000, 401. 
19 Andrea Smith Conquest: Sexual Violence and American Indian Genocide, (Brooklyn: South End Press, 
2005), 15. 
20 Smith Conquest, 10. 
21 Rebecca M. Kluchin, Fit to be Tied: Sterilization and Reproductive Rights in America, 1950-1980 (New 
Brunswick: Rutgers University Press, 2011), 108.  
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twice as many children as the average white woman.22 Native activists conducted a study 
revealing that by 1975 the IHS sterilized 25,000 Native women. Pressure from Native 
peoples forced Congress to oversee a formal investigation of the IHS and its sterilization 
policies.23 These investigations confirmed that many IHS personnel were not complying 
with proper informed consent regulations, including oral discussions, informative 
documents, and required waiting periods before procedures.24 In response to the 
investigation, Congress passed the Indian Health Care Improvement Act in 1976, which 
gave tribes the right to chair and control IHS programs. While this act had some success, 
the Department of Health, Education, and Welfare did not audit IHS programs, making 
the act virtually unenforceable.25 The government’s lack of regulations compelled Native 
activists to monitor the IHS’s treatment of Native communities. 
 Charon Asetoyer’s decades of activism as a leader of the Native women’s health 
movement prepared her to organize a campaign against Norplant.26 Her participation in 
 
22 Smith Conquest, 81; Lawrence, “The Indian Health Service and the Sterilization of Native American 
Women,” 402. 
23 Lawrence, “The Indian Health Service and the Sterilization of Native American Women,” 406. 
24 Lawrence, “The Indian Health Service and the Sterilization of Native American Women,” 409. 
25 Lawrence, “The Indian Health Service and the Sterilization of Native American Women,” 414-415; Mary 
Crow Dog, Lakota Woman, (New York: Harper Perennial, 1990), 78; Also in the 1960s and 1970s, Native 
women activists saw their decision to procreate as a valuable part of their activism and the continuation of 
their culture, traditions, and people. Their ability to have children was considered to be a “sacred” power, 
therefore many of them chose to not use contraceptive methods. In her memoir, Mary Crow Dog, a Lakota 
woman and member of the activist organization, American Indian Movement (AIM), reflected on her and 
other Native women’s decision to reject all contraceptives, “Birth control went against our beliefs. We felt 
there were not enough Indians left to suit us. The more future warriors we brought into the world, the 
better.” Later in her work, she explain why this was so necessary to the survival of her culture and 
community, “Like many other Native American women, particularly those who had been in AIM, I had an 
urge to procreate, as if driven by a feeling that I, personally, had to make up for the genocide suffered by 
our people in the past.”  
26 Jennifer Nelson, More than Medicine: A History of the Feminist Women’s Health Movement, (New 
York: New York University Press, 2015), 199; Asetoyer, whose mother was of Comanche descent, grew up 
in East San Jose, California in the 1950s and early 1960s. As a child, Asetoyer knew only a few other 
Native people. In an interview she remarked upon her childhood, “the neighborhood was mostly African 
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the Native led occupation of Alcatraz in 1969 “intensified” her political awareness and 
for the first time, linked her activism to her Native heritage and culture.27 It marked a 
turning point in her activist career and motivated her move to South Dakota to be closer 
to other Native people. In the mid-1980s, she worked on a project for Women of All Red 
Nations (WARN), the female entity within AIM, an organization active in the 1970s and 
1980s that was committed to protecting Natives’ cultural identity. Working with WARN, 
strongly influenced Asetoyer’s activism and political philosophy.28 This program focused 
on education on topics such as Fetal Alcohol Syndrome (FAS), defects and 
developmental issues affecting children whose mothers consumed alcohol while 
pregnant, and nutrition.29 After working with WARN for several years, she became 
frustrated with the leadership and the organization’s mismanagement of resources. 
Therefore in 1985, Asetoyer and her second husband started the Native American 
 
American, Latina, low-income white people, and I am pretty sure I was the only Native American in the 
school.” When she was in high school, a counselor discouraged her from continuing her education, telling 
her to, “forget any dreams you may have—there is nothing out there for you as a Native-American 
woman.” In the mid-1960s, Asetoyer dropped out of high school during her junior year to begin a dress 
business in San Francisco. Her store, which was located on Haight Street, sold “hippie and Native 
American flair” dresses. She also became involved in the political and anti-war protests sweeping the 
Haight-Ashbury neighborhood.  
27 Charon Asetoyer interview by Joyce Follet, Voices of Feminism Oral History Project, Sophia Smith 
Collection, Smith College, Northampton, MA 01063, 21-22; Asetoyer’s experiences with domestic 
violence informed her eventual involvement in the women’s movement. While living in San Francisco, she 
married a jazz musician of Native and African American descent. Not long into the marriage, her husband 
became “extremely” physically abusive. After several violent incidents, Asetoyer, with the support of her 
immediate family, moved to South Dakota and enrolled at the university, eventually earning both a 
bachelor’s and a master’s degree. While in school, she became close friends with a fellow student who was 
completing her master’s degree while also raising nine children. Despite their close relationship, for a long 
time Asetoyer did not know about the abuse she endured. Unfortunately, her friend’s husband tragically 
murdered her. These experiences greatly impacted Asetoyer’s life and motivated her to fight for women. 
28 Silliman et al., Undivided Rights, 110. 
29 Charon Asetoyer interview by Joyce Follet, Voices of Feminism Oral History Project, Sophia Smith 
Collection, Smith College, Northampton, MA 01063, 25; “Fetal Alcohol Syndrome,” Kids Health by 
Nemours, August 2016, accessed on March 30, 2018, https://kidshealth.org/en/parents/fas.html.  
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Community Board (NACB).30 Initially, the NACB focused on FAS and its impact on 
their local community.31 Because there was a severe lack of knowledge surrounding 
alcohol use, especially during pregnancy, the NACB placed much of its efforts on 
informing Native women of the potential risks.32 Additionally, the organization aided 
women suffering from chemical and alcohol dependency by providing access to better 
resources, services, and treatments for both women and their children.33 
During the 1980s, Asetoyer saw women of color begin to form their own health 
organizations, the first being the NBWHP in 1984. This energized other women of color 
to do the same, and in 1987, at a NWHN conference, many people encouraged Asetoyer 
to start her own group. With their financial support, she was able to purchase a house in 
South Dakota to act as a main office and resource center.34 The following year, she 
founded NAWHERC, an organization dedicated to Native women’s health and 
empowerment.35  
From the start, Asetoyer prioritized coalition building amongst Native women 
across Native communities. She along with her fellow NACB members, identified Native 
women from a number of Plains tribes to be NAWHERC’s leading representatives. These 
activists were invited to discuss reproductive health issues facing Native women, 
 
30 Silliman et al., Undivided Rights, 144; Charon Asetoyer interview by Joyce Follet, Voices of Feminism 
Oral History Project, Sophia Smith Collection, Smith College, Northampton, MA 01063, 27. 
31 Charon Asetoyer interview by Joyce Follet, Voices of Feminism Oral History Project, Sophia Smith 
Collection, Smith College, Northampton, MA 01063, 27. 
32 Charon Asetoyer interview by Justina Licata and Hannah Dudley-Shotwell, phone, September 29, 2017.  
33 Charon Asetoyer interview by Joyce Follet, Voices of Feminism Oral History Project, Sophia Smith 
Collection, Smith College, Northampton, MA 01063, 27. 
34 Morgen, Into Our Own Hands, 61. 
35 Silliman et al., Undivided Rights, 144. 
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particularly women living on reservations who relied upon the IHS, the federal agency 
responsible for providing Native people living on reservations with free healthcare. 
Networking across tribal communities became crucial to the growth and spread of 
NAWHERC, while also aiding isolated Native women living on rural reservations. 
NAWHERC used these connections to empower women with knowledge and the right to 
make decisions about their health and bodies.36 NAWHERC’s early programming 
covered an array of topics, including AIDS prevention, domestic violence, child 
development, cancer prevention, FAS, nutrition, scholarship for Native Americans, and 
reproductive rights and health issues.37  
While Asetoyer focused on her community, she also participated in the national 
women’s movement as a member of the NWHN. Working alongside other professional 
activists at a national organization provided her with connections and alliances that would 
later play an important role in the reproductive justice campaign against Norplant.38 In 
the early and mid-1980s, for instance, the NWHN and NBWHP organized a campaign 
against Depo-Provera, a method of birth control that involves injecting a woman with 
hormones every three months. Before the drug was FDA approved, the NWHN charged 
that the injectable contraceptive was a “‘massive experiment’” that could be detrimental 
to many women. The organization created a registry of 529 women who had used Depo-
Provera during its testing trials, recording the side effects they experienced, including 
 
36 Charon Asetoyer interview by Joyce Follet, Voices of Feminism Oral History Project, Sophia Smith 
Collection, Smith College, Northampton, MA 01063, 52-53. 
37 Morgen, Into Our Own Hands, 62. 
38 Charon Asetoyer interview by Joyce Follet, Voices of Feminism Oral History Project, Sophia Smith 
Collection, Smith College, Northampton, MA 01063, 28-31; “Charon Asetoyer: Bio,” Women’s Media 
Center, accessed on March 29, 2018, http://www.womensmediacenter.com/profile/charon-asetoyer.  
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depression, irregular menstruation, and breast tumors.39 Publicizing these first-hand 
accounts in the media, and particularly in women’s magazines, the NWHN urged the 
FDA to not approve Depo-Provera. As a member of the NWHN, Asetoyer celebrated 
with her colleagues in October 1984, when the FDA denied its approval.40 This 
experience gave Asetoyer the skills to speak out against Depo-Provera later when its 
eventual approval led to tremendous suffering amongst Native women users. Further, 
Asetoyer’s participation in the campaign against Depo-Provera prepared her to respond 
swiftly to the FDA’s Norplant approval in 1990.41  
In the early 1990s when NAWHERC first heard that IHS practitioners were 
prescribing Norplant to Native women, its members sprang into action. The organization 
immediately began an investigation of the drug’s development, testing trials, and the 
IHS’s use of it. While their early research focused on IHS facilities in South Dakota, 
NAWHERC quickly expanded their study to also examine Alaska, Arizona, North 
Dakota, New Mexico, and South Dakota. To learn about the IHS’s prescribing practices 
and their Norplant protocols, NAWHERC interviewed healthcare professionals and social 
service agents, some of whom worked at IHS hospitals and clinics, while also collecting 
dozens of anonymous surveys from Native Norplant users.42 In addition, the organization 
looked at other women’s health organizations’ campaigns opposing Norplant’s FDA 
 
39 Kline, Bodies of Knowledge, 103. 
40 Kline, Bodies of Knowledge, 112, 123. 
41 Nelson, More than Medicine, 199; Charon Asetoyer interview by Licata and Dudley-Shotwell, 
September 29, 2017.  
42 “Tim Giago,” Huffington Post, accessed on January 30, 2018, 
https://www.huffingtonpost.com/author/tim-giago. NAWHERC used an advertisement in the Lakota Times, 
the largest independent Indian newspaper distributed in South Dakota’s Pine Ridge Reservation, to called 
on women who were currently using or had used Norplant to complete a survey. 
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approval, scientific research that led to Norplant’s development, and reports about the 
drug’s testing trials in Bangladesh, Sri Lanka, and Nigeria.43  
Following their investigation, NAWHERC produced two reports laying out their 
findings. First, in 1992, they released “The Impact of Norplant in the Native American 
Community,” a report that documented how the IHS’s misused Norplant on reservations. 
Later in 1994, after discovering that the federal government had no national statistics on 
the IHS’s use of Norplant because the government deemed this data unnecessary, 
NAWHERC published a second study that examined both Norplant and Depo-Provera. 
These reports traced the drug’s development, testing trials, and FDA approval, while 
placing particular focus on the IHS’s lack of Norplant protocols, the ways in which the 
federal agency unethically prescribed Norplant to vulnerable Native women, and lastly, 
how it was a poor choice of birth control for many Native women. Asetoyer and her 
organization used their investigation to inform Native women of Norplant’s risks while 
also attempting to bridge the gap between the IHS and the Native communities they 
served.44 Finally, the reports challenged IHS practitioners to rethink their contraceptive 
prescribing protocol and encouraged the federal agency to control both Norplant and 
Depo-Provera like it did surgical sterilizations.45  
 
43 Natasha Lewry and Charon Asetoyer, “The Impact of Norplant in the Native American Community,” 
(Lake Andes: Native American Women’s Health Education Resources Center: A Project of the Native 
American Community Board, June 1992), 3, 43-45. 
44 Lewry et al., “The Impact of Norplant in the Native American Community,” ii. 
45 Smith Conquest 94; Lin Krust and Charon Asetoyer, “A Study of the Use of Depo-Provera and Norplant 
by the Indian Health Services (Revised),” (Lake Andes: Native American Women’s Health Education 
Resources Center: A Project of the Native American Community Board, July 1993), 15. 
 
 
 
109 
Both reports focused heavily on the IHS’s failure to establish specific guidelines 
to secure informed consent from every Norplant patient. The idea of informed consent 
dates back to the Nuremberg Trials, with many scholars considering the Nuremberg Code 
of 1947 to be the initial authoritative statement of consent stipulations in biomedical 
ethics. The code was created in response to the heinous mistreatment of humans during 
the Holocaust, and more specifically the Nazi’s use of “medical research” to justify 
abuse. The code asserted that the voluntary consent of human subjects participating in 
any research is indispensable. Despite the Nuremberg Trials’ strong emphasis on the 
importance of informed consent, in the decades following, the medical field frequently 
ignored the practice of properly securing consent. During the 1960s and 1970s, U.S. 
feminists brought the idea back into circulation. In their definition of informed consent, 
feminists centralized patients’ needs. They argued that to properly secure a patient’s 
consent, healthcare practitioners must provide each patient with all pertinent information 
and options, and while they believe in thorough counseling, feminists argued that patients 
should not be coerced during counseling sessions, but instead empowered to make their 
own decision.46 Many women’s health feminist critiques of Norplant published in the late 
1980s and early 1990s focused heavily on the issue of informed consent.  
Because the IHS lacked a standard procedure to ensure informed consent, Native 
women received inconsistent information and counseling before their insertion procedure. 
While all of the Norplant patients NAWHERC surveyed had some form of counseling, 
 
46 Neil C. Manson and Onora O’Neill, Rethinking Informed Consent in Bioethics, (Cambridge: Cambridge 
University Press, 2007), 2-3. 
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their experiences varied dramatically. Most IHS providers supplied patients with either an 
informative pamphlet or video, but few discuss Norplant’s risks and side effects specific 
to their patient’s medical history before implanting the device.47 In addition, NAWHERC 
discovered that many IHS facilities relied solely on Wyeth-Ayerst’s, Norplant’s U.S. 
distributor, informative pamphlets and videos to advise their patients.48 They argued that 
these biased sources created misconceptions about the drug’s safety. For example, 
although Norplant was less effective in patients weighing over 155 pounds, Wyeth-
Ayerst’s informative video included an overweight woman pleased with her Norplant 
implant.49 Based on this discrepancy, NAWHERC reasoned that the video “might do 
more harm than good.”50  
Many of the IHS’s healthcare professionals prescribing Norplant were not well-
versed in Norplant’s risks and side effects. This was particularly true when it came to 
prescribing the drug to teenage girls. Richard L. Larson’s, a doctor at the IHS hospital in 
Belcourt, North Dakota and a member of the Turtle Mountain Chippewa Tribe, 
questionnaire demonstrated his dedication to serving his Native community and his 
propensity to believe his female patients.51 In fact, Larson had performed four removals, 
 
47 Lewry “The Impact of Norplant in the Native American Community” 29. 
48 Krust et al., “A Study of the Use of Depo-Provera and Norplant by the Indian Health Services 
(Revised),” 13. 
49 Lewry “The Impact of Norplant in the Native American Community” 29. 
50 Lewry “The Impact of Norplant in the Native American Community” 29. 
51 “Dr. Richard Larson selected as Indian Health Service National Council of Clinical Director’s ‘Physician 
of the Year’” Family Medicine Quarterly 32:1 (Spring 2006): 5, accessed on June 20, 2017, 
https://www.ndafp.org/image/cache/Spring2006.pdf; “Larson Named IHS Physician of the Year,” North 
Dakota Medicine: University of North Dakota School of Medicine and Health Science 31:2 (Spring 2006): 
22, accessed on June 20, 2017, http://www.med.und.edu/nd-medicine/_files/docs/spring-2006.pdf. Larson 
typically worked weekends to train EMTs. His mentorship of younger healthcare professionals and the long 
hours spent caring for his patients led him to be awarded the IHS Physician of the Year in 2006. 
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all on women who had their Norplant device inserted at other clinics showing his 
willingness to remove the device upon a patient’s request. Despite Larson’s commitment 
to his patients, he was unaware of Norplant’s insufficient testing trials. When asked what 
population he most often recommended Norplant to, he responded, “especially single 
teenage women, age 15-19.” This answer shows that Larson did not know that the drug’s 
testing trials failed to examine Norplant’s impact on adolescent girls’ health.52 
Furthermore, an interview with an OB/GYN working at the IHS facility on the Rosebud 
Reservation revealed that although the government required informed consent paperwork 
when a doctor prescribed Norplant to a teenage patient, the IHS did not mandate 
informative counseling.53  
The IHS’s inconsistent policies resulted in IHS providers inserting Norplant into 
patients who had high medical risks.54 For instance, IHS practitioners implanted two 
women from the Rosebud reservation with family histories of breast cancer, despite 
Wyeth-Ayerst’s recommendation to avoid prescribing Norplant to patients at risk for that 
type of cancer. When activists questioned the patients, neither woman recalled being 
informed of the potential dangers.55 And even though the IHS required women to 
undergo a pregnancy test and sign a written consent form before Norplant was inserted, 
 
52 Richard L. Larson and NAWHERC, “Norplant Questionnaire,” box 21 folder 19: “A Study of the Use of 
Depo-Provera and Norplant by the IHS.” Questionnaires Naomi Sunshine, Spring 1993, NAWHERCR, 
SSC. 
53 Dr. Heffron interview by Native American Women's Health Education Resource Center Records, box 20 
folder 14: “The Impact of Norplant in the Native Community,” Interviews, Spring 1992, NAWHERCR, 
SSC. 
54 “Native American Women Uncover Norplant Abuses” Ms. Magazine, September 1993 69. 
55 “Native American Women Uncover Norplant Abuses,” 69. 
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NAWHERC found that many women were not given a pregnancy test and that the IHS 
assumed that a woman’s presence at the clinic was an indication of her consent.56  
NAWHERC also discovered that the lack of strict procedures and protocols 
allowed IHS doctors to coerce women with addictions into temporary sterilization rather 
than treating their dependency issues.57 For decades, popular culture and conservative 
governmental policies linked poor minority women to substance abuse. The 
criminalization of African American, Latina, and Native women not only lead to 
inaccurate perceptions of drug use amongst this community, but it also disregarded the 
need for more rehabilitation services. Native people living on reservations struggled with 
alcoholism at higher rates than other American women.58 In fact, in the early 1990s, the 
mortality rates of Native women between the ages of twenty-five and thirty-four were ten 
times higher than the national average. Many Native women used alcohol to cope with 
the harshness of life and traumas such as rape and sexual assault.59 Due to poor 
education, many Native women were unaware of alcohol’s negative effects on unborn 
children.60 Instead of investing in rehabilitation and education, some IHS professionals 
saw Norplant as a simple answer to this complicated issue. Ann Holmes, a nurse at the 
University Physicians at Sioux Falls, advocated prescribing Norplant to women addicted 
to drugs in order to prevent them from a “pregnancy that could be complicated severely 
 
56 Jennifer McGuire, “Cheyenne Tribe Objects To Use of Two Birth-control Devices: Tribal Council Seeks 
Ban by December,” Sun Sentinel, July 25, 1996, accessed on December 3, 2019, http://articles.sun-
sentinel.com/1996-07-25/news/9607250134_1_depo-provera-norplant-birth-control. 
57 Charon Asetoyer interview by Joyce Follet, Voices of Feminism Oral History Project, Sophia Smith 
Collection, Smith College, Northampton, MA 01063, 34. 
58 Smith Conquest, 116. 
59 Silliman et al., Undivided Rights, 145.  
60 Charon Asetoyer interviewed by Licata and Dudley-Shotwell, September 29, 2017.  
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by their addiction.” By “protecting” these women, Holmes asserted, medical 
professionals preserved “another person from the addiction as well.”61 “We have to think 
about controlling an epidemic,” Holmes explained; “we are not harming these women in 
any way. Its [sic] not like we are sterilizing them...”62  
In addition, Native populations were at high risk for health issues that 
contradicted Norplant’s use. Citing Wyeth-Ayerst Laboratories’ research and informative 
pamphlets, NAWHERC warned that Norplant was unsafe for women with acute liver 
disease, noncancerous or cancerous liver tumors, unexplained vaginal bleeding, breast 
cancer, and blood clots in the legs. Moreover, any woman on Norplant with diabetes, 
high blood pressure, gallbladder, heart, or kidney disease, a history of scanty or irregular 
periods, as well as smokers could be at risk and required frequent monitoring.63 Because 
Native women suffered from many of these health issues, including diabetes and high 
blood pressure, at higher rates, Norplant was a poor choice of birth control for much of 
the population that the IHS treated. Accordingly, NAWHERC’s patient surveys showed 
that many Native women were unhappy with the contraceptive device. They experienced 
a number of unpleasant side effects, including headaches, tenderness at the place of 
 
61 Ann Holmes (Mulkey) interview by NAWHER, box 20 folder 14: “The Impact of Norplant in the Native 
Community,” Interviews, Spring 1992, NAWHERCR, SSC. 
62 Ann Holmes (Mulkey) interview by NAWHER, box 20 folder 14: “The Impact of Norplant in the Native 
Community,” Interviews, Spring 1992, NAWHERCR, SSC. 
63 Lewry et al., “The Impact of Norplant in the Native American Community,” 5; Wyeth-Ayerst 
Laboratories, Norplant System Levonorgestrel Implants, box Ch 43 folder Choices: Norplant Information 
and policies, 1991-1994 HMP, SBC.  
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insertion, mood swings, and significant bleeding.64 These issues led many to request an 
early removal.65 
 Like thousands of women across the nation, Native women also experience 
painful and botched insertion and removal procedures. Although Wyeth-Ayerst claimed 
the device could be simply inserted and removed, NAWHERC’s interviews with 
healthcare professionals revealed that many found the training to be shockingly 
inadequate.66 The insufficient training resulted in countless healthcare practitioners 
inserting the implants too far under the skin’s surface, causing an easy removal procedure 
that should have taken about fifteen to twenty minutes to be a very painful operation that 
sometimes lasted more than an hour and often left serious scarring.67  
 As an organization birthed as reproductive justice was coming to prominence, 
NAWHERC’s investigation of Norplant was part of the crucial expansion of reproductive 
rights to look beyond access to contraceptives and legal abortions. In their effort to share 
their research, NAWHERC distributed both reports to Native women, other women’s 
health and reproductive rights organizations, the IHS, policymakers and legislators, the 
United Nations’ Permanent Forum of Indigenous People, and population control 
conferences, including the international conference in Cairo in 1994.68 The reports 
 
64 “Norplant Questionnaire,” (for patients) NAWHERC, NAWHERCR, box 20 folder 15: Norplant Project 
interviews Tiaya Miles, fall 1992, NAWHERCR, SSC. 
65 Karen Hawkins, “‘The Shot’ in Indian Country,” Albion Monitor, May 5, 1996, accessed on June 20, 
2017, http://www.monitor.net/monitor/controlled/bc-native.html.  
66 Lewry et al., “The Impact of Norplant in the Native American Community,” 22. 
67 Lewry et al., “The Impact of Norplant in the Native American Community,” 22. 
68 Charon Asetoyer interview by Justina Licata, phone, May 2, 2018.  
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informed readers about the risks, side effects, and sterilization practices associated with 
Norplant.  
 NAWHERC also used their reports to lobby the IHS to adjust their protocols and 
procedures. In February 1993, the IHS dedicated much of its monthly newsletter, The IHS 
Primary Care Provider, to Norplant and the proper way of prescribing the birth control 
device. The newsletter, which is distributed to IHS’s healthcare providers across the U.S., 
supplies IHS practitioners with important information and advancements in the healthcare 
industry particularly related to American Indian and Alaska Native populations.69 
Clinical nurses, OB/GYNs, and family physicians contributed articles to this issue, and it 
included copies of proper Norplant treatment protocol and consent forms. Although the 
newsletter did not mention NAWHERC or their reports, it is seemingly a direct response 
to the feminist organization’s campaign. For instance, it addressed the IHS’s informed 
consent policies and procedures. One article urges providers to “avoid the trap of seeing 
this new technology as a panacea for all problems having to do with an unintended 
pregnancy.”70 Further, because of Norplant’s common side effects and risks, they 
implored IHS providers to rigorously screen and counsel patients before prescribing 
Norplant.71 To implement good counselling practices, they encouraged providers to 
follow a pre-insertion, insertion, and post-insertion process, and to become 
 
69 “Primary Care Provider Newsletter,” Indian Health Service: The Federal Health Program for American 
Indians and Alaska Natives, accessed on April 20, 2018, https://www.ihs.gov/provider/. 
70 William L. Dienst, Jr. and Louis Billedeaux, “Subdermal Contraceptive Implants in the IHS: The Crow 
Service Unit Experience,” The IHS Primary Care Provider 18:2 (February 1993): 21, box 175 folder 1: 
Contraception Norplant 1985-1993, NWHNR, SSC. 
71 William L. Dienst, Jr. and Louis Billedeaux, “Subdermal Contraceptive Implants in the IHS: The Crow 
Service Unit Experience,” The IHS Primary Care Provider 18:2 (February 1993): 21, box 175 folder 1: 
Contraception Norplant 1985-1993, NWHNR, SSC. 
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“knowledgeable providers” because improved counseling would “help maximize the 
continuation rate (and cost-effectiveness) of Norplant.”72 While the IHS was promoting 
better patient counseling, the agency’s newsletter also advocated for more“cost-effective” 
prescribing habits. The IHS noted that removing so many Norplant devices before their 
five year expiration marks was becoming costly.73  
 
72 Michael D. Brown, “Norplant: The Newest Reversible Contraceptive” The IHS Primary Care Provider 
18:2 (February 1993): 18, box 175 folder 1: Contraception Norplant 1985-1993, NWHNR, SSC; William 
L. Dienst, Jr. and Louis Billedeaux, “Subdermal Contraceptive Implants in the IHS: The Crow Service Unit 
Experience,” The IHS Primary Care Provider 18:2 (February 1993): 31, box 175 folder 1: Contraception 
Norplant 1985-1993, NWHNR, SSC. 
73 Michael D. Brown, “Norplant: The Newest Reversible Contraceptive” The IHS Primary Care Provider 
18:2 (February 1993): 31, box 175 folder 1: Contraception Norplant 1985-1993, NWHNR, SSC; Jacqueline 
Darroch Forrest and Lisa Kaeser, “Questions of Balance: Issues Emerging from the Introduction of 
Norplant,” Family Planning Perspectives 25:3 (June 1993), box 175 folder 1: Contraception Norplant 
1985-1993, NWHNR, SSC; Smith College, Northampton, Massachusetts; Julia R. Scott., “Norplant and 
Women of Color,” in Dimensions of New Contraceptives: Norplant and Poor Women edited by Sarah E. 
Samuels and Mark D. Smith, (Menlo Park: The Kaiser Forums, 1992), 43-44; The Kaiser Family 
Foundation, November 1991, box 8 (Unprocessed) BWHIR, SSC. Other women of color organizations 
looked to NAWHERC’s thorough research to understand the way Norplant could endanger other 
populations of women. For example, NBWHP disseminated information to Black women about how the 
government used Norplant to discourage women living in poverty from having additional children while 
simultaneously faulting authorities for not providing more access to Norplant for working class women. 
Unlike NAWHERC, who believed Norplant was too dangerous for Native women to use, the NBWHP was 
both concerned that the contraceptive device would be used to forcibly sterilize Black women and that 
Black women who were interested in using Norplant would not have access to it because of its high price. 
Therefore, the organization’s early 1990s literature published in their newsletter, called Vital Signs, 
emphasized the fact that a woman’s health insurance or public assistance grant controlled her ability to 
access a range of contraceptives. Women living in poverty struggled to gain access to Norplant because of 
its high price, which was about three hundred to five hundred dollars for the implant and an additional one 
hundred fifty to two hundred dollars for the removal. In the early 1990s, the desire for Norplant was so 
high, many family planning clinics that catered to the poor communities could not afford enough Norplant 
kits to meet their patients demands. At the same time, the NBWHP’s discovered that although Medicaid in 
all fifty states and Washington D.C. covered the cost to have Norplant inserted, many women struggled to 
have the device removed if it caused any contraindications because a number of states refused to pay for 
early removals. This meant that a woman suffering from side effects caused by Norplant was required to 
either scrounge together the funds to pay for the removal herself or continue to suffer for five years. 
Additionally, Luz Alvarez Martinez, a founding member of the NLHO, argued that Norplant appealed to 
poor women not because it was safe or effective but because Medicaid patients could obtain it for free or a 
low cost. Therefore, she saw the government forcing poor women to pay for other forms of contraceptives, 
but have Norplant implanted for free as a subtle form of coercion that was often overlooked. Martinez and 
the NLHO pointed out that because all fifty states’ Medicaid services covered Norplant insertion, Medicaid 
recipients were sixteen times more likely to choose Norplant over other forms of contraception. In 1992, 
California Medicaid allotted five million dollars for Norplant kits alone, an amount higher than the state 
had ever spent on other forms of birth control. Martinez feared that because Norplant was so accessible to 
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 Asetoyer joined feminists from around the world in putting Norplant on the 
international feminist reproductive health agenda. By the mid-1990s, a coalition of 
globally-minded women’s health activists were attending UN conferences to call for 
significant population policy reforms. Rejecting ideas about “population control” that 
held that reducing pregnancies and births would alleviate poverty, they argued that family 
planning services should be geared towards providing women with greater autonomy 
over their bodies and reproduction.74 The global feminist coalitions preparing for the 
1994 International Conference on Population and Development (ICPD) in Cairo used 
their common experiences with Norplant to call attention to state sanctioned sterilizations 
and to push for more funding for patient-controlled contraceptive research.75  
Leading up to the international conference, a number of prominent U.S. 
reproductive justice activists formed The U.S. Women of Color Delegation to the 
International Conference on Population and Development to prepare their agenda. As a 
delegate member, Asetoyer worked alongside African American, Asian American, Latin 
American, and other indigenous women to construct a platform focused on reforming 
population politics to better serve women and their reproductive needs. State-sanctioned 
sterilizations targeted at poor and minority women were the centerpiece of their platform. 
 
poor women, they would look past the devices risks and side effects. Martinez and her organization 
demonstrated that while it seemed like the government was allowing women to choose their birth control, 
giving women Norplant for free and forcing them to pay for other forms of contraceptives was a subtle 
form of coercion.  
74 James G. Connell, III, “Norplant and the New Paradigm of International Population Policy,” Wm. & 
Mary J. Woman & L. 2:1 (1995): 101, accessed on May 2, 2018, 
http://scholarship.law.wm.edu/cgi/viewcontent.cgi?article=1285&context=wmjowl. 
75 The U.S. Women Of Color Delegation To The International Conference On Population And 
Development, “Executive Summary: Statement On Poverty, Development, And Population Activities,” 
September 1994, 1-3, box 3 folder 8: ICPD, U.S. Women of Color Delegation, 1993-1994, CAR, SSC. 
 
 
 
118 
They emphasized that Norplant and other provider controlled contraceptive devices, like 
Depo-Provera, were targeting at women of color and indigenous women. Their platform 
condemned Baltimore’s use of the contraceptive device to curb teenage pregnancy and 
opposed programs being proposed that offered welfare recipients additional monetary 
benefits in exchange for using Norplant.76  
At the conference in Cairo, attended by over 10,000 participants from more than 
150 nations and 1,500 different organizations, feminists from around the world voiced 
their concerns over the uses of Norplant and the drug’s risks and side effects.77 Feminists’ 
arguments against Norplant focused on three specific elements. First, they argued that 
Norplant gave providers control of women’s reproduction. Second, feminists 
demonstrated that long-term forms of birth control, like Norplant, were being researched 
not because they benefited women’s health and reproduction, but instead as a way to 
decrease fertility, especially in the Global South. Finally, the women’s activists argued 
that governments’ uses of Norplant was a part of a long history of state-sanctioned 
sterilizations targeted at poor and minority women. In addition to presenting these 
arguments, women told personal stories about their struggles with the Norplant. One 
Bangladeshi woman displayed her scarred arm while explaining that she was no longer 
able to use it after a doctor was unable to find and remove the Norplant implanted under 
her skin. Another Brazilian activist told the story of a woman who experienced early 
 
76 The U.S. Women Of Color Delegation To The International Conference On Population And 
Development, “Executive Summary: Statement On Poverty, Development, And Population Activities,” 
September 1994, 1-3, box 3 folder 8: ICPD, U.S. Women of Color Delegation, 1993-1994, CAR, SSC. 
77 Connell, “Norplant and the New Paradigm of International Population Policy,” 86. 
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menopause after the Norplant inserted under her skin released the full five year dosage of 
progestin in just six months.78  
Also, at the Cairo Conference, Wyeth-Ayerst, Norplant’s U.S. distributor, along 
with population control proponents endorsed expanding the use of Norplant globally. As 
a conference sponsor, Wyeth Ayerst used their platform to counter the feminists’ 
disapproval of Norplant. The pharmaceutical company described the birth control device 
as a tool of reproductive empowerment and the most innovative contraceptive technology 
since the birth control pill. Like the Population Council’s common narrative, many 
population control advocates at the conference, such as Population Action International 
and Population Connection, celebrated nations with significant Norplant programs, 
including Indonesia and Bangladesh.79  
Nevertheless, the international feminist campaigns against expanding the use of 
Norplant won out in Cairo. The 1994 ICPD marked the first time the international 
community emphasized women’s health and welfare when considering population 
politics.80 Before 1994, population control advocates urged the use of family planning to 
limit pregnancies especially in the Global South, and a population policy was considered 
 
78 April Lindgren, “Rich Nations Must Tread Softly,” Ottawa Citizen, 4 September 1994, A1; Connell, 
“Norplant and the New Paradigm of International Population Policy,” 90. 
79 Betsy Hartmann, Reproductive Rights and Wrongs: The Global Politics of Population Control, Third 
Edition, (Chicago: Haymarket Books), 201; U.S. Congress, House of Representatives, Sense of House 
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successful if and when demographics showed a decline in births.81 At the 1994 
conference, this measure of success was regarded as a failure. Leading political figures 
agreed with the feminists arguing that population policies needed to provide all women 
and men access to healthcare, including services related to reproductive and sexual health 
and family planning.82  
Yet the fight against Norplant was far from over. In the U.S., welfare reform was 
looming, and neoliberal politicians were still implementing policies that criminalized 
blackness and urban spaces. Asetoyer and others were raising their voices, but many 
mainstream white-led feminist organizations prioritized the struggle for abortion rights, 
which were coming under greater and greater attack. Many women who had Norplant 
implanted appreciated having a long-term option and felt that the side effects they 
experienced were a small price to pay for the confidence that they would not become 
pregnant. It would take feminist activism against Norplant coming to the attention of 
class action lawyers for a major change to happen.  
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CHAPTER V 
 
 THE LITIGATION BOOM 
 
 
Between 1994 and 1999, fifty thousand women brought two hundred class action 
lawsuits against Norplant’s U.S. distributor, Wyeth-Ayerst Laboratories. The plaintiffs, 
many of who were poor and minority women, sued the company because they 
experienced damaging side effects ranging from irregular bleeding to blindness. When 
researching Norplant and constructing their legal arguments, attorneys building cases 
against Wyeth-Ayerst relied heavily on a legal publication that collected materials and 
wrote about ongoing class action litigation. After collecting extensive materials related to 
Norplant, Mealey’s, the legal publisher, summarized their findings in a report. Their 
Norplant report reveals that while they had reviewed many feminist critiques of Norplant, 
Mealey’s chose to avoid addressing issues related to coercive temporary sterilizations 
because they believed the cases could not be won on those grounds. Consequently, the 
attorneys, instead, drew on feminist discussions around informed consent and proper 
prescribing practices to inform their legal arguments. They charged that Wyeth-Ayerst 
was responsible for their plaintiffs’ suffering because the company’s direct consumer 
advertising campaign created inaccurate perceptions about Norplant’s safety and 
hindered proper informed consent practices. The lawsuits and the publicity surrounding 
them enriched lawyers and forced the drug company to take Norplant off the market. Bu
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 the cases did not win a significant financial settlement for the women or draw attention 
to the population control efforts directed at them.  
In the early 1990s, as the Norplant litigation effort began, class action litigation 
was in the midst of an important change. Product liability litigation that pinned tens of 
thousands or even hundreds of thousands of plaintiffs against a large and wealthy 
company was on the rise, and lawyers were cashing in. This was a stark shift from just a 
few decades earlier when class action litigation was closely tied to social activism. Earlier 
in the twentieth century, activist organizations used class action lawsuits to shed light on 
social and political injustices, including ending segregation in public schools in Brown v. 
Board of Education and the legalization of abortion in Roe v. Wade.  
Class action lawsuits allow an individual, or the lead plaintiff, with a singular 
grievance to speak on behalf of themselves and a larger group of plaintiffs with the same 
accusations. The 1970s marked the first time that class actions were used in negligence 
tort law, or cases representing a group of individuals harmed by the actions of another 
individual or group.1 This change allowed lawyers to file class action suits representing 
thousands of plaintiffs claiming to be harmed by a specific product. Occasionally, mass 
torts, which treat each plaintiff individually, are consolidated into a larger class action 
case. Because class action suits can be massive, the plaintiffs are broken down into 
 
1 Marcia Angell, Science on Trial: The Clash of Medical Evidence and the Law in the Breast Implant Case, 
(London: W.W. Norton & Company, 1996), 69-89; Deborah R. Hensler, Nicholas M. Page, Bonita 
Dombey-Moore, Beth Giddens, Jennifer Gross, and Erik K. Moller, Class Action Dilemmas: Pursuing 
Public Goals for Private Gain, (Santa Monica: RAND Institute for Civil Justice, 2000), 10; “Supreme 
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Use 6:1 (February 2011). 
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separate classes and a single plaintiff represents an entire class.2 Lawyers were motivated 
to participate in mass tort litigation because it often resulted in large monetary 
settlements. In all class action lawsuits, a judge must certify the class action suit, meaning 
a lawyer must convince a judge that the class action process is the most suitable method 
for reaching a just and efficient ruling. The judge then appoints the representative 
plaintiffs who stand for the rest of the members of their class, decides on the leading 
attorneys, and sanctions their fees. The first successful decision in a product liability class 
action lawsuit occurred in 1973 after over 200,000 cases were filed against the 
manufacturers of asbestos, a substance in fire resistant and insulating materials that 
caused lung cancer. This legal victory led to a significant increase in mass tort litigation 
over the next three decades.3  
Class action suits can be lucrative for attorneys. The fees for these suits are a 
smaller percentage than the typical one-third contingency fee, or money lawyers receive 
only if they win a case, but their overall earnings tend to be significant if they win their 
case or negotiate a profitable settlement because of the considerable number of plaintiffs 
involved. In class action litigation, the plaintiffs and defendants can agree upon a 
settlement either before or after a suit has been certified. About seventy-five percent of 
mass tort litigation is settled before a lawsuit is filed. Judges then must review the 
settlements and decide if it fundamentally treats both sides fairly. Before making their 
decision, a judge sits in on a hearing where each party presents arguments in support of 
 
2 “Mass Tort vs. Class Action,” Searcy and Denney: Attorneys at Law, accessed on March 7, 2019, 
https://searcymasstort.com/what-are-mass-torts/mass-tort-vs-class-action/.  
3 Angell, Science on Trial, 75. 
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or in opposition to the settlement. Following the hearing, the judge either consents or 
objects to the settlement.4  
 The women’s health movement has used class action suits to improve the health 
care system’s treatment of women and challenge the medical industry. In the 1970s, 
activists used class action lawsuits to aid victims of the Dalkon Shield, an intrauterine 
device (IUD), and to warn other women about the dangerous contraceptive. An 
investigation of the Dalkon Shield IUD, which caused over 200 septic abortions, or an 
infection of the fetus or placenta, and eighteen deaths, proved that A. H. Robins 
Corporation, the producer and distributor of the IUD, did not adequately test it.5 After 
one Dalkon Shield victim successfully sued A. H. Robins, women’s health organizations, 
including the National Women’s Health Network (NWHN) and the Boston Women’s 
Health Book Collective (BWHBC), filed a series of class action lawsuits on behalf of 
almost 200,000 women against A. H. Robins.6 These lawsuits forced the pharmaceutical 
company to file for Chapter 11 bankruptcy. While the plaintiffs did not win much equity, 
the suits brought attention to the dangers associated with the Dalkon Shield and taught 
people to question contraceptives’ safety.7  
 
4 Angell, Science on Trial, 78. 
5 A.H. Robins’ parent company, American Home Products, was also the parent company of Wyeth-Ayerst 
which produced and distributed Norplant in the U.S. Rebecca M. Kluchin, Fit to be Tied: Sterilization and 
Reproductive Rights in America, 1950-1980, (New Brunswick: Rutgers University Press, 2009), 58; Rainey 
Horwitz, “The Dalkon Shield,” The Embryo Project Encyclopedia, January 10, 2018, accessed on March 
14, 2019, https://embryo.asu.edu/pages/dalkon-shield. 
6 Nicole J. Grant, The Selling of Contraception: The Dalkon Shield Case, Sexuality, and Women’s 
Autonomy, (Columbus: Ohio State University Press, 1992); Mary F. Hawkins, Unshielded: The Human 
Cost of the Dalkon Shield, (Toronto: University of Toronto Press, 1997); Karin M. Hicks, Surviving the 
Dalkon Shield IUD: Women v. The Pharmaceutical Industry, (New York: Teachers College Press, 1994); 
Nelson, More than Medicine, 177-178. 
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About two decades later, in 1993, attorney Jewel Klein filed the first class action 
lawsuit against Wyeth-Ayerst on behalf of Norplant patients in Illinois. The plaintiffs, in 
this case, alleged that they had been injured during the removal process. They argued that 
Wyeth-Ayerst failed to adequately train healthcare professionals to insert and remove the 
birth control implant. When the case was discussed in the media, reporters frequently 
repeated Klein’s argument that Norplant caused women tremendous pain and distress. 
For example, an article in the Chicago Tribune quoted Klein describing a plaintiff 
“‘bleeding all the time . . . not interested in sex” with moods that were “out of control.’”8 
Eventually, Klein’s case would become part of a large multidistrict litigation that brought 
together over a hundred of the class action suits against Wyeth-Ayerst.9  
Quickly following this first case, other lawyers across the country began filing 
lawsuits against Wyeth-Ayerst. For instance, in 1994, lawyer and women’s health 
activist, Sybil Shainwald followed with her own suit against Wyeth-Ayerst. Before 
becoming a lawyer, in the 1960s, Shainwald had protested against the Vietnam War and 
supported the Civil Rights Movement. She attended women’s consciousness raising 
meetings and as a Jewish woman, she participated in feminist Seders. The feminists 
leading these women only religious ceremonies altered the scripture to only represent 
female pronouns.10 In addition, Shainwald became a member of the National 
 
8 Bryanna Latoof, “The Norplant Debate,” Chicago Tribune, October 28, 1994, accessed on March 7, 2019, 
https://www.chicagotribune.com/news/ct-xpm-1994-10-28-9410290009-story.html.  
9 This multidistrict litigation case will be discussed further later in this chapter. In Re Norplant 
Contraceptive Products Liability Litigation, United States District Court for the Eastern District of Texas, 
Beaumont Division 215 F. Supp. 2d 795; 2002 U.S. Dist. LEXIS 16929, August 14, 2002, 203. 
10 Sybil Shainwald, in email to author, July 22, 2019; Abigail Pogrebin, “The Feminist Seder in the Time of 
#MeToo,” Reform Judaism, March 12, 2018, accessed on July 27, 2019, 
https://reformjudaism.org/blog/2018/03/12/feminist-seder-time-metoo.  
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Organization for Women (NOW). Even before the 1960s and 1970s, when the women’s 
health movement first began to challenge the male centered medical industry, Shainwald 
was wary of the industry’s treatment of women. She insisted on giving birth without the 
use of drugs in the 1950s, when this practice was highly unusual. Many of her fears about 
the medical industry were confirmed when she read Barbara Seaman’s bestselling 1969 
book, The Doctors’ Case Against the Pill, which investigated the oral contraceptive’s 
side effects and shed light on the acute lack of informed consent in women’s healthcare.11 
In 1972, after completing her Master’s in history at Columbia University and learning 
that her daughter’s sixth grade teacher was attending law school at night, she applied to 
Columbia Law School. Her application was rejected, and the university informed her they 
preferred giving opportunities to young men who could go onto have long careers.12 New 
York Law School accepted her, and in 1976, she, along with another six women in a class 
of one hundred sixty-nine, earned her law degree.13  
 
11 Sybil Shainwald, “Sybil Shainwald’s Speech at the Cosmos Club in Washington, D.C. on 11/7/16,” 
Washington, D.C., November 7, 2017, accessed on July 25, 2018, 
ww.womenshealthadvocate.org/articles/sybil-shainwald-speaks-at-the-cosmos-club-in-washington-d-c-on-
11716/; Sybil Shainwald interview by Justina Licata, New York City, May 31, 2017; Kelly Susanne 
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Shainwald’s first significant class action legal victory came in 1981 when she 
represented diethylstilbestrol (DES) victims.14 DES was a drug given to pregnant women 
between 1938 and 1971 to prevent miscarriages. In the 1960s, the FDA discovered that 
the drug had harmful effects on a mother’s offspring, including higher risks of cancer and 
reproductive injuries.15 Shainwald won $42.5 million for eleven women often referred to 
as the “DES daughters.” Over the next two decades, Shainwald took on a variety of 
important class action cases involving the negative impact of medication, medical 
procedures, and birth control on women’s health. She represented women harmed by the 
Dalkon Shield IUD, silicone breast implants, the contraceptive injection, known as Depo-
Provera, a drug used to suppress lactation, called, Parlodel, and in the 1990s, Norplant. 
Throughout, Shainwald interfaced with the feminist movement, serving on the board of 
the National Women’s Health Network and writing and lecturing on an array of legal and 
women’s health topics, including product liability, obstetrical malpractice, IUDs, and 
hormone therapy.16  
 As mentioned in the previous chapter, in the 1980s, Bangladeshi women who 
campaigned against Norplant’s testing trials warned Shainwald of both the 
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contraceptive’s harmful side effects as well as the unethical accessibility trials conducted 
all over the developing world. Shainwald focused on the former. Unlike the women of 
color health activists who centered their campaigns against Norplant on ending the 
temporary sterilization practices, Shainwald was more focused on exposing how Norplant 
was a poorly tested, unsafe drug. Using her clout as both an activist and a lawyer, she 
hoped these arguments would enable her to stop the use of the contraceptive device 
altogether. In the late 1980s, she testified against the Food and Drug Administration’s 
(FDA) approval of Norplant for distribution in the U.S. on the grounds that Norplant’s 
testing was insufficient and that is was unsafe for use.17  
In the mid-1990s, after Norplant patients suffering from harmful and painful side 
effects approached her, Shainwald filed state and federal class action and individual suits 
against Wyeth-Ayerst.18 One of the plaintiffs Shainwald represented was Leidy Ramirez, 
who suffered from headaches, weight loss, hair loss, and significant pain in her arm after 
receiving Norplant. The continuous arm pain led her to request a removal a year after she 
had the device implanted. Ramirez’s removal procedure was so painful the practitioner 
was forced to suspend it. The remaining capsules were removed a month later, but 
Ramirez’s arm pain, numbness, and weakness only worsened. Ultimately, the 
 
17 “Human Laboratory Documentary Transcript,” BBC Television: Horizon, Air Date November 5, 1995, 
December 9, 2010, accessed on May 26, 2017, http://www.oldthinkernews.com/2010/12/09/human-
laboratory-documentary-transcript/; Seaman Eldridge, Voices of the Women’s Health Movement, 362. 
18 Laura Duncan, “Norplant: The Next Mass Tort,” ABA Journal, (November 1995): accessed on 
September 7, 2016, 
https://books.google.com/books?id=XSWsefm8Av4C&pg=PA16&lpg=PA16&dq=Laura+Duncan,+%E2%
80%9CNorplant:+The+Next+Mass+Tort,%E2%80%9D&source=bl&ots=WaDeLjnZIK&sig=AnNpMqGk
nL4_rKYNc50ewrhf940&hl=en&sa=X&ved=2ahUKEwiHw9a2-
JfdAhWSPN8KHSPyBRIQ6AEwAXoECAcQAQ#v=onepage&q=Laura%20Duncan%2C%20%E2%80%
9CNorplant%3A%20The%20Next%20Mass%20Tort%2C%E2%80%9D&f=false.  
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contraceptive device did permanent damage to the nerves in her upper arm and caused 
significant scarring. A medical expert’s examination following the removal argued that it 
was likely that the nerve was pulled out of her arm during the removal procedure.19 
During the trial, Finney, the practitioner at Planned Parenthood that had performed 
Ramirez's insertion, testified that her training was minimal. While Wyeth-Ayerst had 
provided her with insertion and removal instructions that included practicing on a model 
arm, the practitioner had never performed any surgical insertions that required skin 
incisions before Norplant. In addition, she could not recall any materials that “warned of 
certain risks of removal including excessive scarring and chronic pain.”20  
In Ramirez's and her other Norplant cases, Shainwald focused her legal arguments 
on demonstrating how Wyeth-Ayerst impeded the practice of informed consent, a 
concept that has become more valued in the medical field thanks to the work of women’s 
health activists. She argued that Wyeth-Ayerst’s failure to adequately inform medical 
practitioners of Norplant’s risks and side effects as well as to properly train them to insert 
and remove the contraceptive device made the pharmaceutical company liable for 
Ramirez’s injuries.21 In Ramirez’s case, Shainwald contended that the written 
information outlining Norplant’s risks and side effects given to healthcare practitioners 
and Norplant patients were “watered down” and neglected to mention the risk of nerve 
damage. While Shainwald failed to prove to a judge that Wyeth-Ayerst’s actions had 
 
19 Leidy Ramirez, Plaintiff, v. Wyeth Laboratories, Inc., a subsidiary of American Home Products 
Corporation, et al., Defendants, 686 N.Y.S.2d 602, Supreme Court, New York County. January 8, 1999, 
accessed on August 31, 2018, 
https://scholar.google.com/scholar_case?case=3577189484609812631&hl=en&as_sdt=6,34&as_vis=1.  
20 Ramirez v. Wyeth Laboratories, Inc., 686 N.Y.S.2d 602, 1999. 
21 Ramirez v. Wyeth Laboratories, Inc., 686 N.Y.S.2d 602, 1999. 
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endangered Ramirez’s health, she continued to represent women harmed by their use of 
Norplant. Shainwald also informed other lawyers of her belief that Norplant was a 
dangerous drug that should be removed from the market.22  
While Shainwald’s feminism motivated her to litigate against Norplant, she was 
an outlier. Most of the firms that filed suits against Wyeth-Ayerst had no association with 
feminism or the women’s health movement. Their blitz of lawsuits was part of a growing 
American trend. Some lawyers saw mass tort litigation as a quick fix for societal issues 
such as poorly tested pharmaceuticals and workplace discrimination. Others saw it as a 
highly lucrative venture and cared little about its social value. More likely, many class 
action lawyers hoped to make positive changes in their clients’ lives while also earning 
significant sums of money.23  
The possibilities of a profitable class action suit against a large and wealthy 
pharmaceutical company motivated many lawyers to become involved. Many of the same 
lawyers who got involved with Norplant had profited from the massive silicone breast 
implant settlement in 1994. The plaintiffs in the silicone breast implant suits suffered 
from dizziness, joint pain, muscle pain, headaches, and chronic fatigue. Lawyers filed 
more than 16,000 class action lawsuits in both state and federal courts on behalf of 
women suffering from these complications. In 1994, in the largest class action settlement 
 
22 Ramirez v. Wyeth Laboratories, Inc., 686 N.Y.S.2d 602, 1999. 
23 Mary Ann Glendon, A Nation Under Lawyers: How the Crisis in the Legal Profession is Transforming 
American Society, (Cambridge: Harvard University Press, 1994), 272; Walter K. Olson, The Rule of 
Lawyers: How the New Litigation Elite Threatens America’s Rule of Law, (New York: Truman Talley 
Books St. Martin’s Press, 2003), 129-152. 
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to date, the 440,000 plaintiffs and their lawyers were awarded $4.25 billion.24 Law firms 
quickly began to target other medical devices containing silicone. Norplant was one of 
them.25 
To attract plaintiffs, lawyers used a number of strategies, including advertising, 
calling for referrals, and town hall style informational events.26 Because lawyers 
understood that Norplant had been pushed on women of color and women living in 
poverty, firms focused their attention on those populations.27 One firm in Philadelphia 
spent $19,800 on six hundred advertisements posted in the Southeastern Pennsylvania 
Transportation Authority (SEPTA), the city’s public transportation. The firm purchased 
the advertising package referred to as the “inner-city campaign,” because it targeted 
routes in low-income neighborhoods.28 Further, many other firms across the country 
advertised on billboards. One typical billboard in Houston featured two white male 
lawyers standing side-by-side sporting warm and inviting smiles. The billboard urged 
Norplant users to contact their firm for more information on how to become involved in 
the growing litigation.29  
 
24 Angell, Science on Trial, 27; For additional reading examining silicone breast implant: Marsha L. 
Vanderford and David H. Smith, The Silicone Breast Implant Story: Communication and Uncertainty, 
(Mahwah, New Jersey, Lawrence Erlbaum Associates, Publishers, 1996); Susan M. Zimmermann, Silicone 
Survivors: Women’s Experiences with Breast Implants, (Philadelphia: Temple University Press, 1998). 
25 Louise Palmer, “Injustice for All,” Vogue, October 1, 1996, 248, ProQuest. 
26 Walter K. Olson, The Role of Lawyers: How the New Litigation Elite Threatens America’s Rule of Law, 
(New York: Truman Talley Books St. Martin’s Press, 2003), 148; Leslie Laurence, “Your Perfect Birth 
Control… Blocked,” Glamour Magazine, September 1999, 308; Arthur Gonzaléz interview by Justina 
Licata, Skype, November 7, 2018.  
27 Angell Science on Trial 70. Also, the growing numbers of personal computers, a tool that became 
popular in the mid-1990s, helped attorneys produce lawsuits quickly. 
28 Scott Farmelant, “Trolling for Torts,” Philadelphia City Paper, July 13-20, 1995, accessed on February 
12, 2019, https://mycitypaper.com/articles/071395/article003.shtml.  
29 Laurence, “Your Perfect Birth Control… Blocked,” 379; Gonzaléz interview by Licata, November 7, 
2018.  
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Firms also used town hall style meetings to attract plaintiffs. These meetings were 
typically advertised in local newspapers and they often took place in hotel conference 
rooms, particularly in metropolitan areas. At the meetings, lawyers presented a slideshow 
discussing Norplant’s developmental history, its unethical and problematic clinical trials, 
and the many side effects linked to the contraceptive device. They then informed the 
audience about their case against Wyeth-Ayerst, and how possible plaintiffs could join 
the litigation. One lawyer stated that close to ninety-five percent of the women that 
attended his firm’s town hall meetings agreed to participate in their class action suit.30  
The media coverage aided lawyers in their recruitment. In 1994, newspapers, 
magazines, and television news media reported on the growing number of class action 
cases against Wyeth-Ayerst, often featuring plaintiffs who had suffered from extreme and 
unusual side effects. Much of the media’s coverage painted Norplant as a dangerous 
drug. One of the first nationally televised profiles was on Connie Chung’s CBS news 
show, Eye to Eye, and it featured several women who suffered painful Norplant removals 
that caused scarring and numbness.31 A wave of national and local television coverage 
across the U.S. followed. One local Dallas stationed focused their story on teenage 
mother, Melissa Diaz, who suffered a stroke six months after her Norplant device was 
implanted. During the interview, Diaz told the reporter, “I really can’t do much for 
myself. I have to have somebody else pick me up, help put me down.” The report went on 
to discuss possible links between Norplant and autoimmune diseases associated with 
 
30 Gonzaléz interview by Licata, November 7, 2018.  
31 Laurence, “Your Perfect Birth Control… Blocked,” 379. 
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silicone breast implants. Two days later, the same story was televised on a local Los 
Angeles channel.32 
Participating in the mass litigation as a plaintiff was fairly simple. Many women 
signed up for cases over the phone without putting down any personal funds. If they lost 
the case, they did not lose any money, but if they won or settled, plaintiffs were 
guaranteed a small portion of the earnings. The great majority of the lawsuits addressed 
an array of complaints--from minor, unpleasant side effects like irregular bleeding, 
headaches, weight gain, and nausea to harmful, irreversible conditions including nerve 
damage, blindness, and strokes. Because virtually all Norplant patients experienced at 
least one side effect, all users were possible plaintiffs.33 
In the end, about fifty thousand Norplant users signed up to participate in over 
two hundred class action lawsuits across the country. Many of the plaintiffs were either 
women of color or poor women or both. For instance, one Houston firm, Laminack and 
Gonzaléz, recruited somewhere between 450 and 500 plaintiffs. The majority of these 
women were Latina, and many had received their Norplant device for free as part of their 
Medicaid coverage. Lawyers like Gonzaléz and Laminack targeted poor and minority 
women because they knew these women used Norplant at a higher rate than white and 
middle class women. Yet their litigation altogether avoided addressing how coercion and 
population control impacted their plaintiffs’ experiences with Norplant.34  
 
32 “Transcript,” Dallas, Texas KXAS-TV News Five at 10 pm, August 11, 1994, box 239 folder 3: RHTP 
[program B&B] contraceptive- Norplant, 1994, BHR, SL. 
“Transcript,” Los, Angeles, California KNBC-TV Today in L.A. Weekend at 7 am, August 13, 1994, Box 
239 Folder 3: RHTP [program B&B] contraceptive- Norplant, 1994, BHR, SL. 
33 Laurence, “Your Perfect Birth Control… Blocked,” 379. 
34 Gonzaléz interview by Licata, November 7, 2018.  
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In the mid-1990s, as the litigation grew, one legal publication largely shaped class 
action lawyers’ arguments against Norplant. Mealey’s Litigation Publication was a niche 
legal publication that created a bimonthly newsletter called Mealey’s Litigation Reports. 
The newsletter’s readership consisted mainly of attorneys and other professionals 
interested in class action litigation. Each report focused entirely on a litigation topic 
gaining national attention such as asbestos and tobacco. Following the publication of 
each newsletter, Mealey’s continued to research the litigation’s development and collect 
relevant documents. Mealey’s subscribers could request access to any of these 
documents.35 
In 1994, Mealey’s published a newsletter dedicated to the growing Norplant 
litigation. The publication instructed lawyers on how to become involved in the litigation 
boom, and it examined possible arguments against Wyeth-Ayerst.36 The newsletter 
reported that many of the firms participating in the silicone breast implant litigation 
believed that the silicone rubber that encased the hormones in Norplant were making 
women sick. Because many Texas-based firms had partaken in the breast implant 
litigation, much of the discussion around the alleged dangers associated with silicone 
rubber in Norplant occurred there. In their Norplant newsletter, Mealey’s featured one 
Texas woman’s allegations that the silicone in the contraceptive device caused her to 
contract scleroderma, an autoimmune rheumatic disease that causes skin and connective 
 
35 “LEXIS Acquires Mealey Publications, Inc.,” News Breaks, August 7, 2000, accessed on March 8, 2018, 
http://newsbreaks.infotoday.com/Digest/LEXIS-Acquires-Mealey-Publications-Inc-17778.asp.  
36 “LEXIS Acquires Mealey Publications, Inc.,” News Breaks, 2000.  
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tissues to harden and tighten.37 Her attorneys argued that the silicone rubber contained in 
the Norplant implant was seeping into the surrounding tissue and migrating throughout 
her body causing her injuries. They alleged that she had not been properly warned of this 
possible risk.38  
The newsletter featured a number of feminist documents from both the U.S. and 
around the globe. For example, it included a reprint of an UBINIG’s article on the ethical 
violations and coercion that occurred during Norplant’s Bangladeshi testing trials; a 
summary of Sybil Shainwald’s testimony against the FDA’s approval of Norplant; and an 
overview of the Native American Women’s Health and Education Resource Center’s 
(NAWHERC) reports revealing the Indian Health Services’ (IHS) coercive use of 
Norplant on Indian Reservations.39 Although each of these sources examined Norplant’s 
ties to sterilization practices, the summaries of these documents presented in Mealey’s 
Litigation Report brushed over the issue. Instead, the newsletter focused on Norplant’s 
insufficient testing trials, problematic side effects, and the cursory labeling that 
accompanied the Norplant systems. For instance, the summary of UBINIG’s 1988 report 
on the Norplant testing trials in Bangladesh included a discussion of healthcare 
practitioners’ poor counseling practices and UBINIG’s claims that the World Health 
Organization (WHO) left out some of the side effects associated with Norplant in their 
 
37 “Scleroderma,” The Mayo Clinic, accessed on February 20, 2019, https://www.mayoclinic.org/diseases-
conditions/scleroderma/symptoms-causes/syc-20351952.  
38 “Texas Woman Says her Scleroderma Was Caused by Silicone in Norplant,” Mealey’s Litigation 
Reports: Norplant 1:3 (December 1, 1994). 
39 “Native American Women’s Group Issued Critical Reports on Norplant,” Mealey’s Litigation Reports: 
Norplant 1:5 (January 23, 1995, 11); “A 1988 Report from Bangladeshi Interest Group Questions Norplant 
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reported findings. The newsletter neglected to examine UBINIG’s discovery of coerced 
sterilizations.40 Similarly, the newsletters’ summary of NAWHERC’s reports centers on 
the organization’s assertion that Norplant’s clinical trials and informational packets were 
inadequate. Only at the very end of the summary does the newsletter passively mentioned 
that NAWHERC’s reports also examined the use of coercion in the “trials, removal 
problems, cost and protocol of the Indian Health Service.”41 With Mealey’s Norplant 
newsletter playing a significant role in constructing lawyers’ arguments against Wyeth-
Ayerst, the lawyers ignored the issues of coercion and population control.  
 To encourage lawyers to participate in a nationwide class action lawsuit, the 
Mealey’s Publication often sponsored litigation conferences. In June 1995, following 
their Norplant newsletter, Mealey’s hosted the National Norplant Litigation Conference 
in Houston, Texas.42 To attend the conference, firms paid $595 for their first two 
attendees and an additional $520 for each additional attendee.43 Around five hundred 
lawyers, medical experts, and professionals came.44 The first day’s panels focused on 
Norplant’s development, FDA approval, the plaintiffs’ alleged injuries, trial strategy, and 
the punitive damages issues regarding claims of both emotional distress and bodily harm. 
Sybil Shainwald also spoke about her testimony in opposition to Norplant’s FDA 
 
40 “A 1988 Report from Bangladeshi Interest Group Questions Norplant Trials,” Mealey’s Litigation 
Reports: Norplant Volume 1:1 (November 3, 1994), 37-38. 
41 “Native American Women’s Group Issued Critical Reports on Norplant,” 11. 
42 Angell, Science on Trial, 83. 
43 “Mealey’s To Hold National Conference on Norplant Litigation,” Mealey’s Litigation Reports: Norplant 
1:10 (March 23, 1995). 
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approval and the problematic side effects and dangers risks associated with the 
contraceptive implant.45  
On the second day, the conference’s chair Turner Branch compared the Norplant 
litigation to the contentious legal battle over silicone breast implants. In the 1990s, 
Branch was the Senior Partner in the Branch Law Firm in Albuquerque, New Mexico, 
and he specialized in catastrophic injury, wrongful death, civil jury trials, and multi-party 
litigation. Earlier in his career, Branch acted as Liaison Council for the breast implant 
multidistrict litigation (MDL), and his wife, Margaret Branch was a member of the breast 
implant litigation’s steering committee. At the time of the conference, Turner, along with 
many other attorneys, anticipated applying the same arguments that had led to a 
tremendous monetary settlement with the silicone breast implant manufacturers to 
Norplant.46  
Day two of the conference featured three panels about the consolidation of the 
growing number of class action suits into a multidistrict litigation (MDL).47 This special 
legal proceeding established in 1968 allowed for the consolidation of hundreds or even 
thousands of cases against a single defendant. Following the consolidation, the case 
would be tried in one city with one set of plaintiffs’ attorneys handling the entire 
 
45 “Mealey’s National Norplant Litigation Conference 1995 Program,” Mealey’s Litigation Publication, 
(June 22-23, 1995). 
46 “Mealey’s National Norplant Litigation Conference 1995 Program,” 1995.“Mealey’s To Hold National 
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workload. MDLs were intended to prevent both parties from replicating document 
discovery, depositions, and motions. They stop corporations from having to fight several 
different cases at once, while allowing a single judge the ability to immerse themselves in 
complex litigation. By authorizing thousands of plaintiffs to present their case as a 
unified force, such cases could intimidate a defendant, even an extremely wealthy one.48 
In 1994, the Judicial Panel on Multidistrict Litigation (JPMDL), a panel created to handle 
the rapidly growing number of mass tort lawsuits against industries and corporations, 
ruled that the Norplant litigations would be consolidated and the case would be 
centralized in the Eastern District of Texas before U.S. Judge Richard A. Schell.49 By the 
time of the conference, over ninety class action cases, or about half of the cases 
representing Norplant users, were included in the MDL.50  
Turner Branch was heavily featured in the conference panels examining the MDL 
because he and Christopher M. Parks, of Parker and Parks of Port Arthur, Texas, had 
been appointed co-chairs of the steering committee in the federal consolidation of the 
Norplant MDL.51 As steering committee chairs and MDL managers, Turner and Parks 
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were required to direct the management and discovery committee, therefore in a sense, 
their role was to organize and represent other lawyers, rather than Norplant victims. They 
used the litigation conference to incorporate more cases into their MDL and begin to 
organize a legal argument based largely on the silicone breast implant suits.52  
Shortly after the conference, lawyers realized that scientific research did not 
support the claim that the silicone rubber in the Norplant device was poisoning patients.53 
While there was a link between silicone gel and autoimmune disease, silicone rubber did 
not cause similar medical complications. Forced to reconstruct their case, lawyers looked 
to feminist arguments about the pharmaceutical company’s failures to properly warn 
Norplant users and healthcare professionals of the contraceptive’s side effects and risks. 
The issue of informed consent caught their attention, but they ignored one essential 
aspect: the feminist analyses of the discrimination faced by poor and minority women. 
During the twentieth century, women of color experienced coerced and forced 
sterilizations at much higher rates than white women, and many women were not 
properly informed before their surgical sterilization procedures. Therefore, informed 
consent became a centerpiece of the reproductive justice agenda.54 Lawyers participating 
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in the Norplant cases utilized feminist definitions of informed consent to drive their legal 
arguments, but they refused to grapple with how informed consent impacted different 
plaintiffs’ experiences based on their race. By ignoring this nuance, they essentially 
whitewashed the plaintiffs’ identities.  
Though many, if not the majority, of the plaintiffs, were women of color and or 
women on Medicaid, lawyers did not address the plaintiffs’ race or socioeconomic status 
in the legal proceedings.55 It is true that when arguing a massive MDL with tens of 
thousands of plaintiffs, lawyers must in some way homogenize the plaintiffs’ identities. 
Yet since much of the feminist opposition to Norplant focused on how the drug was used 
to control minority and poor women’s right to conceive children, this omission requires 
explanation.  
It appears that lawyers believed that defending the reproductive freedom of poor 
and minority women was a losing strategy. At the time, the federal government was 
gearing up to pass the Personal Responsibility and Work Opportunity Act (PRWORA), 
which ended a sixty-year-old entitlement to federal government support for poor single 
parents and replaced it with state administered work for welfare programs.56 As discussed 
in chapter two, the PRWORA was the culmination of a growing backlash against welfare 
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mothers in which politicians and pundits vilified Black mothers and claimed they were 
irresponsibility having children out of wedlock while cheating the government out of tax 
dollars and living leisurely. In a political climate that supported the government stripping 
welfare mothers of their basic needs, lawyers did not expect much compassion towards 
poor women of color being coerced to use contraception.57 
 Attorneys may have also been aware of the challenges that minority women faced 
when attempting to legally prove discrimination. In 1989, legal scholar, Kimberlé 
Crenshaw, examined a number of anti-discrimination cases brought forth by Black 
women and concluded that the courts could not see discrimination that impacted minority 
women. Crenshaw’s research demonstrated that because Black women did not represent 
the experience of all Black people or all women, they were often excluded from 
discrimination policies and left unprotected.58  
 The lawyers just wanted to win the cases. Unlike Shainwald, they were not 
women’s health or feminist activists. They hoped to win their plaintiffs significant sums 
of money, but they did not approach the litigation with the hope of ending state 
sanctioned sterilizations, improving contraceptives, or rectifying a long history of 
reproductive injustices. Most lawyers saw Norplant as an opportunity to participate in a 
nationwide class action suit that, like the silicone breast implant litigation, could end with 
a profitable settlement.  
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 Therefore, when constructing their arguments, attorneys shied away from issues 
of coercion and population control, instead focusing on Wyeth-Ayerst’s inability to 
properly inform healthcare providers and patients of Norplant’s risks and side effects.59 
Although they used the term “warn” rather than “inform,” litigators working on class 
action cases against Norplant employed feminist arguments about how Wyeth-Ayerst’s 
actions impeded informed consent procedures. Lawyers argued that Wyeth-Ayerst had 
failed to provide prescribing medical professionals with adequate and accurate 
information about Norplant, its risks, and side effects and that Wyeth-Ayerst’s direct to 
consumer advertising campaign inappropriately minimized the risks associated with 
Norplant. Consequently, they argued that the pharmaceutical company was responsible 
for thousands of women’s negative experiences with Norplant.60  
When these arguments were tested in a series of bellwether trials, or test cases 
used in tort law to try a broadly disputed issue, they proved difficult to substantiate.61 
During the bellwether cases, lawyers presented plaintiffs suffering from a variety of side 
effects ranging from minor to severe. Many of the cases were tried in the Texas court 
system because it was known to be sympathetic toward plaintiffs in product liability 
cases. Texas is one of the few states in which all state judges, including those on the 
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61 “FDA Reaffirms Safety of Norplant,” Mealey’s Litigation Reports: Norplant 1:21 (September 8, 1995): 
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with Wyeth-Ayerst to improve the informational packets discussing Norplant’s risks and benefits. 
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supreme court, are elected, and there are no limits on the amount of funds an individual 
can give to any political campaign (plaintiffs’ attorneys often made contributions to 
judges’ campaigns).62 These circumstances made Texas a breeding ground for mass tort 
litigation. Norplant was no exception.  
In addition to the large MDL, other smaller but significant cases against Norplant 
were also happening in different parts of the country. In the late 1990s, one lawsuit’s 
bellwether trial was assigned to Judge Mario Ramirez in Hidalgo County, Texas. In this 
bellwether case, five different firms, one of which was Laminick and O’Quinn, 
represented the 4,500 plaintiffs. Because the cases in Hidalgo County had survived the 
pretrial motions that had terminated previous federal suits, plaintiffs hoped these cases 
would be victorious.63 To strengthen their case, Laminack and O’Quinn employed a jury 
consultant to locate potential jury members who would be sympathetic to a plaintiff pool 
dominated by women of color and poor women.64 Additionally, during the bellwether 
cases, some firms, including Laminack and O’Quinn, hired phantom jurors, or shadow 
jurors, to observe the trial and communicate their reactions to the jury consultant or 
counsel. One lawyer remembered meeting with phantom jurors for three to four hours 
after each day’s courtroom proceedings. The phantom jurors helped the litigators gauge 
the jurors' reactions to the trial. Despite these efforts, in early 1998, eight days into the 
trial, one of the plaintiff’s attorneys accused another of encouraging his client to lie about 
being examined by a particular medical professional and expert witness forcing a 
 
62 Angell, Science on Trial, 146. 
63 Arkin, “Products Liability and the Threat to Contraception,” 8. 
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frustrated Judge Ramirez to rule a mistrial. When releasing the jurors, Ramirez stated that 
he was “totally disgusted.”65 Wyeth-Ayerst’s defense attorneys objected to Ramirez’s 
ruling, arguing that the plaintiffs purposely forced a mistrial because they were likely to 
lose.66 Separately, in an unrelated disciplinary proceeding, two Texas attorneys were 
disqualified from participating in state Norplant cases because they had knowingly hired 
a legal assistant who had formerly worked for Wyeth-Ayerst. This left three thousand 
plaintiffs in Texas in need of new legal representation. Another setback for the lawyers 
occurred in September of the same year when after a jury in Brownsville, Texas listened 
to over two weeks of medical testimony, they only took two hours of deliberation before 
ruling in Wyeth-Ayerst’s favor.67  
Turner and Parks, the lawyers heading the massive Norplant MDL, similarly 
struggled to convince a judge that Wyeth-Ayerst was responsible for Norplant user’s 
suffering. By the late 1990s, over 160 class action lawsuits had been consolidated into the 
nationwide federal multidistrict case, involving 31,112 plaintiffs. 68 Once the MDL’s 
bellwether case was put to trial in 1999, it was apparent that the evidence against Wyeth-
Ayerst was weak. Like many other lawyers, Turner and Parks focused their case on the 
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issue of informed consent, alleging that Wyeth-Ayerst had failed to sufficiently inform 
consumers and prescribing medical professionals about Norplant’s dangerous side 
effects.69 They also maintained that Wyeth-Ayerst’s aggressive advertising featured in 
popular women’s magazines such as Cosmopolitan and Vogue led consumers to have 
unrealistic and false expectations, and because patients went to their doctor appointments 
with preconceived ideas about the new wonder drug, physicians were unable to conduct 
proper informed consent procedures.70  
 In response to these allegations, Wyeth-Ayerst Laboratories cited the learned 
intermediary doctrine, which states that a manufacturer of a product is required to provide 
all obligatory information about their product to the “learned intermediary” and not the 
consumer. In this case, the “learned intermediaries” were the prescribing medical 
professionals, which made them, not Wyeth-Ayerst, responsible for providing their 
patients with the necessary counsel regarding both Norplant and all other birth control 
options. The court agreed with this argument and required the plaintiffs to provide 
evidence that Wyeth-Ayerst had not provided prescribing medical professionals with 
accurate and or thorough information about Norplant and its side effects. The plaintiffs 
responded by presenting depositions from doctors and nurses, who professed to be 
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unfamiliar with all of Norplant’s side effects. For instance, many claimed they did not 
know that the contraceptive device could cause mood swings or depression.71  
To refute these claims, the defendants offered testimony from Dr. Anita Nelson, a 
board certified obstetrician-gynecologists and Associate Professor of Obstetrics and 
Gynecology at the University of California Los Angeles (UCLA) medical school. Nelson, 
who was deeply involved in Norplant’s testing in the 1980s and its introduction to the 
American market in the early 1990s, spoke with some of the women who participated in 
the studies and conducted trainings for physicians and nurse practitioners. In her 
deposition, Nelson drew attention to Norplant’s close similarities to other forms of birth 
control. The hormone used in Norplant, levonorgestrel, could also be found in a number 
of other contraceptive options, including an assortment of IUDs and emergency 
contraceptives. Consequently, because all Norplant devices came with informational 
inserts that discussed the drug’s side effects, she argued that all prescribing medical 
professionals should have been aware of the risks and that it was their responsibility to 
make sure their patients were also aware of the risks and side effects.72 In addition to 
Nelson’s testimony, the defendants challenged the credibility of the experts’ testifying on 
the plaintiffs' behalf by disclosing that none had ever prescribed Norplant to a patient.73 
Ultimately, the court determined that the plaintiffs did not “prove that even a single 
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healthcare provider who prescribed Norplant was not fully aware of the 26 side effects 
listed as ‘Adverse Reactions’ in the Norplant physician labeling.”74  
 This series of legal losses led to a very small settlement between Wyeth-Ayerst 
and the plaintiffs. In August 1999, the pharmaceutical company settled out of court with 
about thirty-six thousand of the fifty thousand plaintiffs. In the fifty million dollar 
settlement agreement, American Home Products, Wyeth-Ayerst’s parent company, 
agreed to pay each of these plaintiffs about $1,500.75 A Wyeth-Ayerst representative 
described their resolve to settle as “purely a business decision,” stating that the cost of 
fighting hundreds of cases was cutting into their ability to fund research.76 Having hoped 
for a much larger payout, one of the lead attorneys told the New York Times: “It's a total 
disappointment.''77 
Even though the courts ruled in Wyeth-Ayerst’s favor, the class action lawsuits 
and the associated negative media coverage gravely impacted Norplant’s sales. In 1991, 
when Norplant was first placed on the American market, its sales grew rapidly. In just 
under a year, over one hundred thousand women had been prescribed the contraceptive 
device in the U.S., and its sales continued to increase the following year.78 As the number 
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of class action suits grew and the media began to pay attention to patients’ horror stories, 
sales fell. Whereas in 1992, Norplant sales were $120.7 million, just five years later, that 
figure had plunged to $4.4 million.79  
Due to the steep decline in sales, in July 2002, Wyeth-Ayerst removed Norplant 
from the American market. The pharmaceutical company offered to pay for patients’ 
removal of the device through the end of the year.80 The Population Council considered 
introducing another implantable birth control device, Jadelle, which was FDA approved 
in 1996 and consisted of two implantable rods instead of six. Because of Norplant’s 
severely tainted reputation, Jadelle was never released in the U.S.81 
In the mid-1990s, the success of the breast implant litigation convinced class 
action lawyers to pursue a cacophony of lawsuits against Wyeth-Ayerst. These suits often 
involved poor and minority women who had been pressured to use the contraceptive. 
Lawyers argued that Wyeth-Ayerst failed to provide healthcare professionals with 
accurate and thorough information about Norplant. While the litigation failed to win the 
plaintiffs a large settlement, the class action lawsuits and the publicity surrounding them 
led to a decrease in Norplant sales, which ultimately led Wyeth-Ayerst to remove it from 
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the American market in the early 2000s. While many women’s health activists saw this as 
a success, much of the public remained unaware of Norplant’s problematic ties to 
population control and eugenics policies. Women of color and poor women continued to 
struggle against negative stereotypes painting them as irresponsible and promiscuous. 
 
 
 
 
 
 
 
 
150 
CHAPTER VI 
EPILOGUE: NORPLANT FORGOTTEN 
 
 
While many feminists celebrated Norplant’s removal from the American market, 
much of the public remained blind to the drug’s link to population control policies. 
Reproductive justice and women’s health advocates hoped that their campaigns 
highlighting Norplant’s risks and links to eugenic practices would inspire pharmaceutical 
companies to develop better birth control options and encourage governmental 
institutions to pass regulations that would ensure women would not suffer from forcible 
or coercive sterilizations. Instead, the public quickly forgot the controversy surrounding 
Norplant, and in 2006, just four years after Wyeth-Ayerst stopped distributing Norplant 
in the U.S., the Food and Drug Administration (FDA) approved another contraceptive 
subdermal implant that would later be used to temporarily sterilize incarcerated women. 
 In the 2000s and 2010s, reproductive justice and women’s health activists made 
efforts to inform the public and policymakers of the history of reproductive abuses linked 
to long acting reversible contraceptives (LARCs), including Norplant, intrauterine 
devices (IUDs), and injectables, like Depo-Provera. These efforts inspired important 
changes in feminist discussions around reproductive rights. Today, many women’s health 
activists and organizations have adopted a reproductive justice platform that seeks to 
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represent all women’s reproductive experiences. Additionally, feminists and women’s 
health organizations speak out against incentivizing policies and coercive prescribing 
practices that encourage the use of any particular method of birth control. Still, much of 
the public, including lawmakers, judges, and healthcare professionals, remain unaware of 
Norplant’s history and LARCs connection to forcible sterilization practices. Therefore, 
the potential of reproductive abuse persists.1 
In 2006, the FDA approved a new subdermal contraceptive device known as 
Implanon. Unlike Norplant, which consisted of six progestin filled rods and prevented 
pregnancy for a five year period, Implanon was made up of a single progestin filled rod 
that was inserted under the skin of a woman’s arm and prevented pregnancy for three 
years.2 Because it used the same technology as Norplant, some Implanon patients 
experienced similar side effects, including irregular and unpredictable bleeding, weight 
gain, mood swings, and headaches. Before it was made available in the U.S., Implanon 
underwent eighteen clinical studies in countries like China, Finland, Indonesia, Sweden, 
and Thailand. While none of the drug’s trials included adolescent girls, Merck & Co., 
Inc., the drug’s developer, relied on a study of teenage girls’ responses to Norplant to 
support doctors’ prescribing Implanon to adolescents. Many scientists examining 
Implanon’s testing trials similarly made direct comparisons to Norplant’s studies. The 
science community that supported Implanon’s FDA approval did not discuss Norplant’s 
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and Implanon’s potential link to population control practices in the U.S. or around the 
world.3  
A few years after Implanon was introduced to the public, Merck & Co., Inc. 
released Nexplanon. This subdermal implant used the same contraceptive technology as 
Implanon with one slight alteration: Nexplanon implants contain sulfate barium, allowing 
it to be visible on X-rays. While this modification was minimal, it made it easier for 
healthcare professionals to monitor the device after insertion. Once Nexplanon was 
approved for use, Merck & Co., Inc. stopped distributing Implanon devices, replacing 
them with Nexplanon, which are still available for use in the U.S.4 
 In May 2017, General Sessions Judge Sam Benningfield signed an order that 
offered an early release date to inmates in White County, Tennessee, who were willing to 
undergo a temporary sterilization procedure. Participating male inmates would undergo a 
vasectomy, and female inmates would have Nexplanon inserted, and all who chose to 
participate in the program would be released thirty days early. While the order was in 
effect, seventy inmates, thirty-two women and thirty-eight men, agreed to submit to the 
temporary sterilization procedure. This represented about thirty-two percent of the 
prison’s population. Benningfield told a reporter that he developed the incentive program 
after removing several children from the custody of their formerly incarcerated parents 
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91S-97S; Arijit Biswasa, Osborne A.C. Viegasa, Herjan J. T. Coeling Benninkb, Tjeed Korverb, Shan S. 
Ratnam, “Implanon® contraceptive implants: effects on carbohydrate metabolism,” Contraception 63 
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because a mother tested positive for drug use and witnessing how a parent’s drug use led 
to child neglect.5  
 Deonna Tollison was one of the women who agreed to participate in 
Benningfield’s order. In 2017, Tollison was a single mother struggling to raise her two 
youngest daughters and her niece. Following years of substance abuse and run-ins with 
the law, she was struggling to regain control of her life when she violated the terms of her 
house arrest by making unauthorized trips to the grocery store and allowing the batteries 
in her ankle monitor to die. These breeches of her agreement led Benningfield to send her 
back to the county jail to serve out the rest of her sentence. When she became aware of 
the order, Tollison quickly signed up to receive the Nexplanon implant in exchange for 
thirty days off her sentence. After sitting through the required prenatal health class that 
emphasized the effect drugs could have on a fetus, Tollison underwent the Nexplanon 
insertion procedure. Following her release, Tollison told a journalist that the opportunity 
to escape prison was what motivated her to participate in the program. “‘People will do 
anything to get out of there,’” she said.6  
 Just weeks after Benningfield initiated the order, the media made the public aware 
of the incentive program, and a backlash ensued. Journalists and lawyers compared the 
order to other incidents of forced and coerced sterilizations and the U.S.’s long history of 
eugenic practices. One constitutional law attorney called the order an “outrage” arguing 
 
5 Elise B. Adams, “Voluntary Sterilization of Inmates for Reduced Prison Sentences,” Duke Journal of 
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that Benningfield should lose his position on the bench and his license to practice law.7 
Benningfield claimed that this response to the order shocked him and that he was 
surprised to learn that many of the participating inmates agree to undergo the procedure 
only to secure the early release. He altered the order to include a document for inmates to 
sign stating that they were not participating in the program exclusively for the reduced 
sentence. But by this point, the opposition to the order had grown to include several 
powerful institutions and individuals, including the American Civil Liberties Union 
(ACLU) in Tennessee, district attorneys, and state legislators. Ultimately, Benningfield 
ended the program after six weeks and before any of the male inmates received their 
vasectomies.8  
 In the early 1990s, doctors and the medical industry told women that Norplant 
would give them greater reproductive freedom. For some women, the prediction was 
correct. Yet for many poor and minority women, the potential for abuse tarnished their 
relationship to Norplant. Although many feminists considered Norplant’s removal from 
the American market in 2002 a victory, the battle for reproductive justice continues. For 
many health activists, Norplant remains a vivid reminder of oppressive sterilization 
policies aimed at poor and minority women and contraception’s link to population control 
politics. 
 Even though most of the general public has forgotten Norplant’s connection to 
temporary sterilization practices, reproductive justice activists have not. Instead, this 
 
7 Daniel A. Horwitz, “Eugenics is Illegal,” Supreme Court of Tennessee Blog, July 21, 2017, accessed on 
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women of color and indigenous women led movement used Norplant’s history to 
encourage significant changes within the reproductive rights movement. In the past, the 
reproductive rights agenda focus almost exclusively on issues related to white women’s 
reproductive experiences: access to effective birth control and safe and legal abortions. 
Thanks to the work of countless reproductive justice activists, today, about thirty years 
after Norplant's FDA approval, this agenda has been transformed to better reflect the 
experiences of all women, including concerns around coercive sterilizations. The swift 
response to Judge Benningfield’s order shows that this more inclusive and sophisticated 
approach to reproductive rights has permeated beyond the feminist movement.  
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